var title_f16_11_16560="CPAM type 1 chest x-ray";
var content_f16_11_16560=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F76692&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F76692&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Chest radiographs of a type 1 congenital pulmonary airway malformation (CPAM)*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiographs (posterior-anterior and lateral views) showing a type 1 congenital pulmonary airway malformation (CPAM) in the right upper lobe. The large cystic lesion was an incidental finding on a film of a one-year-old child who ingested a coin. The coin is visible on both views, lodged in the esophagus.",
"    <div class=\"footnotes\">",
"     *CPAM was previously known as congenital cystic adenomatoid malformation (CCAM).",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher M Oermann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16560=[""].join("\n");
var outline_f16_11_16560=null;
var title_f16_11_16561="Atrial switch repair";
var content_f16_11_16561=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50524&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diagram of the atrial switch repair",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 403px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diagram of the atrial switch repair (Mustard or Senning procedure). Patch material is used to create a baffle that diverts the deoxygenated systemic venous return from the inferior venous cava (IVC) and superior venous cava (SVC) into the left atrium (LA) where it crosses the mitral valve and into the left ventricle (LV) where it is pumped into the pulmonary circulation via the pulmonary artery (PA). The baffle is positioned in the atrium so that the pulmonary veins which are located posteriorly drain into the right atrium. This allows for flow across the tricuspid valve and into the right ventricle (RV) where blood is pumped into the systemic circulation via the aorta (Ao).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: the Multimedia Library of Congenital Heart Disease, Children's Hospital, Boston, MA, editor Robert Geggel, MD, www.childrenshospital.org/mml.cvp, with permission.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16561=[""].join("\n");
var outline_f16_11_16561=null;
var title_f16_11_16562="Stage II sarcoidosis CT";
var content_f16_11_16562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 287px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEfAXQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5tg1/XZpo4l1rUQzsFGbqTGSfrXQwWXiyaISDX7hVPTdey1x+ljOp2gHeZB/48K9r8H6BfeIrqCy02NmYgZJBwg7k0AcXbaR4yuplht9bupJWOFVbuYk/pXoNl8EPihcWK3U3iS2s1bkJcajcB/yCGvfPB/g/TPB8G5Qt1qRGGlY8A9wK6IyvM2Zj/wABNMR8wp8EfiW7EL4qs/r/AGjc4/8ARdCfBL4lsxA8V2XHf+0bn/43X06hbBVc7f51YtoGdsFcDrntQB8tN8EviWAceK7M4441G5/+N1MnwJ+J7rn/AISmyA99Ruf/AI3X1XDEoJwM47kdanwcgqfunGPWgZ8of8KF+J+Mnxbp+P8AsJXX/wAbpf8AhQnxQ/6Guw/8GV1/8br6uJ5xwAaBkcBc/SgD5S/4UH8UCcf8JZp+f+wldf8AxumJ8B/ic+dvi2w4OP8AkI3X/wAbr63S3lcfdCD1Y5/SpkhiVsOxdh1BpAfIf/Chfidkj/hLtPyP+oldf/G6B8BficSQPFunn/uJXX/xuvr+Zoo4C0ihV7CsxACDjIz0I6GgD5UHwE+J5/5m3T//AAZXX/xuj/hQvxPzj/hLdPz/ANhK6/8AjdfVyCRyM5x60P8AJksRz0zQB8of8KF+J3/Q26f/AODK6/8AjdL/AMKE+KGOPFlgf+4ldf8Axuvqvf8ALmTYijuxwKqXWpWUYBa/tSf7okFAHy8PgL8T8/8AI2WH/gyuv/jdKPgJ8TznHi3Tz9NSuv8A43X1BFqlqy/LLG2Bj5XBBFSR3EJwVDevBpgfLR+A3xOUZbxbp4HvqV1/8bpp+BHxM/6G7Tyf+wldf/G6+reJN6k/dI6+9RtGHJA4IOQaQHyxB8BfifNMY18WWAIUNk6ldY5z/wBM/arC/s9/FNs/8VbpwH/YSuuf/IdfUYPkxLK/AU4bJ6Kf/r4rXhYPEADnbwfagD5Eb9nz4pKP+Ru03POANSusn6fu6SD9n74pTQRyr4t08LIoYBtRugRkdx5XWvrWewt5762vZULXFsGELbiNoYANxnBzjuKlUsQSQQcnFAHyR/wzz8U/+hu03/wZXX/xqmt+z38VFGR4s09vpqV1/wDG6+uFznHI9s0/c2eDn8KAPj1/gL8UY8eZ4ps1ycDOo3X/AMbpT8BPifz/AMVZYHH/AFErr/43X2BcRmeB49xQsOo7VjorxfJI3zA9h2oA+Vh8BfigT/yNdj/4Mbr/AON08fAH4oH/AJm3T/8AwZXX/wAbr6qjjPmbwzMcYI7flUz/AHT8rDcMbh1FAHyd/wAKC+KGM/8ACWaf/wCDK6/+N0D4B/FA5/4qzT+P+oldf/G6+scqqKpJ4xgt1oAO4YGVPWgD5O/4UF8UMZ/4S3T/APwZXX/xuj/hQfxPx/yNun59P7Suv/jdfWAPGAT1pzgEDkg/SgD5N/4UH8UMZ/4Syw/8GV1/8bqGb4FfE+LJbxTZEDqRqNz/APG6+tm6c8DpikP3QoHH6mgD5EHwT+JROB4ssifT+0bn/wCN07/hSHxLwT/wldlgf9RG5/8AjdfV81lE+Ao2D1qjPBJEowpYdiKYj5it/gZ8Sp/u+MNOX03aldDP/kOsvxD8H/irosLTf2jNfxKMlrO/mcAfiBX1UrkBVPJ/h9KlguZYmX5sKeqnkUAfCk1r4tglaO41q8hkXqsl3KDUfl+KeP8Aie3fPT/TJa+3fEHhbw/4njP9p2aQSkYWSFQp/GvG/Gvwb1XTA1zoTJe2S5IQnMij8KQzwYp4oBwdeus9x9sl4qreXXiS1iaSTXL0qBn5buSurv7eW0mK3cUsUynDLIu01z+vY+wSYHY/yoA9G+DesanP4Yumn1G9lYXjDLzsxxsT1NFUPgp/yKt1/wBfr/8AoEdFAHkGjDOr2IP/AD3T/wBCFfcnwys7PR/A+lxWSf6RPEHnkI5ZvavhzRf+QxY/9d4//QhX3T4DJbwnoqhQSYAMmmhHRBdpGcFicjNWEhaQ5bAz/F6fWprK0Bw0xOR0B7VpKqooCjBoAgt7UIOcEjoasAfKAccdaVsAbT09aaSTjbgk8AetAxQAA27le5qVImlXEaHaR948VagtVXaz/M4HTPA/xqHVNX0/So9+pXsFsMZCs3zEey9T+FIB6WYGPOkz7DirKIq58tAvvjrXmmofFixN61no1pLKfui5m+RAfXafmNchrHi7U7+e4im1OSWF12sLbKR/TFOwHr+ueJtE0UbtW1eCD/Y38n8BzXPQfFHQpS32dJzEG2iVgFU18+3qxm7ZoYiIuoJ/rTre5kuItjsAqngAdaLCPoXXfFMK6eJ7V7a4uTyieZjaK5W48Ta9PE3kXVsgUZbKghK8r1CO4tbVDM5Vn+7zyRUNjKbiV4rmVhEcMTnkAUwOrufGPiQSyG01SKWJM7nhyFFZUni/xHext5mpSSqSRggcViXYigZ4LJibdz8p+7j8Kt3YS3hW0sIJjIoy8o5BzQBWudX1m7BmmvZwF+XCOVH5VHewXJhieYylJOjnvVXdIk0ZkPf7tasl+97sEke0RjaqjkE+tIDPku2ghEUE8iAD5gDjn1q3ba3q1uImtr+Xj1Y4FP1C08jRoleBN8rFjKRzjNZkMbSiXJUFRnr1FAHfaH8UtYsmjivYYbm2zhjzu/CvRH+I+ix6ZHfy7wH4EWOcivALYSzSwwDnJOFUc1pXNpctZLILdmgiziQL0oA9E1j4uwTWzxxaTMI2xhhIOzA/0rqfCnxL0jUpjGT9jncZ2TsAGrwIJ51zDGxJQjc7AZwKfI9pLJMIv3EcYAEp60AfW8d+0i7o0QrjOd2QfpSC+l3kGNMA46mvFPh145Ol232PWZ/tFpIwEcoOWT65r1mG/trnD2siyxsdwZTnNAzTOqQrL5cylWPtmrMdzbswAkQMegbgn864D4jeIZ/D2mLeRQoZmOELDIHbmvEr7VvEGpzC6l1GWRGBIEbHansKLAfVc9ykeVUhpP7oNUGwUJ5LDvXyo93qMoZpLq4wgwW3EflXQ+EfEXiO0uMabd+bD3W4O7NArn0PEIYAoiyRknJctyTk/rV5ZFc8nGDivI4fiVef2fcvLZxTz27bD5SnBGOpqrp/xSmktGmm0qM+U28bJeG/Giwz2SVY5jtcE4qAwMGLRSH/AHa4DSfiHaakf3VvJEE5lO/O38a2LLx5oUs4tjqEKTSHhy4Cfn60WA6JHeMnzB34NKblTkbiPXNT201tNBmC4inTuY2DD9Kd5NvK4ULwec+tICFHB+ZQCx6ZpWJVck8dOBWg8EToF2AYHBHUVnThoWIlGVH8WKABgCBkfQU0lSDu59vShSJD8rEr14P6U4jdyScZ6UAU5rJZ/ukJn09aoyWrISJBlT071snhtxJx2poIYBiMD0NMDnyqq+Od+Bu/pVyzu2hJKs4Y8deKtXVoWB8sg56is4qU+XbtUcbRxQIxfGfgXRPGFr++hFpqByBcwoC2ffNfOPxc+GGs+ENGnvJmS400ZXztw3ZI4yBX1OGMTfu5CCTjJPFed/tIP5nwpvVLAneCR9KAPEvgp/yKt1/1+v8A+gR0UfBT/kVbr/r9f/0COikM8i0PnWtPH/TxH/6EK++Phxar/wAIjpMrfe8heK+B9D/5DWn/APXxH/6EK+//AIe4PgzSCOT5A4NMDqByTnuMninH72ASGI4qMEhMj8fcVIgHByeOhoAb99wRnPueM0BW87eWEWPuntRd3FvaWzT3T+VEvLE9T9K8z8V+KpHkM8dwI7EHESn7zmgR12v+Kp7aeSFphaWyD5rgpyT7DvXhniS4jvNVa4S6nvmLf6yRifyzWj4w1860IlmaQRwqTkDgmsZtKu4bOO7ZFFvJ90lsH8qYBqVpeW8KyyRsI5F+WQjg+2aj0C3M0hWAst0M4OCV/GmNeTXCJb3MrmJTkA9Me1dXb3Oiw6YbPSpJbeeTEtxLORnA6gUAcjPb3j3DQxgySFtu1OhPpVxFvNBaL7Zpqskpxl8gg+1Ml1OazJWzlAhEhbfjJrGubq5nuQ01zLJhtw3NkUAdX4g0q78iG52SSxuNy4QnaO9c3AhIn+RmUDGR2rrfDPjy90/zLa+CSW037vLDJUH0qh430a60i6ikUBrW5/eK6HrnnBoA5xCUcjJbaOhpYLhp7pVib7OrHBOcgD1qaC4WAMHVWLkDkdqo3kaJckQ5ZSvANICxeoomZIpFmRTgOB1NPhmuYETYqmMn7vcUPbGK2imYgxsOADyD9KksrO4vY5vs+SkS72YdgKAOksdNttY0xBquqpYxRHCgqW/Djmr0fgbR9nnw6wbi1QfOYchh+eK4+1cQWADB2ZpdxbGcCusuNbSLw9DoFtaJGWDSNOjjJ780wH2nifw74dkl/sPSPtN5jAuLnhkrEv8AxBq/iFCb6WMK77Y44kC4Hv61hshTKtgvnbk96IH+z4CnIzSAsSIYi/kO3lsuxmXtWc+MlF3M5PIAyT+Fdz4U8C6pr8is0b21nnJkf+IfSvWPDngXR9EUGO1E8u7O6X5ifcUAeKeFfCWra/dRIbd4rP7rSHjH4V7/AKBo1vo9mlrBuZY1ALMc5NakEMaHEaqqeijGKljiCw98k4zQMxPFGlQa1pE1jdRKwblcno3avmnUIr/Rr2fTpd6COQsARjcPX6V9Xy26ttwTwetcV8QvBC6/At1Zqq6nCCVPZx6GgR4RbTXU1ssUaeaQSceuat6RAsdxI87PbyIN3AOD7Gqd+11ZXrLPbyWt5btkg5A4/DmtG+1qe7ZpGtYMGEByq859aYGZpmsT6Xqk9zbss3mOfMSQfKwNXdVvgGVY7bybW4OTCByTWe+nNcLi2kQTSjciOQBgdeatCGZY47m9zEYR8qN/G3tSAjtJ5ba5kt7J2Td8shI7VWWS3WaSKeLMY+6/oaqw3Mw1bzUG9nbds7H2qxFqMEOqSyXdlvjHDR5x/wDqoAt6J4mvrOSO1sNVu7Yu2NsR+6e2fQV2w+J2u+Hx5WpT/wBqD7vXB/A1wN3a6ZFb21zpgKRXgEpPPy57ZqNvKW62Xk++IAYZBlvagD3LSvjJaxQRLqulXEO77rRurZ+vNdbY+OPD2uRKtvfwxynpHK4Br5q0/wAq5meyneVSxwjOlMk0gaTNvmlV7gH+Ejcw9iO9AH1fbETIxgww7spzTwCpOOnpXzh/wlWsWVtbrpGozQbfvKzcn2Ndh4W+L0nmLa+I7cLkhRcLkk+5GKBnr+d+7B3Y6jPFAOcZwTVPT7621ONprG4jlhC5BQjj6ip7VnlUARMGAyw64oAlznkcqP1qGeGO4T5gQc8FR0qUvhyOp/u+lKQM/O2B6CkBkT23k7gjce46V5R+0FtX4ZaiCSXL9z7V7U4URlSvy88dSa8b/aRtjH8N7plxs3H8OKYjxj4Kf8irdf8AX6//AKBHRR8FP+RVuv8Ar9f/ANAjopDPItD/AOQ3p/8A18R/+hCvvz4fvnwdpClWOIAeK+BNB/5Dmnf9fMf/AKEK/QL4b2txN4K0p44xjyAAxOP/ANdMDoVcLhUaq+rapbaRYS3d44CIOF7sfQUBBBPK9wwVY/vknp7ivI/G/iq01q5ItS5+zyfKmPlYjjJoEax8aR6gL9r6B8ov7hH6D6153d3lpO7y36F3ByhDHFW7fU7i+vhbuqvcupGAg69qztU05bSM29z5j6gTkoo6LTA1LsTroKSwpGI522hWXJx61j3FxI8MSXNy3lx/di9DXVeF2a88PiLyTPJExADcbM9K5bULF7e/mivVCMuc4OeaALMEcl/CGtGjj+zqSyMQPy9axrja7u7EFzwRjirAify3aNGZRyxAqCFQFDKw3BunrSAvQG0sRvZBc7ht8s54zWbfwjduAMak4C+la0WpIk0skUaNhdrZXv6itbwBJpk8uopq1vPcK6fI2MiM+tMDlEaAIqoDNJxg+ld/4c1Sx1ixl0TXHeOaRcwvjIQjtXIT2kEF/OIZAY42IQryTn2qbw+6rrdqZiCC+GYjpQBuWngrZqcovnb7JEODj/Wc1ka7pvk6p9ltIQh4CDcCTXrnjd4rmzjs7KVU2xZeQHkADPFcd4CsdA1AXdxql02ISUjkkJDMaAODudOktpmgnkQSE4OD0q9pWn3FtdxC4mSC3fjcHzvHoRTLuG2h1u6VhJcW+8mPDfMfxNZV4jGcSTbwDnap6gUAamoxC1nkto5AY924kVQnZYp5ZYC539GPXFWtFs5L/McZAigXzHLHHy09oFaQ/ZZPPHQKq/pigCtawPMggSMvNKeAvJFeu+AvhzbWlpBf6tH5l0Tnyn6L9RT/AIbeCG06NNT1JR9sblIyPuivSymU+9jIxxzSAcqgBFjAVB0A6YpWZRg9zwarkSoyjdjIxgDr70RMS7Be3GT3oGTwr94ngE8VOByDnJXn61GgAQbj9Kk4Geccdc8UgE5Iz6mnDAbp0pp4wD96lUFTnHJ7UAcl4/8ABtv4msmdFVNQUfu5cckehrwZtOuNM1aS0vco6DawYcV9UdCRke+a89+K3hj+1LL+0rVCLu2+ZgByy+9NCPFZNB1C8eOeyi860ilBZ0GSgqv4rv2vNSijDHyoIguB0JroPCOpjR/E0VxcSMNNu8xXC5JA/Dt1rC8TadJZ+ILuEuDGJCwkbncG5AH0zQBm2cEd3G0iyFZ05CLwSPXNZckrTzyfNvfP/fRrbtbNZvNiEgibPDLySPerul+GH02SS91eJxEOYT03+9AFvUtAuf7I00oIrexRRuDttKjHYd6wpG062mHWYD5g3SrnivXbnXZrZ5nSNQuxYU4AHQZrDgsZJZTDG6eaBgLmgDRJuWu/tUqP5cg3RsOn0rPjmZrnhj5m4ncecVpW2kX15EIrU/v4usfmdfpVe+aGCQQspFwgPm7OMGgBMPcwSykMrAZJHPT2qfRNVNsYnW1F0yYLCUHBHpSaBrB0/V7adYg6oRlGHDL6V1eqTaNcgawii1lyS8A58wn09OaAOy8IiH7ILvRHfTL0HfLbbcrL7cnivSPDHiS11GRoz/o9yPlaF+M+4Jr5ctdX1QCfybgsc71Yn7oHYV2sPimLX7G2tNXl+xagi7UuFJ3fjQB9JTwxyLh1xn+IcH86py2zxZKgOnYgZIry3w98TINGtYrfW5XurfIjNwoztA4yR6V6tpt5b39rHeabcx3NnKMoyHI/A/0pDKg5B+bOByfU/SvIf2lnH/Cr7nBGS5GR3G2vapLVbiNJCvlTbckKQRn0Jxz9a8Y/aZEkfw0uopgFbcSoA+XG3tTA8M+Cn/Iq3X/X6/8A6BHRR8FP+RVuv+v1/wD0COikB5L4dx/wkGmZ6faos/8AfYr9F/hxMJPBmiRxD5UtUycfhX5zaCca5px9LmP/ANCFfoL4c1JfD/wks9RYL5kdmGjVj99sHaKAMD4n+JjFqNxo9hhZG/18h/hBH/1q8ptnsZb3YS0bIpLyA/KxFarXUGtaBeX+oiT+0wxaTPQk8gfhXI6XZvdXqxuRCrjJZj2qhHa6TrtnpD/bbKwjmuVGPNc4x7imapr39u2s1+zxw3afKQU6/jWZrmkXOlRBWZZIGHBWnabpdo+jyXmoTRLggpEp+bPuKAH20+q6fYhIf3Mcw8x3BwTism4mm1O4cyDc4492NXdZhWKxhb7VJ50rZEZXAA+tZqySWjrKnDjnHf8ACgDpW12e305NMubKNZpcIz4GVWsq+0+OCR0R1aFELCROPzqlqV3JeyrcymR5HHR+1UVV/nDbm7khuKAFAZCS5+RhgEd61rSe1tNOihFw4kncF2X5duD096znZGVUZhjpkU6WZCIrQwru3Bt460gNiRrKO5u70SRCVAfKhUY3ehrH86eUq9uqRzSMSFBpbiWWaYSuqloQFHHBFWYBA975tqjtsQ57kH2pgXbU6pJqElxds7soBdVfjaOoqHWLyG9zJDClvAOAiDGPektdVmsjsSR98rfMGHUVf0G6s7HUodQvrU3NsdxeHp/PrQBiQoJ0YoRvA4YnrUlvatPaF423zxjmMjOR9a3X1zRI7m6n/sx/LnOYoiAQo96m0vVFkvIrR9HTT4JvuzKD1x1oA5qCbypEWP5VwNwH8jXr/wAMfDKR2ses3MMaNJ91OuR681xFho6PqcWl2sBnubiTe1wT8oXOele8afafYLKK13AmMbQRwKQE7AbieQBytOhhWBPLjHyjkDOcZ7UKOQPXjNSKNvzY3Y4x60hjWwxUckevpUYjXzem309zUxHIzgd8UwjYTtUk/wAqAEuYI7u3kt594icYJRyrD6EcipI40ggSGJVSJVCqi9FA6AU4tlQi9epHcD1pcbeDgjHX1oACu4L69qM5UA9fWkXOGx0Hf1pOFOc/n2oAcw5BIO49OabIqSKRJypG0indB1yB2FN3ZDZBPp70AeB+L9FfQvEV3FBCXj5kTC9c8muM1SaWSS3MqBSY84617B8ZmnttNhu4QBt+XeOv0J9K8wF/pmo+GTLfwbb+I8iMfKR2qhFGw0+9uo5JNLaF7hR89uy5bHrmvSPEus/a/h9pl8tkbjYPKlVQfkJ4rzG2v7201CG/so9oXCsByNvcYroPEPiDUpLFzZxIlnIchQMBfw9aQGZc+HzabZbhkhWdPMhQ8kA1zt5b3FlM8rIYwnJkJ+9mtTWJLvUGU3fmyYjVAUGcD2rR8JzWT6ilhrcbz2MaEkfdx070Ac5I0loYJULC7dSwY9AKqRXAnnEjt5j+Z82fSt7V7jRzrLx2Kzy2i5XrkovoM96q6lp1jp9nEbV/PNwxKsTll9jQBZutFMNil9azRulzxGgHzAjrWa6SRJ9mkMhl2FiMZyakg1GSxhSONd/l5wTyBntin3+pN9st5IwFmaMfMegP4UAVYlZ7SNLUslwDkoVqvdTyiZRNEnmL1BHJqzLezzyO0bDc4w2D1pIEjeFvt6kGNThwen1oGaujXrQWsr2blAD88MgG0jvWx4N8d3fg6/aewaS80mVwbmyOfkHqmehrnvDOnpqtxJBHcD/SI/LyeCPcUXkT6HeGxwrSRjDbzywoEfW3h7W7HxDpMWpaJcJNBIORn7p7gjsa8z/alljf4TXZUqW80BT+BzXmPw/8TX/hLVXv7WQnTpHC3FoW+Vh/eHuK9A/aQ1ez1b4LSahZsGjlkUAHqCVIIP6UDPCvgp/yKt1/1+v/AOgR0UfBT/kVbr/r9f8A9AjopAeRaIca1YH/AKeI/wD0IV9eeJ728v8Awf4dsbFCI9Pt0lkYn5ZGK4x+FfIGkHGq2RHUTp/6EK+u5ri5m8B6Xa2Uce7yFZmbqfxpoRi6CZNWvrti0SymM/umX5S3bissaVe3Ls9+BDbAlC/ReOwqa1s9St4pLq0VlaPlwik1W1HWrzU7S2tJlZY4CSQFxvz60wK8Uxtpnt/OMsJ4BY5rrfDHhFPENjcJFeLHfgZSFieR2rI8I6NHql/J5wIijG/Pp9ah1CWTTNWe4068KvEcBlbgY7UAaniXRddtTAuqWxWwtflV0U4Jxjmo7VrCXQZre8uV3x8qqjPPpmuo0z4nXElgseu6eLu3YjJIGCK2LnR/B3iqNJbKSHTpSoJjU7SaAPJ4tNnktDcQgtATg8/covY0h063jiRftUhwzj9BXdX/AMMdfs3P9nyG6tm6Atjis9fh1rwtg5tmEscnBLAgAd6QHOwWTaW8RkEckknDLkHYfWtTUppJtPkuo4rKNYVCl3j5b6H1rG1HdHdTWsFxHKyvmaXP8XcV02lazo9voz6bd6ebpihPmbiuG/KmBz8FpcPDbxhBGZPmZgPmYZquYI49US2tJZAxbadyld1bXheQajKFv5vIt7Qbl28O3tn0qpC0U+sQx3AXy3nOx3Pz4zwKAK3iGFjrjw3ELR+TGmFj6t71Yhs5UgW9uVSS3VSqwu238a7f4s+GLeztrbUbYMsu0K7jvXJ20dtqBWDUJjZ20UQcMz/6xvQYoAyLS7RmSN1Hkby23HI9s1r6hq+paj9je8hhhgUERALgkdBn8qzIbVGlVraaPG44Zjj6Vr3l5DNZOdTRodQjXahZThx7CgDqvg7A02tzS3G6TyYmw3YV7E4O35ApJ7GuM+EejNpXhUSTRlbu5cud3XaeRXaE5OQMHHapYxgXIIQjctOHAz/EPyo2gdeAaJMkg9Vx0oAUjklxkjnjvTGLBuvyHquKk64wcqaYOGI6AD7x7mgB/G0ccA5FKcg5AwD60ijgEnr1od1WItITsXkgAk/kOaAFbO8bOn909qGwM4x70/HzEA7j6CmDBHv6UAKBhznkfyqN32xO2NxA4pzZzyOehIqG5GUCc5bjjvQB538aYll8CST8gxtv/GvD7BEms5YHuEhVwDuYdcV9CfESy+2eCb6IBtoGcYzjHXNfN1qpmQfZx8/3VJ6GmI6nwO8Nlqaf2ycWEvCyds/jWl43t9M0d1t3umnWWQuu0ZJU9AcdK4eW3lK/Z53YsDnrwPwq7cGS5ukyd0q4UMx+Vh70wL17rluLK3S3tJInj+UvuyDnvWTbyuLprlHDwH5X55Ndlpfh9JLpZYszW0KCadiOPdaxUNtql7c25j+zw7i0O3p+fegDnrgwR3qG3LEBgxJGPwrZ8T6ot80cgtEgdflBXGG+mOlZhi8288iJShDbSX7n2p1xb+XI5cBinXmkBRZ2aI7I8HPPHOKSaNz5LLEzdi2OgqVxkhQ+xSck+lTWt7cWsLpauZDIMnAzigZSYhW/d5yTgEcYNXtJtZruK5hIla42kg4yD7Vn73uAeocnnI6mprOW4gU7ZnSZCCMcZoAueHoJbe/ivJY5I5YZAoR8p364PWui8R+ILTVPEFwuoWsb4wsbwrgg4HX1rP1nX5dS0qKM28BuVZS7qPmAHesnTJUa9mmu7dZ7bHIV8EGgReeG1vI3S3b5GyjAnqe9UfG2s3cPw2ufD2oy5ZJDLAMdVArTSbR4Iobi3hkgIYkQl87cnkmuL+J93DfWrzwNJlWK5fuNp6UAaHwU/wCRVuv+v1//AECOij4Kf8irdf8AX6//AKBHRSGeO6b/AMhG1/66p/MV9AaRcvqFjaMbiUyQKMwqxGF7CvANM/5CVp/12T+Yr6n8GW+kz+GbA3X+j3EkKgz44cjuPWmhDo9ck0+8uJ4I5BMqhRGT8p4qeWxFxo/9sNNbKerxFwpPtise8jto9TeJ591sW2PPnGPesqSGO+vhZ6eJrmPcAMH360wL+iThY7qOOf7I856ZJyD2qrfWUdlMsc0iTOeWVQRmutfwy/lyXUaxRGzXLIxwScVy1wZNTjNzO6rOG4A7igCxdWepT2SXKQLLp0Q+7u2ge1RRwtcXyJBFIjAAjy2xirDX7nwp9hBnUJISxB+VsnpVe0ubxG3Wyky52DAycelAGoPFmv6belLTVZ7hF+8C2QPYV3ng74qRuDb+IYzFL/C0YLFh7ivILiZ/tZZVIkDfOMY5q3dMIpEuISyzED5x0BpAd/r9h4R1e5uLrTL6O1uVJZ4XQjeevpXHobGOK5md5FlUfKB90n0qjaadqOpaoskStdzn5329q3H1Cwv9N/s2a2WIxSnzXGAd2cY/OmAanBYMYbvT2ICRqJlQcZI71F4e05G1S3ub/YlvA24MzA5OfSrGqWn9mWU0UEUiCUDkYOR71nyWKWsNi4icO6gy8nGPU0AfQGu2cWveFpVjIbdHmLHPavCJ4NI89De/aGZPlaIoQAR717d8N7hJPB9pIGypZsMea5n4i+EZru4bUdI+eI8ywL6+wpAeXXz2k7xvHNEiIwKQhCDj61f0xl8R6rbWdyZGLPhOMtgdvpUmlaLcyyTRzWcyq3d05WvS/h14RNnfjVLyII0QxAoHJ9TTA7yKIRQxRxLtWNFUDpwBim42SbixAParLDJ6MM9M9qjcDYN3OTgVIxgU9c8Gl+YgfLg5xiowSjsH6dj2oaXOGDYHr60ASEBkYP0X0pQOACaiSQksduD608McsWIwBzQAkkm1NqrnB7UsUgJX1J4xVe3DOXlJPHQCppl+YcfP60ASHocHBpc4X5R7ZpgPyrvIz6UoOehGF6KOlABkAKNxPqagkBklBU8DjntUjNgFurDr7UsQAGCfvHIoAhv7EXmmXNofn86MoT025HWvli90s6XrkmnTK8YikbYT0IFfWOWXDDlugNec/FTRIJJY9Sit1+0sNhkxxnoOKaA8JgvVh1uSa5ifaV27WHXitbQtFuPEuri0sYWjRsM5HRBVnU9Lns4FbUkVTnAyPmIr1nwDHp/h3wQ978xlJJ3uPmPoPpTEZPjqa18K+Gbfw7pwDXV0CszfxY9f0ryRftSQvBAzvFCcfd5HrWp4j1K41nXn1C7lY3UhCkAfKij3+lZ0JlF5dRwTkRj5mC9X+lICTTdCl1eGW40tZH+zplh3z+NY5gnM5hmLxsTgk85PpXV6ZbahBpF9qOmXb2saqFkZRnIPY5p+m6rY6fo8lld2Pn3d03yXG4NtPrjHFMDkEWaxuJIriAh3HAfjPvTtL1aXSNUgvI4opDGcMjplWFdXd3lvazacdV8m4gjXynYLmQj/ABrAubeA6hM0AD2bEtGrnBWkBe8TyWWqtHrenNFamdQDaAYZT3OKzoDZOY1vE3OnDbT1HrUtvHG1hI1zJFA0ZIjyMn6ZqXUdNl/s61u7Xy5DL8hKjGPrQBlmeyW8L2chMcb8KQeR6VXnlMc7iJdgkPIUUOshjKtH5ZY4JIxu+lNmhZGPUuBu4PSgY+VXcOQF/dcyfUVyPji48zTdmAMsWwOP4TXYaHzq0Owhll4dZTwaofEXToZPCbaltWC5EhRoR6YPNAD/AIKf8irdf9fr/wDoEdFHwU/5FW6/6/X/APQI6KQHjuncahan/pqv8xXtmkPNc6dawlpGihjwqA9BXiem/wDIRtf+uq/zFfQPh+2iOkQpGyy+YgAbO0qaaAfbTJbxhZLdJyDwrEjHvWtP9o0+4TUzp0kdnMoKNET1+tYuo6dJb3jQzl0AxmQHgiun0zxvd6foraeqi/ss4WNyTgelAjNg1S4/017n7S/2gZB38fiKveF9Js7uyvnmlWGRFBi54NaGmeGp/EWny3NsqWdztJ+zk5wPxrEneGzhtrW2jZb0KwnMjZQnPYUwIA8siEW+Dbu4SX5cgN25q4bb7DeRwxahHvVRIJE42n0+tUY7qS30ySxAwGfeSnRjTrVNMa1hj8yQahJKqeWynGCwHWgCDUQzXbhZcseuO59aW1EgSNGwwjYfKRkkV0fjrSItEvba0swP3kQlLNye3Q/jXPIGs7px5hWdlzk0Abena1c6LFfXVvE9qzqEjYcE5PSqGn6Yz33m6lE6JOS+9uNzHn+dTvrUs+lmx1KDzbYMMMoCkn61e0+6udantoXj2QQviKI8sfx9aACytr59W8i2YSFv4JOePQV2o05L6+W1e2cyCIKR/AcDoabYeH4j4ht1kcR3TfMrDqn1ru7XSPs2pG5WcvIV5JXAoAZ4R0+XSNCitGhjj2ZwiHitsEDaQCGHocYpuC+dpzk9qcrlevTt3NSMUAK5OF3Hv61Zj4G5gM+1Vi3AzyAfTmp8YAbjPagBzdM9yMe1RsEYHuPSlLNj5fl9zVOYHbguQTzmgCO6O/jJIU/nUQIkwFP3OxqfZ8i8bh22jmiMA8MvHXIpgRwRSEucsozwepqVYWUbnbIB6nqak4j5UHbj16UMQRlmBJ6ZPBoAZBuI+U/ePJ6basTYJJx81N6hix5XrTEYMcFsKfzxSAViWZCo2n3pG3gFsAj1FOfqAN5PY0p2qclc9+D0oAYeWJ3ADuR3p+VAwVAA5GOajJypAAOfanL0AUg/WgB5YgDB4PasvxHa/wBo2H2VTtmB3xkDOCOlaLFsD+73NNKA8htpHR/6UAcZq/gmHWDZS38xaZPlds46e1cp8S7fVYNSt7DTbaaPS4MK8v8AA2a9awArMAT71X1K0jvofLucMCPlPcH1NMR4vpMlra299p17bgo4LRy4zz7VP4M8KyatqDTvDm2A2q+dpPXqK9DXwVYvOJHkdmXk+hrUYaToFhNumjgfaSuSN2e34U7geIePNEu/ClmNO+0OyTSeYVUna4yTjH41j+IjBZR2F3p4EMkgBkQD7reprX8Y+Lb+/wBWgvJEhka2P7vcAQ34UNJaarY3F5qkOEIHyRLtIJ9KAOS1SW51V0umUSwxAAuMDBqeysZ54o2SNWV/lOe3uas2tul7fPpmmxutvMykxkc8dzXW6H4WupDc20cjfa0GxIwvyhexz60AYmn6GmvRhdFtpHFgwM0hX5XYcED161Bq1vqJuW0lWRXi+fC+lewaYk3gXwJ5XlQNdmQ5UjHLHGT6143rFxPpfir7S88My3P3wrfdzQBhTz3dzfJalYcQNlS/qOxrf0axs9dnuRPKlpqES/Ii/ckPpk1BPLoOl3jLc2cs4n+YPFMRtJqj4b0v/hJNWks7CRraViWQyN0GaQFC6sLi1uyWKC4ikBKqeMZ61gfFXUJNUt/MaIRiIFflGFYYPNd5f+GbzR9bkbU7iCTyx821uT7VyPxZ1a0uvDUFvYWHk4mbzJS2c4U8UAHwU/5FW6/6/X/9Ajoo+Cn/ACKt1/1+v/6BHRSGeO6bzqNr/wBdU/mK948MxQtb2cUgmSJ495Zf6V4RpWP7Us89POT/ANCFfVfw70nTta0W1KTCC8tI9rBwcEd6aAu+HNV0pmNlrcElxYg4imIOV9uKw9XSCK6+12rRrbiQ7V2jkA8Zrspk8PLp92/nBru2+5Gn3WPQ8V53rv2DfEdPZ2djmQn+VMRp3PiHUPtck9s4tDIoVWj4yMYqgs1zqE1rbS/vZOFSQ8Gt5fDqposOpw3CyQP8rIw/1dZwaxtJra6spJDcox3hz8o9CKANLWdMbQoFtbkxyXJG5gB93PSuXMMyBbkwlkVx+8PTIrqdTg1HVhBftEzGXA8zBIPpWTDqNza295p80MbrK5XcQDg/SgB+o6nPq2p209zIoMUIjU9QB/kVE9xBNdi61RS8YUgxxDDEjpWo/hS6fT5JoTHsiAPH8Qp/huW0t951SOKZclETeMmgDO1BoSkLPOTbModYCeh7Z9K6fwDfR298u2SKBAd25l3Z9gK5qfRpLi4a5soCbeRyoJYEIM+lS6hpkukXFuIJ4LiXeABHnkn19qAPbrK2tL4pfbiJ84Eq8Bq3RkhVYLtHcnk1xGh6jBFZw3mp2iQPCuxRE5Ybh7V2VrKJYlYMpMnzDcKQFnbxhW2kdhzTsjdknkdcVHkliq/KfajcAcA9ep60hkgYeYpI6np2qyxIHIzVKMZmBDDb70+DU7C5untIL22kuo+sayAsPwoAfJ91j69ieTUbAnA46cCi+YIANrbz1FIHwgLdaADAxwTxTMybCQFwDzj0p0gAGWJOTxk0mR90kkkdaYCuFOMja7ZNRxY3FTgnGc9qezbsMuwn3qDChm2An+9jpQA4OQz99wxQ06sG3kYXC5/wpChYE5PtTUgcAqVVsnIJ6YoAtqR1z8p4FJIrCPchIY8D0NLFE6pjcq5PQHtTiArFtxOcDb6UgIEaTzG8xsgfrTwmTuKFD6ZpzAYZ2yRnkdqYzA8sTsI7UASHIztJHHSmMWBO35hj+KkeSOOPPzbfXvSAPIcBXx29TQApyADEN3qtNA3Pllww7HvWHr/inRtBIj1K8WOT+6hyw+o61BoHjbw7rWoNa2F/vlK5GVKk/nTA6ONgrFnwqryw9BXBXkEfiTUL2XaPscZKCRzkAcV21ygeJkADbhhs9cVn6b4a0/S5Gks0ZfNyXQnjmgR5vrfhKyRrUaSov3BOdvO2tnT/AAdcatootNUt4rIoceZG2d3vXeWEEFo7LDGiluScVZUZkxuBOeF7UAec23ge4jeOzs8QRRv898ow5Hsetb+uappngzTEjDGa9chfm+9ISepq5401S7sLP7PpPlm7uFOGZgAmPrXh+qWV8jT6n4luWVkzsiznH+1npQBZ+IXiG9u7gm4uwyKQRGrD5a4G7hJmW6dn2Od3zNmtTV9L+zxwXUwMkt23ysPT3rM1G2a0e3SRyUfnB6gUAD2oeR59rCNCB0zkmtHRrlrO8NxagpInAUcE1qadBp39myteXTeSvzIqkgkjpWNBFFc6jmGWbL87DjpQBX1KbUriS4v737RJHIxO4tkJ7Vzfjq1WbwbBqMVwokeUrLb55HynBr0uC9+16VcWGmoPtqffjdOo9s15j8S4biz06OK5i8ppGLjC4z8poYGv8FP+RVuv+v1//QI6KPgp/wAirdf9fr/+gR0Uhnj2l5/tK0wMnzkwP+BCvf8AwtNNbaajMHVmjHTrXgWjnGrWR9J0/wDQhX0RoI8+w0/94qlkXzMnoBTQD4oZJPMMcmAwycjkVf8ACUGnw6pnVf39tt2goPun1Oau6rZ2mm3JlguhOkiZxnOB6Vjx3hFssVvsEe8nao3HmmI0tZuvMZ7LTpCbHcTyccVk26wQXUDyHzYg2xxjqDWpbaLdXcmIoXS32nErDaM1t6B4bhn0+YX0saOpO1lPBNAFdLy+khNppt2sdoT8isfu1zN5E9lqTrqI3yYJbb0P0Nd94d0nTtHFzJqN6J4ugUDkZqzaap4SinjtUtZbtyuXdzuEZz3oA4i1aKPSJZXuLhTKpVYVc9xwaq6hcQ36aeLa0cXUPyuYxyQB1Ndz/bHhS9nuLRLIoyDG8jAJ9jmrfhe60HSLy4e30b5yQvnGXI/I0AcsLGXTtOjki8xr2Yb0UAnaM85FTWq6vPqMFzFFBGI1yzTgYJ+nWr/iHx5J5k0WmWlvEyMU810+bHqMVgw282vRQvd3zrIsm4tuwT7ADrQB0NhJd3+rbZpo/J3ZeJMjPqQK9e06W3ntkNrnywNuWHP415Ta3NrFqd2VbbJbRlQu37zY9a9P8NKRodu+R5kiB3AGOTSYGiijOcYwetNyPmIDYPfFOA+Y+YWYmmblQEs2PSgZj+LLrTbPw9qDXtwYXMTGPB+YtjjFfMVjqF3Z3iXtrcyxXYO7zQec+9ev/G4qba1+YrIW6E9q8YYBeXIyKBH0R8OPFV14o0xBfSD7ZAcHtvrvWQ+buIGcYxXjX7PVrNLe6jcNERbInyuRwWPpXs7KCSzn5u1JjGTAHBbB44OOlM/5aAHkj+IVIwyTtBKt0J7UxflbJ+U9AP71ACCNAx3ADvkHPHvSFCudpG0+lPGVXLIBnqR2pygjhQBjnOepoAjD8EY2nuMVIpBA29hStyRuGZGqIxhmDfMMdqYD92GBYA4p7ngHlQ3UAVCRwSSTzisHxz4lk0DSfNjgLso7cnFIDbu7iK0gMl06xRjqzHGa5m68c+HoT+91GIAf3TXgHivxrqWvki4nlWMnAUHtXKSIpyCob6nNMD6Vv/i14Xs9vlyzSyf3QuQfxzXBeMPjFf38f2fw9GLGI/edvmLfyxXFeF/B9/4lBXRjC8i9U6Fa7TS/gn4gmcf2hcWsULdSjksPwxQB5ReXEtxM1xd3LzyueXkOSa7/AOFPhjUrjWbfVxbOtrA24Fvl3YPSvV/Dvwh8OaRcJdXStqFyi/KzjGD9K7toYEjSKCJYol/5ZgYWgCBj5wVwhUHk4NTYI5bOSOgpFAUYwGB9+lTRlQwDN9PpQBk6he29gv2i7lhhRRyGcBgPXFZZ8aaGRFJHeKyyEqBjBJrhviP4Ru3uLqaC4MyS8qsrE7a82FhPGUZQ4ki4DAEqGoEe66t4o8Mx20k97++MR2yKOWQ1x+o/ELwlqUqWlvpzvFwA0g25PSvHrq4uTdTtcytLNIxLjbtyfetANp7aCiPFOL9X5ZcY68YoA73xPeiyuLjTmtY47tVVomfldp54/Cs/WNOPiXR7SGyskTUbdMnfxvXuciqFxq66jaomqRCVraE4lJw7H0NXNO18Wd5p9xZyAKoCyR9Tj3NMDl5Y5LO2MLpGhjONqnPNNj3tceVDIqXBXO7GCfpW7rs+mabqV1OsDz/bDlEPIBPU1zcikSCSVHiZT8hA/rSAfpFze6Xezagrf6Sv7vB5YH3rN+K3iy71/wAMRW9+iGSNyQ4XH8Jq9eBUAbypd7nJKnINcz8SUjGkxSQMApJGzuPlNAzV+Cn/ACKt1/1+v/6BHRR8FP8AkVbr/r9f/wBAjopAePaWCdTtABkmZOP+BCvoLwnptxPpluwURoyDDlsZX1r590okanZkHBEyEH/gQr6N8HWi6v4etbYXksd4BnDN8uKaA39J0qwgEkl/I0kA/jzxmtm5utD0bTLWTSraC5uZDjzOykk1GLfTtL8PT2mplllJBiKDO8e9cdp8c93JN9jgLiI7hHn9aYjqdQ13WW08Qz3SzxT5WNdirsbvyBWFFbXt5eW1k07WitlsuTjP1qOe/uLzR47O1s2edJCxbHQ57VZuNa1LUbJLOG1UXcI27h1IoA2tOsJbDUZrGaaGUzIdjluCfaoNJ020kW4jtraRdRLFctkCTB7GsKyFxf6hare3S2hiG3e5Py4rej1G3N5EtzcTvDBkx+WMhz60AQalpcCanFbww+Q7KRtkOfm7ZP1q7e6SbeKHTbi5RJTieVg2PwFTaw9nr7RGORrdlTBbGCW+vaqlj4X1rUrpVaJ5NuAJWORt7ZoAybG+ms9SZbaGOdtxGZEBBX6VtM1oVaPS7R5XkIkRgM4f+6PrXZ2Xg600pnuNZuYQ74T5D8vTpVz+19I0bZZ6Xp5uJB8wIGFH0agCPTPDF5LBDczJElxOgLKTyrV3aoIY1R8AqoGFry9NS8SatqX+iYkiVwdkXVR36V6VG5FuJJopElxghh3pMCQEBWwzbScgio/lfc2GzjBGOKWM7lwOrdPSsXxN4hsfDkUQ1S5EbTHhQcEj1oGcx4/8M33iR4ys0MNirYeZ+1N8O/DTw3gOlwdSdDh8n5M9xjrVHxlqo1W4gg0mbbbKomKM2A/vXN3ev3+m3Trp0gtoNo8xAd24nqQe1MR12reL5fD04sfDdiscMTfvIgvX6ZzXVeDfFtn4nlkhjVob2EZkhbv7ivNre58jTba6/wBbeODhzyWyafpMtzpOn3esxOlvftKRtJwWHpzRYD2uRiGI3cYzQRwuG+XsK5HwJ4xj8TWjLOFgvYjiRM/e+ldQFYKBvUNjoaQyZR8xDn8B6UbONpAKjt6+lRLh35GQo596epLyc5wOnNICTcUK478NxnHpTW3liCQPmpAdqks4UZxikO0rlVyvrnvQA1yxySoZl6Y6GsTXtIi1mOW0myokUhSf4Titxg0ZxwoP41X2p54Lu7cZzTA+XfGng3WPDE7/AG23LWZbEc6jIb8O1crwV/h5719lXsEdwjw3EUc9uww6vjp+NeGfEv4YSWUc2reGwtzYA5khXrF60COJ+HWonTfG+lzJPLEJJPJwrkA7vUdD0r67cHcW35zyuO9fFVi3lzpKm4uhDKR1Br6t+HPiODxF4ZgmbIuYVEcg9McA0DOn+6DtI3d8VDK5PG1Qe464oj3iJfMl8w8guAFJ9OlMYrluOnr/ADpAMbzFOT5ax+gU5/PNTRnAPTHr3qNjjncM+lRxXtubgW32iIT9Qo9PrTAwvG8e60jfzlgVTyW/i9sV5Jrge91m10+Of7NbyfMzx8YPqa9P8TXltLczWWqxTSBRuDRLkVwg0ywuNQa70K5JkC7TDcLt/nTEeb6rai1v5Y7e6e52tnzGAOf0rodH0OC90+aSBleQJ5p57jtVjUdF1u8R4Hs7cSQAhPKXDOPf1p3gW2MV3cXV/EbdI0EboBgEg0Ac9cW7XMv7pGMirtaNRyxqPQ7OK+t9RE++0ng5ww545rZ1S9jsNWmubQbw3GOm2s6O5yjPKQZZ3xwP50AZN1CxCXLT7424VSOc1dvVlFrbyCOT5+GjfkgetV57URXjpMGQJg8jpV24E02qhru4+027RY2R4TaQOORSAeshj02R0H+iAhcMBnca89+IzF9LQmPaoY4/75Nd/b6ZdX9nM0KyNbW3zvEpycjvXCfEsMmnqDvwSeG7fKaGBq/BT/kVbr/r9f8A9Ajoo+Cn/Iq3X/X6/wD6BHRSGePaX/yE7T/rsn/oQr6I8BWkUyaeru8IIBkdc4x9a+etETzNasE/vXEY/wDHhX014Z/4lXgzy3kjMt2hjjXuFI+9TQEHiOVm1WVIrwvbq2yLcxOR7Vm2M91b3IETMCASwPTFWpreO2aC3t0eaYgb32kgfjVq40qWN2uGkCbl+WPvTEJ9rEEMN1p8bfbQNsnPBB6nFNsppbe6W+jlMU6tuw5qbRLJZr9DMVaGMDfGxxvHpUviRLNdTaG0QQw4Hy9e1AETG31ET3F5LIJFYbmRd1aNlot5qcDXFm6pbRHCFhgge9Y0PnRTRRRMqQnq2OW96uWusXFneMvnie2f5GjDfrQBtwWdxatbiDTZrmAt++lmGY2/3a6C78ePp6/YEtUTZGcbOCD2Fc/Pq2pXqJCs4WG25jAGM/41gakJU1NLm4w0jkM4x1HpQBqDVBcN5l5JPIVYTSI0hK89sV0+i3sOqRTWypc20TYXeoztrnpNAZ763nix9nn24Cc/XNek+GPD1tHfSXEociP5VXoH46mgC54V8K2/h6HFrcT3PnDcZZOD+lbt1cw2yIs8mC3TJqZydgUngdFrE8QafZz2LTXcWZR1IbApDBdRht2LW1x9pyfuqc7T715B8YRNqPi3T4njYeZCMhTxye1di2sWVrZG30xPLuIlywPzeYPQVmW97Frd3LcXaeXqdqgMAA9Ox/DNMRPe+FUvlJ0m4BuLW1QPGevAri7ZWb7QwtHkaMEHC9fetm21Jtblur/T5Psl7HlJ4weGA4NZ6pJbzpHazETy4IUehoAk0m3J8qaWTZ5QDRxZzn/ZPpV3xrNeFrM3awFHAAjjUDj3x3qW70RtJ1OC0vJWVblN4dOucZrCFjPea3PZ27sZFUgyzHGT+NAGjFbw6RdjUbY3EEr4KnHyA+len+HPFUWsRra3YWK/QBh3D15ouYLNUldZ40/dtE3zHcO4Nd54L8NxXM8OsapAtswX9zb4xx6tQB3KRttyWwT0Bp2fnIJGPUdqd5cmQArsO3HGKSRRGpyjAMecipGM+VnIZdwHIJoOSp6Ae1IZkMgPyHI4x6UrBWQkde/NAASCT6Y4qEufNyMHb1XHWpHYAD5hu9KaGIlyxHI/h70wOF+JuvT6WsFsQ0EV0OZ17e1c/wCD7y/0nxDBA13JdafcoA6OoIYH+td1470y31bw5ciWIyS2w3xhfX0/WvONGkudJjtrq5kG1cso759KaEYHxZ8ITeFdca7tVH9m3bFkbGdrHkj2pfgv4uTQ/EL2F8QLG84D/wB1+34V6DL4x03xNaPpXiKyxbzjCuwxsPrXkPjXwVd+HZ/PtHa700sWjnAAZfwpAfVLrGQpByvVSOhFV5A6KWI59OteKfCn4nbU/snxNKFjBxb3BPb0YmvZy0ckKz27rLCy5VlPGKBlfWJ5hpsywRbpZAVBQc9K8WvIJoBOJLi5tyxxyCGz/hXqOv3/AJOmTuMq6jghsYryW4uJ57ic3szq7YMTZ647GmhF/T/EN8bwPeKTBapgDHzSDHUmqevlryyhn0uAyXjjzAyDhR6VLN4geJbfZJFLxteAkDH1ov8ATb/UpGvPDt2oSOMFol4we4FAEnhu/wBSUma4iaCdUCIHHBYdTW/oOrGPVpbLW30+W2kGWYQgYPbNcxokWq6xqCwMsxeNDtjHIHvVj7A2gXM02u28A5+URSZMp9/SgDvb/SvB52/aYrVmm6KuACayE8DaYWmNjchN3KxFchPoay9U1G21yex0u1s/LkA3o6tyvHc1yF74jvfD+q3dlLcXLyxNsI6jBHagD0DX/DjanbpDY28F1IsZ3uiAMSO1ecz2q2sL2+oab9nlhOQQCGPsauweaIIr231OdJJZPu4/Q10UGu2trbTWuoWYurxhkMy5zQBk6neadY+E3ks2EV1cjYY0b+deS/FW/vNQ0eA3trDCI3PlNGuC42Hk17Ivh/w1qdwLv7Q1pPjmKRwqMfTGa8++OVvfv4dtJCtummQO0USxsCSwQ/MfwoYGR8FP+RVuv+v1/wD0COij4Kf8irdf9fr/APoEdFSM8o8LKG8T6QrfdN5CD/32K+s/7Ie28BeHNUtoVl+02qgM4yEb0x9K+TvCQ3eKtGB73sI/8fWv0F+HdjBqPwr0O1mCshtVH+6QaYHmwvYtN0a3ElsguwPmdRxzT9JtbDxHYzW1/Ns1ANujYDjHbmr/AIlsLWz1xEvmyynb9nHdfr0rnNbuLZdaI05vs0apgrnHamI25/DEmmtFI9qQU+65YFW9+DWFrWh3N1cef5CnedvyA4zVG18TaxD5cD3TOiHKgjcOtasXiDUdRZFtnQIr7pFxQAlzYaho9nDp88X2ppjuBVclAfeq2teHpLC7sopIcrcEbWUYIJPetrUNbv7UxzwtsDAeWxGSfWpdM1DV7yxutUkeOYWeV2tjOB3AoA57U7eTSNUtre4L7VIYFRmjW5DeaqxiwYVUZZRnmu08K6qddvlE9hHJvABMqZ49q6PWNE0jS0lnVPKVmBMaAfMfpQBzXgDTr24uYZn+SwjU/K/Un2ruzqlmt6tksuZj2FY9/Nd2+nwzWS7vN48sDGFqETwxS291L5EWSFww+fJ96QHS3l7b2UTzXLeVCPvMQTWdeS2moaXLJFLvtDHvDE8YrlPGOp3WLmylAnsogdrDPP1rN0zVbnT/AAvLb5hNs44G4Zwe1AEvh+wsItajupJUe234BJ+6an8YyafP40SG2j8udFyrIcBvrXOXOjah/ZCT2INwM+a4TpgHNOtrr7Te21+A8t2RtKnotMD0fSvDumPDPIbeOC6nQrKwGBnHUV5JqG7T9UliinFx5T4j8r5iOeM4r0S41xJ/C2oDUJH+1KoVQg2leeOa8t0q6ax1WK+CghH+dex9zQBb8R6xqOq3Vk99C8NzAuA3QtVi8kF3ZpIuFlCgOV+8ara3dTa94hWW4P7t2JjVegFXbfSpnuzGR/oQGWkzgigCzoenzat4kg0+3cfZ4wGZhyN3X86+gLW3EMa+ZtaTAGcdPYVxnw50OxsoBcWiP+8USMznPPtXdd+tJjELZJAPTrSAhhtPOR3HWlPUcZpe3TB7ZpAZGoxG1dJUUGLp0+77UENn5Np9cenvWqyrIhRhkEY6Vk7GSRo0BLLweegpgDHKnaMgc8jpTFO5t4G5vQCnMJMKu5owD+BqP95hmBDZ4yDQA6dlaKVZjtjKHIA6cV4hqwlvhMtnGzpHLsJUZwP6V6n401+HQNEuJruMb5Y2RAGBbJHWvK9E8SLp1m8NqjxpOgMkkg5cnqKEIxtOWC21nytQjma2XkjcCa9OXVbfXNIWx0S0JZcK6SDjH1rLHhO1vtGW9inU3IBk3ZGWHpjNRfB/UbZNU1S3uT9nkZ8RRt16dM0wOW8eeA7PRRb37RmKBjsnRMkJnvmrOmafq2jXFpd6T4ha70KRQcMx2j/Z5FegfEC/so9KmivZQVwfkAySa8v8PW8eteBpP7OvDGdPuCrRf3tx570gO48SQXOvWCR2tzHAuATNG2WP1FcbLBbWLi2lhknnnbyluN33TjrirccFxDbosEzqSM7lPy5qtp1zdXelSCOJZtXt5WbyXOA47c0wORvrQwTusaMwRv8AWDqx966PTNOvrOLzIv3NuULNKh+76g1JZ6lNrd5/ZVjoy299GC0ySSY3H2yBW7c6xqNtpp0y/wBFeKMnEh4IP1INAGZoOoizlluY9QEQRchtp5HpUFtI3iG6mv76486KPIUfw1L9kQyxo8dnHbv91UbC49802+tIUnitdPGyIqS7hwFz/WgCbTtG/wCJTPe6dI63bZ+d+MfjXnOoafd22oOfNaa6ZtzuwzknvXawajcyQnTrqdUhSTG5BjctVPEFxDp91FaWriYKMtM/X6UAYlrHdRNiW6WOdCG8p2wua7SXVGiNlMRHJehPucEfU07RvC41R7S5vrfy7DAaaYt94jpSeM7jQYBPFbCTcq7UeLnj3oAytSubu6klEiwNeSciMKCE9xiuF+KMlxF4aitJ/PjljkZnic8co3NdTbFi8HkrKFblZWHI+tcn8Wo7qWxaSWQSY3FpAeuFPFJgL8FP+RVuv+v1/wD0COij4Kf8irdf9fr/APoEdFIZ5V4TGfFOjD/p9h/9DFfoB8IFuI/Bmj71P2eW33Jz0571+fvhc7fE2kMOovIT/wCPiv0Q+FTK/wAOPD5HO22UHnoRmgCp8RvD0F+IdQORJH8rADr715bc6Pp+64kXUYzJtP7tl5/Ovd/ETKNMdHbaJCE475rwrxR4Xl06/kaD94xbdGxPGPSmhHP2Wn/PEryFbZmwzD7wFdLqFtouh2vnWwk+1yrtDkHHH41hQ29xErSXEZ3ZxgHgGpbqPV75TbLbpJHAck4ztHr1pgRWrXl7dWqyQyywL8uVPTnr7V0epwrp9pDDp28yTtiYA8Ae9QaTpWs2sMjWksYglGHJI+X/AAqLV5IbOYwTRyyzhSGdHwKAOkj8TaLpNslvcXDLcxLx5Me45/CuU1HVfFPiKSVdKtJFse80oxtX156VV0C5TD20aQRXLP8ALO/3gPQmta+j126srmymu9yIo3M3G4e2MGgCbSLp9Ct1iutbF3ckYOGzsNReINSe7Cw210zBfnd2TA4rn9Lso5ZBbxoBIWCEsc5NSXthcQ6r9jncwEcDe2FoA3LCZtQlH2i5Zodu3Z0yfU0yHS7CBFN6J5GlfEUIGQcnGazre5SLVUhm2gjC7kOVrfg0+41DxbAtm522tuZFbsWzwKAN3S0t9M0m9tpvNf8AdlGGSCDXIypD4dnV4JTcI+GZR/CDV3WrqWzLw3U0kd/LIWdR0I965x3S51YqVeSJly23JAoA0dWvm1BmurNSbWQbZFHQnHFYEVnJDd27SRMLYnDuTwBXSeGL0W18kEsUf2NZM7MfeHvTvFpuWmKWwiW2uGO2IcY96AHeGdNTVW1JLYkpAoaJgPmz3xVjw54b1TWZHuZJGis4ZAJEY43Y9KofDmWey8RP5xn8tQUI2YGfSvd9Nto3G7ACgA7AMDJ9aAJtEtVtNNhiRAigYAHp2q7jLbs9KAc/d6DilxgnjBNSMKQrkZAww6c0p+uCaRiQDgZPpQAgBB5PWsnVrcNeq4Z1cp2rVLbGOcmqerBmtPOiLDZycdcUAUjuEQ3qxce9ct4g8YWulXT2qKHuCpAQdQe1dBrFy1voskvmYYL8pbpXiF/eajcX4lmSKUM+VdQMj8aaES6lb3erudQ1S92zxn5Yz8w29himXEEs9r5FrAroxAOBkgn09KtraXGqgSxCKJBxMz/w/StfTdQsfDl9ZR20UWoh+fOLcKc0wKXiq0vrbwWlnY3Is9RhlVWwf3hXv7e1QaxLH4f02zuIVjuLx41ZnVvn346kVL4nvnudTlvHHmMWJCj+VYc+lXk8ZnNrMqHnzVGcUAXrq0l1LTZ7+1Ml07xlmDc7QBWP8Eol8/V7a7jIR4mkAbu3pXffDHU8y3GmXUSJFu2eZ6rWLPHZ+CvGlxLr8i29pPJ/o8oOEYHoKAJIdQh0OcR28ayQ7txj689+TW1c6la+fHdw2CwNIu8zDGAR2NJqOj2V7HcTWMsLIw3xlP4649TfaepjmXzUZ8lc5xQBq3VjYeK7uaaW5Sy1MDdBNbnGW7ZNUDrF5o99HpHjVzskwkV8oLKc9MkDFZ1vZ3VzcT/YkDyHkqp+6KvQ6+ot10vU4ftcefuvy0dAF/xPoT6dpglW2e5glcAOnOfcegrItIo9WkW1lQ21vHDs80DlT716P4Q1K2msxHbuZbJPkZJQBtPfGajvPCdtfSzS6PNGIGOZMnIOewoA8y1IxaSux2S9WDlSpGW+tbvhWw0Tx/bxyRQyQ3MXEqZAAI9eKyvF/h9tJikMgSG2kb5JVH3ves/wTrCafqDWWlu3lffmnIwWJ6jH5UAdL4pkvk0640e1nVLVDtCoeTXK2/hG5mUiSYJMVG1Cc5xWhr5Md1Jc7mEhOUHb61UuEulngk+2RSC5XAMbZK5oA07yQ2GmQ2Nt5RnYAz+YM4HfGK5z4s+H0074axXaBf8ASJZDlTnpGTXb+EfDd/cSrp0w81S+53Iydh6c1Z/aZ06DT/hba26RqH8xycHoRE2cfkKAPFfgp/yKt1/1+v8A+gR0UfBT/kVbr/r9f/0COipGeTeGv+Ri0rH/AD9xf+hivvX4TXYsvCGkmR/3EkA3AfwnPWvgvwyM+JNKHrdxf+hivvTwDauPh/oTypuhe3U7s+vrTA73VYDdWJWPBKkSDjriucu7WG+t3jeElsEg91NaOnX7WrCGZt9v/C/Ur7fSnatFHajzYULRyHJCnofWgR5rqVpPp9ntmt1MZb58+lRaTHpenGfUZXaO2kXYyDJ3fjXc31qmpWrRMAoP97kVzVzpRjsjY30C/ZFJOIx96mBj6p4sE1rJbW9iVtJcAFQMketczdtcmL5fN8lTtTzePxq3PpkL6m1vaGRUUHYWUjmresW7iWG2eUSLCgeUKuD0oA5JleW9hmkBLqwXCjHevUDqE0ViqNbQzOSqGQp09q47TbVtQvUaHMcTsAAB2BrqPGetLYrb2FpECiqNxHd/XNAHOa1Zxw6qHtlaCXO8sRja1ZVzNFdatG93KZEwdx/vEV1V7c2DaM0QilmvmXLHOcVy9jpX2uNrxW2CN9hjPXn0FAEItVl1C3eISKjMMqOcV7B4dgtIrGRUBWQrkykc/SuV8OaSdL1CC5nCNb8NtcZJH0rStbptS1CYac2y3dgFHb3oA5vx2our+N4FOQp3MRycdKy9G0u6s7kGe+jUXCZwnHynsa3vE7C18QJaPELkr94oeK0zc6Ld2TQxj7JeR/dD5bk0AZstjo1vpsptJZjcbcB3XgNXNaHa3Os3y2U9wYpEbKynIAFdDpjrLdzaZfJ5k0asfkGA3vXUaFoNuNMZJRuaT5i46gelAGn4Z0mWxtGFy8RAkwrp/Fjua7a1RBErqPmZRk9z9awbVBJ9mtIMCNe3cAV0RIVewUCkximj61mHUW38BV5ztbr9KJ5mkXEhPsFPBpAXXuoo2wXyfbtUqMrqGQgqehrIXoNq575NPtppInJIAB6r60AamOc4ycUo96rNeIu/KN8vWrCNujViQdwByOlAHI+NrGWTw7PGkW9gS2zrkeleRmxSEBJnaEMMrHjg17prAV7hVdGIKYz2PNeNeOLK4i8UpFcndERhGUYC5poRiapqY07T00+AELMu5yrc1labeW8UUmDvIHEZ6A+ta2saOlrf26JcGVSBjHJzVnUfCraZGt2djqwyyhqYGVaXTl2LqsgPJYnn6CugtNVa9PkFnjsmjIaMdQfrWFDb2t3IkaSG3faQozyTWnpxGhti4ZbqQHcqryCaAPQvDWk2MGnQ+UpODzIetVPi5plrqvhRY5TtltH+QqM5B61n2Pim3ndr2bMcXCqgBwprD8X+JbiSKR3aNonmBjGMbl9DQA/w9p+qWenQRX3zaVIgaKSMgMnsT1q5f6Pc7ozE4Vc9XP3hRrfiGxsYbBLXOWjUyQdAD3xXb6bead4g8OgQOsJ2fMCMlfxoA8q1Y6bo2oma0JEsmA7JyBWDqDfbbp2tPvt/GDjFdveaFprXhKTCeAf6xO5PtXD6pNZ2mptGbLbETtVo8/L9cUAass6aX4fjtNOnM9xcFjKWbO3vVLRdQ1S30hCk5hkjb5e4J9CKqxRMmuRrPMDaz8AgdB069q07izt/NkttLlka0TmWWRslT6r70AdJda4dfsoY/EMMeIlHzADH5Cn2ug6FaFrqwubZHkH+rZgCDXKeHpnv7iW2tLYzRqCDI5xnHr6VUkWaKOYwbQYiU3P8woA2bZ521/bcypcWzHy2j46HuDUw8OI+vta6SWljZQVHdTnpS+HEhvpoTPAY5IkGJYxwT6mvYvB/hyKzmOqyu0lzKmEyPur6/WgC54W0RND08NcMWuCBudjnaPQV5f8AtUIT4AWck5aSVVHZR5L/AOFe0ROLl3yvyIccjqfWvEv2rbxW8Gw2seGCmZnYHgERMAPrzSGeHfBT/kVbr/r9f/0COij4Kf8AIq3X/X6//oEdFIDybw0ceItKI7XcX/oYr75+HN+//CudDhRAY/swUEdxXwL4cwfEGmA9PtUX/oYr7w+HEkp8G6VLKWlLxZyRzTA6pFVoxhfLX0zyaD5kaAFmeP8AujoaAwIAdScdsdKF2eaQu4N1FAhTH5g3gHcOinikng86LZL0PQjsakG8NllwDxmngNwBt/OgZxupaI9tOhZXYO+4TIOE+tY+pyzWuoS2+prHPaSqAJVPI/KvRW34KqN45JB71i6holrqKuWzFKEO0dBmmI5Cw0+SDcNOkX7KEJjdhyPauT1GaVyUuJN4DnIY16PAXtj9ieBo3C7fNK8MPrXH+JNNivrlBBmOVM+ZCoOWPrmgDAV5VgEkBKpjDDGak0kvLNtMzRRRYeQnIzWlc6DdQWKzeaIVJDMCegrotOu4bC1+1vaRPIEC72/i/DvQBSubnULmZV0vM52YQSnqAOaZYXY0W1i8tgJ3B82EnBjPfFQXkhsVtru0WdmcneynbsyfQ9q07fQ9L15FubYNcXXWYrzigCvcW86pHcBlLTvuY9WUfWtC3s7N9T+0zxxpKoALr91qsaa8lyZ7FInEUBCx5Xr681tafolvDKDJG9xvGPLXkA0AVNHtFub6W4gjEEZBV5CM5+ldCicpbWuD9B1q7Z6XcGJY9v2WAdE4JH0xWxb20NnGSgC/3nbqfqaQFfTdPFuxmmAa4PGfQVHq8rSMlpA/71+WC9cf0pL3Um2FbGMue8hHyj6etQafKLe7LXERDSjBmb196BmwkMaIECLgeozVC/R4G3xkJAeuBnaa0gQQCCCD3FR3EKzxGN+hpAYnms+cyblPQjipFw0ikh3PRRnqambRIfKwsjrJ/eBwPyq1ZWS27b85cDaMdKYCJYgp+8d95GOOgqxCrJH5bNnAwG9RUlVdSmaC1E8eNysCM9wTyKQDNWgaeyO12SRPmBX9a4Hxxodxq2kLNYhWvY+XYnDFfYV6Ja3UN2haFt2OGUjkfWsy60x4JWmtCxDfeBPQf4UxHhr2lzFbRh5w6R8mPZiTPs1Zs17ql3dPBGJGCrjy35Nexaz4fh1GRLi1ZBLFkbQeCfesXRLGzs9Xmlv/AJZVHOVNMDz/AMOWd1cz3BWNA9ugLRE4P61ja1eXVrqBVlxcIfuZzgfWvVdV8PWkUTXFhdGAzuTI7HnGa4/xL4UVpHu4L0zWwHzt1z+NAGTpOrstm1uYWEZOcNV3RbdLl57i4hMqr0jbjbz1HrRZaDBNZRw2t2omPIiYfM30p82n6wmpTsQ8Qg2KAg4I9TQBm+K7e4t5hd+VvyMpx90Vp+EZ9QstLmvlkMUbqQUGcNmsrxBqd4+rQ4kVXA2kMMqwqSDX7hrF7F4ghDEqccH6UAbNxKlzdQ3Viwhu9oBRjw1cp4r0q8Q/am81QwywQ8Zq7cbL3SFdktzLCeJASGrT0S4W0ntPOVZICATzv59MUAcvGLqy06Ka6aWLfyiBc5/+tS3+q3tnYxYAaKQneo6kV1HirTjfXLPDPsCjcqsCB9AKyNG0gXsUsFyudv8Ay0Y9aAINLuZ9PaN7aXC3oBbacBV6c/nXZeGWt30+4s7mwkVt+YyEOJD65rk7DRrxtXisRatsztWQNwB64r3XTNKFjFAtwyyMij7q4PSgCn4b8K29ibeSQ5ZmB2dRzziu+lVim2Mhe2fQVlaVZHzxcsCEA+QHv71a1C+FspSIB7jGQvYe5pDIdXv1sITFCCbmQHaAM7c9zXgn7SgceDYvOzvMkzE9cnyW5NezxxzYdywaRjkluteP/tOGQ+CbUP8Ac3Tceh8pqBHkPwU/5FW6/wCv1/8A0COij4Kf8irdf9fr/wDoEdFIZ5L4d/5GDTP+vqL/ANDFfeHw4Yr4I0YK2CIAPWvg7w9/yH9N/wCvmL/0MV9yfDecL4O0lCr5MIbJGM/SmhHcffbDcN6inn5SC4y3aq0QBA38jsc1MEQDO5mX0U8igB4JGWC7c9OaVRuDkoWHc/4UxNpyA7A9gTTzGn8LMPpQMiYqB852MfTtTkfK7c5PbcO1DFfunDH171FsH3dz+oPagQ27iFzsWZWO08YrPudHRr37TE4iuguM4zkehrXjeQEBECr6k5pzFWGQ0ef9qgDmLfQpQ90NQIkhnXGM9KzLnSZlgClDNGD8gQfdxXcgJjDKrYHG2iMJ5I2pmTP3gcYoA4RdEvLyXzLkEqU27W459a3/AA74WbSIvPsQVWTPmAHBP+TW6URTucE59eanedjCI8ny8ZwPSgLE2maesVuWmwCSS2OAR71KL2ztl2QjC/7C8Vno+6PYDJ5ZPK5wRQirt2E8HsOv40DLE1/cMDtZVVvukLyKpI7yOPte58HAY1OoBYBl3J2H92lJYAhTnb6igBwIZ9yuFKjjFO3KVw7eYOmMYFN24jEbRgDqGUdaDk8oEOfftQBJav5ILQ5CZwUJ+X/61aaOs0QZTwfQ1ksM4+Ut64OKmgl+zyqx+WNvv5PAoAupNukMZcbzyMA8CpJHWONnkIVV5JpJHSJGdj8v8/pWXK7zTgyPx2THA/8Ar0gJ5r9mIFuF29dzd/wqk6SXE5e4kaQYyIx90fhT89SAjepHalTe7DYqjjGd1MDNZbqJ/OgXynP3TjoPTHetjS9VFy4gugIrodBzhx6j/CoSrBABkt2ye1Vbq1MhyR93nJODn2oEbNxYpJJ5kZ8qXuQOGHvWNqVnFMjQ3cewnhWIHNWdOvJowUf97GvTnLD8a1UeG6TjDD0I5FIZ5B4itJUuore6Drax55GcMaybmxu/LdLLfFbSc4c8V65q+kCVPnXz4Ac7D1X3rm9U0iSKNn02YOpwGiYdBVXEcNZadptvcC71CTfcxqTH5RJAwOapa742n8gWlrbn9+QRJjp7V0kvhyOW8UhmRWbBUcVzEmlwQeIJw0jS7P8AVow6fSgDJ1ZluNNWOWANd/xADkDsRWbpkDPBJ5166FeEUoCa2pQ9sLqe+HkSbwoJGeKdPaQwWf2go539GUc49aAK+l28VtazOXWVmJVQRwG+lXLOWSyuLdHgUYbeWUdfpW34V0Rbi0E0aTKw53SLw1dXeeGE1KOITnZIo4ZeKAOR8Ur/AG9qEVzp4yoT5o14xirPhjw7fz3fl3EbCwYbs45U/Wu70fRbHSIB5aCSXpuNXZPN8vakgRSfugUAV9MsYLIiOCITTdmf7xHtXSW9juYSXSqWHRQeBVPTXtLG3Ltuacn5jjJ/Co7q6uLlmG9EixwgOCfrSAuXmpqpMVqQzg4ZscKP8ayTHvm+cFjnOe7H3q3psfm3RXIjjUcrj73tWyPKiUAFFA9e1AGNFazTEKsTR8/ebjAryP8AamsorXwJbMCzys8y7j/1xc9Pwr269vo7ZA3MrHoqmvCP2oruSfwhavIo2v56hc5C/uW/WgZ458FP+RVuv+v1/wD0COij4Kf8irdf9fr/APoEdFIDyLQ2261p7elxGf8Ax4V9kfDXxbYJ4X0201KIRyxRCNZ9+dw7+4+lfFkUjRSpJGcOhDKfQit6w8Y69YLts78xL6CJD/NaAPvq3himQTWN0ZYSOMHipgWTgrtYckjvXwrYfFXxpYPvtNckjOc/6iIj8iuK1T8dfiMcf8VEOP8Apxtv/jdMR9tLLFIBnC98kdKefL6pOxX0Wvh0/G34gk5/t8Z/68rf/wCN0o+N/wAQhwPEGP8Atyt//jdAH3NlXT5NzbT34NAYg4Ugr/dIr4b/AOF4/ET/AKGE/wDgFb//ABunf8L0+Iw/5mL/AMkrb/43QM+5MHOcjJ/lTSMkHyxxwTnpXw6Pjr8RguP+Ei4/68bb/wCN0p+OvxGPXxEOf+nG2/8AjdAH3H90HZ94DnH9KFDBtwAGevrXw5/wvb4jYA/4SL/yRtv/AI3SD46fEYZ/4qI8/wDTlb//ABugD7kbIYb5AcdgKf8AKWBUn2xxXwwPjp8Rv+hi/wDJG2/+N0p+O3xHPXxF/wCSNt/8boA+5ZChChTg+p7U0AHfhy5+mK+HD8dviOQQfEQIPrYW3/xuk/4Xr8Rv+hiA+ljbf/G6APuZS4H3eMYx61IjMSMYKmvhf/hfHxIxj/hI/wDyRtv/AI3SL8dviOBgeIuP+vG2/wDjdAH3QQyueOMdmzSlflwFGR1wOlfCy/HX4jL08RAd/wDjxtv/AI3QPjt8RwxI8R8n/pxtv/jdAH3OVQrtMhVv7vfFEwURhAxfdgbcd6+Fj8cviIZvOOvp5u3bv/s+13Y9M+XUkfx5+JMb708R4bp/x4W3/wAbpAfdkrXPnRpdKiRrypB+8cVEWDkESNkDuK+G5fj78S5V2yeJAwzn/jwtf/jdRt8dviOxyfEf/kjbf/G6APugAKCFGG9T0/KmtHgDbkD1FfDDfHb4jsMN4iz/ANuNt/8AG6F+O3xHVdo8R8f9eNt/8bpgfdL4YYOcgYxTQRgAA7SOpPSvhr/hfPxJ4/4qP/yRtv8A43SD47/EgdPEf/kjbf8Axui4H3SqMi4AiAPccA05copK8EdMHpXwmPjr8Rv+hiz9bG2P/tOj/he/xH/6GP8A8kbb/wCN0gPvD7bIVxnGO/rWdLDH5zMQpJ5znmviE/Hj4kEAf8JHwD/z423/AMbpD8dviMc58Qrz3+wW2f8A0XQB9vJANxJUFhzVRdHs/N814ImlGTuK8818WJ8dviOhJXxHyf8Apxtv/jdKvx3+I69PEY/8Abb/AON07iPse80CzunzcRJIM5YHvTbfRrW3VStsnJIAbkAdhg18cP8AHX4jOct4i/Kxth/7TpD8cviKf+ZiP0+xW+P/AEXRcD7jCJHbxxBFVR/cGAKjVMMd2NuOOa+IP+F5/EXbj/hIuP8Arxtv/jdM/wCF3fEP/oYSfrZ2/wD8boA+51COBsi+cd91RF03ZhG5z1OOlfD4+OPxEHTxD/5JW/8A8bpw+OnxFBJHiHBP/Tjbf/G6Bn3Apz97lyec9qlwCvRQV4PrXwyfjn8RT18Rf+SNt/8AG6B8c/iLkH/hIuR/0423/wAboA+4+FLcsCeuT0qvNI8GcBpB15r4k/4Xl8Rec+Iev/Tlbf8Axuhvjn8RWXafERx/15W//wAboEfbqTIU3KdpbqAOteNftOFj4TtBlcfv2x/2yavBU+OHxDjUqviHAP8A05W//wAbrH8T/Erxb4otEttd1b7VAhYqv2aFMEqVPKoD0JFAzuvgp/yKt1/1+v8A+gR0UfBT/kVbr/r9f/0COikB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stage II sarcoidosis according to Siltzbach's classification. Multiple miliary peribronchiolar nodules are scattered diffusely throughout both lungs. In addition, both hilar regions are enlarged due to lymph node enlargement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16562=[""].join("\n");
var outline_f16_11_16562=null;
var title_f16_11_16563="Dyshidrotic eczema moderate";
var content_f16_11_16563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83056&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dyshidrotic eczema of moderate severity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16563=[""].join("\n");
var outline_f16_11_16563=null;
var title_f16_11_16564="Aminophylline: Patient drug information";
var content_f16_11_16564=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aminophylline: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=see_link\">",
"     see \"Aminophylline: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/47/9975?source=see_link\">",
"     see \"Aminophylline: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F133450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aminophylline Injection;",
"     </li>",
"     <li>",
"      JAA-Aminophylline",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat breathing problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aminophylline or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697357",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you stop smoking, talk with your doctor. How much drug you take may need to be changed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698996",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Peak flow measurement low.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10805 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-FB51BAF4EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16564=[""].join("\n");
var outline_f16_11_16564=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133450\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011900\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011899\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011904\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011905\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011907\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011902\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011903\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011908\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011909\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14648?source=related_link\">",
"      Aminophylline: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/47/9975?source=related_link\">",
"      Aminophylline: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_11_16565="Clodronate: Patient drug information";
var content_f16_11_16565=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clodronate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/3/9270?source=see_link\">",
"     see \"Clodronate: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F152938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Bonefos&reg;;",
"     </li>",
"     <li>",
"      Clasteon&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691890",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high calcium levels.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clodronate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703807",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Poor kidney function or stomach irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698211",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low calcium levels.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bone, joint, or muscle pain may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A broken leg may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698193",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the jaw bone may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698194",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Jaw pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699013",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone, joint, or muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2927623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad groin or thigh pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bonefos&reg;: Take on an empty stomach. Take 2 hours before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694621",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clasteon&reg;: Take on an empty stomach. Take 1 hour before or 1 hour after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11195 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-4E1BBEB838-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16565=[""].join("\n");
var outline_f16_11_16565=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152938\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011823\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011822\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011827\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011828\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011830\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011825\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011826\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011831\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011832\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/3/9270?source=related_link\">",
"      Clodronate: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_11_16566="Anaplastic astrocytoma Light";
var content_f16_11_16566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anaplastic astrocytoma histology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hypercellular tumor with marked nuclear pleomorphism, mitotic figures, and lack of endothelial vascular proliferation or necrosis. Hematoxylin and eosin; magnified x 200.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Prepared by Mila Blaivas, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16566=[""].join("\n");
var outline_f16_11_16566=null;
var title_f16_11_16567="Paradoxical vocal cord motion";
var content_f16_11_16567=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Paradoxical vocal cord motion",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16567/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16567/contributors\">",
"     Jo Shapiro, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16567/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16567/contributors\">",
"     Peter J Barnes, DM, DSc, FRCP, FRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16567/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16567/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/11/16567/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paradoxical vocal cord motion (PVCM) refers to inappropriate movement of the vocal cords, which results in functional airway obstruction and inspiratory or expiratory stridorous breathing. Patients with PVCM are often misdiagnosed with asthma, because the sound produced can be mistaken for asthmatic wheezing.",
"   </p>",
"   <p>",
"    This topic will review the presentation and treatment of PVCM, also called vocal cord dysfunction, Munchausen stridor, psychogenic stridor, factitious asthma, pseudoasthma, and irritable larynx syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Features of wheezing illnesses other than PVCM are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36613?source=see_link\">",
"     \"Diagnosis of wheezing illnesses other than asthma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"     \"Diagnosis of asthma in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the normal larynx, the true vocal cords abduct on inspiration, opening the glottis, and adduct partially during expiration, closing the glottic aperture about 10 to 40 percent. Normal inspiratory abduction is controlled by the vagus nerve; inspiratory abduction can also be induced by sniffing and panting. Normal adduction of the true vocal cords occurs with phonation, swallowing, and during a Valsalva maneuver. Normal cough mechanics also involve vocal cord adduction for 0.2 seconds following the end of inspiratory phase; this is called the compressive phase as the expiratory muscles initiate shortening against a closed glottis; finally, the vocal cords abduct and forceful exhalation ensues [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In PVCM, adduction of the true vocal cords occurs on inspiration, expiration, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]. The false vocal cords may also adduct abnormally and the posterior laryngeal wall may move anteriorly to compress the airway.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;PVCM has been associated with psychosocial disorders, stress, exercise, perioperative airway and neurologic injury, gastroesophageal reflux, and irritant inhalational exposures. Some patients have concomitant asthma or have been misdiagnosed with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Psychosocial disorders and stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;PVCM has been associated with a variety of psychosocial disorders; however, it is not considered to be a form of malingering as patients do not intentionally produce their condition for secondary gain.",
"   </p>",
"   <p>",
"    Several studies have reported an association of PVCM with a history of prior psychiatric illness, including depression, personality disorders, posttraumatic stress disorder, or a history of childhood sexual abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. In a case-control study comparing adolescents with PVCM to those with asthma, PVCM patients had higher levels of anxiety and more frequent diagnoses of generalized anxiety disorder and separation anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=see_link\">",
"     \"Factitious disorder and Munchausen syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;One form of PVCM occurs predominantly in young female athletes who present with dyspnea and sometimes stridor triggered by exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In a group of 40 military patients with exertional dyspnea studied prospectively, 15 percent had PVCM [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Neurologic injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;PVCM has been demonstrated in patients after thyroid and cervical spine surgery and in one patient after a polycranial neuropathy from herpes simplex. In this setting, the presumed etiology is aberrant reinnervation or synkinesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Postoperative",
"    </span>",
"    &nbsp;&mdash;&nbsp;PVCM may occur in the postoperative setting with the onset of dyspnea and stridor after extubation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]. The use of flexible laryngoscopy in the immediate post extubation period allows differentiation between PVCM and other pulmonary etiologies of postextubation respiratory distress. It should be noted that postoperative onset of acute dyspnea and stridor is much more likely to be caused by laryngospasm rather than PVCM. Laryngospasm is usually an acute onset brief episode of sustained vocal cord adduction, often seen on emergence from general anesthesia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11434?source=see_link\">",
"     \"Overview of the management of postoperative pulmonary complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Gastroesophageal reflux",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux to the larynx and pharynx, also known as laryngopharyngeal reflux (LPR), has been associated with PVCM. Laryngoscopic findings consistent with LPR were present in 95 percent of juveniles with confirmed PVCM [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/21\">",
"     21",
"    </a>",
"    ]. However, other studies have questioned the reliability of laryngoscopy in making the diagnosis of LPR [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/22\">",
"     22",
"    </a>",
"    ]. It is unclear whether there is a causal relationship between LPR and PVCM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/10/33960?source=see_link\">",
"     \"Laryngopharyngeal reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Irritants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposures to a variety of irritants (eg, ammonia, soldering fumes, cleaning chemicals, aerosolized machining fluids, construction dust, and smoke) have been associated with PVCM [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/5\">",
"     5",
"    </a>",
"    ]. The exposures typically occurred within 24 hours of the onset of symptoms. Sometimes patients feel that ongoing problems with PVCM are related to a previous inhalational irritant exposure. While an acute exposure might cause temporary laryngeal irritation, it is unclear how a previous remote exposure would cause ongoing episodes of PVCM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;PVCM occurs most commonly in women between the ages of 20 and 40, but has also been reported in men and in the pediatric population [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/6,23\">",
"     6,23",
"    </a>",
"    ]. Patients may present with significant respiratory distress and dramatic inspiratory stridor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/15\">",
"     15",
"    </a>",
"    ]. Often the diagnosis is suspected after multiple visits to the emergency department for these episodes, or during an evaluation for severe asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/6,24\">",
"     6,24",
"    </a>",
"    ]. Some patients may have both asthma and PVCM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/49/14105?source=see_link\">",
"     \"Evaluation of severe asthma in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to dyspnea, patients may complain of throat tightness, a choking sensation, dysphonia, and cough. Less often, patients report gastroesophageal reflux, dysphagia, and rhinosinusitis. Onset of symptoms may be spontaneous or induced by exercise or irritant exposure.",
"   </p>",
"   <p>",
"    During symptomatic episodes, stridorous sounds are loudest above the throat and are less audible through the chest wall, where the sound is attenuated by transmission through the airways and the pulmonary parenchyma. Typically,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/61/16344?source=see_link\">",
"     albuterol",
"    </a>",
"    has minimal to no beneficial effect. While there is little information in the literature regarding the specific duration of these episodes, most patients' episodes last anywhere from several hours to several days. This distinguishes the episodes from laryngospasm which usually last seconds to a few minutes. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Some patients with PVCM experience dysphonia during or between attacks. On examination this is often associated with vocal cord hyperfunction (eg, excessive false vocal cord adduction and anterior-superior laryngeal compression during phonation). There are no reports yet of formal voice analysis in these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16009?source=see_link\">",
"     \"Hoarseness in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, acute respiratory distress may be of such severity that patients require endotracheal intubation or tracheotomy to restore airway patency before diagnostic tests can be performed. Immediately afterwards, cessation of wheezing and stridor is noted, suggesting that the airflow limitation was due to an upper airway process instead of asthma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most useful tests in evaluating PVCM are pulmonary function tests (including flow volume loops and bronchoprovocation challenge) and laryngoscopy. In addition, patients with PVCM should be assessed for underlying psychosocial disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pulmonary function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients have normal expiratory spirometry, and a few have mild restrictive physiology. In contrast, flow-volume curves often show flattening of the inspiratory loop and an increased ratio of forced expiratory flow to forced inspiratory flow at 50 percent vital capacity, consistent with extrathoracic airway obstruction (",
"    <a class=\"graphic graphic_figure graphicRef76811 \" href=\"UTD.htm?34/31/35325\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/25\">",
"     25",
"    </a>",
"    ]. However, flow-volume loops may be normal when the patient is asymptomatic between episodes.",
"   </p>",
"   <p>",
"    PVCM may be induced with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    inhalation presumably through an irritant mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/26\">",
"     26",
"    </a>",
"    ]. However, normal flow volume loops after methacholine do not rule out PVCM. Methacholine inhalation challenge may be most helpful in conjunction with laryngoscopy to confirm that airflow limitation is due to PVCM and not asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=see_link\">",
"     \"Bronchoprovocation testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arterial blood gases usually do not show significant abnormalities, although mild hypercapnia may occur. The alveolar-arterial oxygen difference remains normal [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiographs are generally not helpful, other than to exclude an intrathoracic cause of dyspnea. Diagnosis of PVCM by fluoroscopy and by color flow Doppler has been reported, but these techniques have not been standardized against direct visualization with flexible fiberoptic laryngoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Laryngoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visualization of the cords using a flexible fiberoptic laryngoscope confirms the diagnosis by revealing abnormal adduction of the true cords (just during inspiration, throughout the respiratory cycle, or rarely just during expiration); the glottic aperture may be obliterated except for a posterior diamond-shaped passage [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. There may also be adduction or bunching of the false vocal cords [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/3,7,30\">",
"     3,7,30",
"    </a>",
"    ]. Although these findings are normally seen only during an acute episode, they can often be reproduced on examination when the patient is asked to mimic what happens during an attack.",
"   </p>",
"   <p>",
"    It is important that the procedure is performed by an experienced laryngoscopist who is aware of this disorder to avoid misdiagnosis of bilateral true vocal cord fixation or paralysis, laryngopharyngeal reflux, or laryngeal edema. Normal vocal cord motion may be restored by asking the patient to cough or breathe in a panting manner [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/30\">",
"     30",
"    </a>",
"    ]. It has been noted that the stridor resolves completely when the patient is asleep or in some cases when the patient is unaware of being observed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/1,31\">",
"     1,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/10/33960?source=see_link\">",
"     \"Laryngopharyngeal reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients suspected of having PVCM, a thorough evaluation for asthma and causes of upper airway obstruction is essential. Certain clues may indicate that a patient is suffering from PVCM rather than asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=see_link\">",
"     \"Diagnosis of asthma in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Subjectively more difficulty on inspiration than expiration",
"     </li>",
"     <li>",
"      Minimal response to aggressive asthma treatment",
"     </li>",
"     <li>",
"      A flattened inspiratory flow-volume loop",
"     </li>",
"     <li>",
"      Normal expiratory spirometry, lung volumes, and arterial blood gas measurements",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PVCM should also be differentiated from other causes of upper airway obstruction including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Laryngeal angioedema due to anaphylaxis, angiotensin converting enzyme inhibitor therapy, and C1 inhibitor deficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=see_link\">",
"       \"An overview of angioedema: Pathogenesis and causes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Paroxysmal laryngospasm usually occurs in an older patient population than does PVCM, often in the setting of a viral upper respiratory infection, or in a pediatric population in the setting of general anesthesia [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/33\">",
"       33",
"      </a>",
"      ]. It is associated with aphonia and a choking sensation; may awaken patients from sleep; or be initiated by coughing. Unlike PVCM, the time course of laryngospasm is so limited (eg, seconds to minutes) that it is rarely observed by the clinician. Laryngospasm may also be triggered by laryngopharyngeal reflux. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/10/33960?source=see_link\">",
"       \"Laryngopharyngeal reflux\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Structural lesions causing upper airway obstruction (eg, vocal cord polyps, glottic and tracheal tumors, tracheal stenosis) should also be excluded. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"       \"Diagnosis and management of central airway obstruction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vocal cord paralysis as in bilateral abductor paralysis caused by recurrent laryngeal or vagus nerve injury or neuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various treatment strategies have been used for PVCM, although none have been studied in a controlled fashion. In general, therapies for asthma such as beta adrenergic agents and inhaled glucocorticoids are not beneficial. It is helpful to separate treatment approaches into acute management and long-term prevention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Acute management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute management strategies that may be useful include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reassurance and supportive care until the episode spontaneously resolves. Asking patients to pant can sometimes abort an episode; panting activates the posterior cricoarytenoid muscle causing abduction of the true vocal cords [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Use of continuous positive airway pressure (CPAP) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/7,36\">",
"       7,36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=see_link\">",
"       \"Noninvasive positive pressure ventilation in acute respiratory failure in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inhalation of a helium oxygen mixture (heliox) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/3,37\">",
"       3,37",
"      </a>",
"      ]. In a case series, four of five PVCM patients experienced an improvement in symptoms and in associated anxiety with heliox inhalation during acute episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/37\">",
"       37",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/54/30568?source=see_link\">",
"       \"Physiology and clinical use of heliox\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endotracheal intubation or tracheostomy is rarely needed, and is usually performed only when the diagnosis has not been confirmed [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Long-term prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term prevention strategies usually employ a coordinated approach combining speech therapy and sometimes psychological counseling [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/23,38\">",
"     23,38",
"    </a>",
"    ]. There are no published studies on the efficacy of either psychodynamic therapy or psychopharmacologic treatment for PVCM.",
"   </p>",
"   <p>",
"    The first step is to convince the patient of the validity of the diagnosis, which may be difficult since the diagnosis is often delayed, and some patients have been treated chronically and aggressively for asthma. Many such patients strongly believe that their health depends upon continuing their longstanding asthma medications. When PVCM coexists with asthma, medications for asthma should be continued during treatment for PVCM.",
"   </p>",
"   <p>",
"    The diagnosis of PVCM should be explained in a nonjudgmental fashion that strives to maintain patient dignity. A useful analogy is to describe how muscle spasms in the neck and shoulder can be related to stress; the muscle spasm isn't under conscious control; and nothing is structurally wrong with the neck. Similar to neck muscle spasm, muscle relaxation and psychological counseling to reduce stress are appropriate treatments for PVCM.",
"   </p>",
"   <p>",
"    Success has been reported with",
"    <span class=\"nowrap\">",
"     speech/voice",
"    </span>",
"    therapy that uses breathing, voice, and neck relaxation exercises to abort the onset of PVCM episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/2,3,7,23,39-45\">",
"     2,3,7,23,39-45",
"    </a>",
"    ]. A speech therapy intervention focusing on respiratory control in 20 adolescent female athletes yielded symptom control for 6 months and allowed continued participation in athletic endeavors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/13\">",
"     13",
"    </a>",
"    ]. In another study all five patients with documented PVCM improved with respiratory retraining [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/46\">",
"     46",
"    </a>",
"    ]. Techniques including focusing attention away from the larynx and inspiration, using abdominal muscles for breathing, and relaxing the neck muscles were helpful in another series of five patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exercise associated PVCM may respond to the above described psychological counseling and speech therapy with relaxation exercises. In addition, pretreatment with an anticholinergic medication prior to exercise may be beneficial. As an example, in an uncontrolled case series, exercise induced PVCM was prevented in six of seven patients who used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/37/33360?source=see_link\">",
"     ipratropium",
"    </a>",
"    prior to exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/47\">",
"     47",
"    </a>",
"    ]. Successful use of inspiratory resistive training with a pressure-loaded respiratory muscle trainer has been described in case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. As an example, an 18-year old soccer player experienced resolution of PVCM symptoms after five weeks of a five day per week regimen (five sets of 12 breaths) of inspiratory muscle training [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16567/abstract/49\">",
"     49",
"    </a>",
"    ]. The inspiratory resistance was set at 75 percent of maximum inspiratory capacity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Paradoxical vocal cord motion (PVCM) refers to an inappropriate adduction of the true vocal cords, most prominently on inspiration. This results in dyspnea and often inspiratory stridor. Rarely, vocal cord adduction will be worse on expiration. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PVCM occurs most commonly in women between the ages of 20 and 40, but has also been reported in men and in the pediatric population. Many of these patients have a history of prior psychiatric illness. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PVCM may be triggered by exercise or irritant exposure, or may occur spontaneously. Postoperative PVCM has also been described. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PVCM is often mistaken for asthma because it is episodic, may be brought on by exertion, and the stridor may sound similar to wheezing. Some patients have both asthma and PVCM. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laryngospasm also causes an acute onset of true vocal cord adduction, but these episodes are of much shorter duration and usually occur in a different patient population from PVCM. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Flow-volume curves may show flattening of the inspiratory loop and an increased ratio of forced expiratory flow to forced inspiratory flow at 50 percent vital capacity, consistent with extrathoracic airway obstruction (",
"      <a class=\"graphic graphic_figure graphicRef76811 \" href=\"UTD.htm?34/31/35325\">",
"       figure 1",
"      </a>",
"      ). Between episodes, spirometry is often normal. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is confirmed by flexible fiberoptic laryngoscopy with visualization of abnormal adduction of the cords; during inspiration the glottic aperture may be obliterated except for a posterior diamond-shaped passage. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with an acute episode of PVCM, we suggest initially using a combination of reassurance and panting maneuvers (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If this is not effective, continuous positive airway pressure (CPAP) may be helpful; inhalation of a helium oxygen mixture would be another alternative. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with recurrent PVCM, we suggest a long-term management strategy that combines speech therapy, psychological counseling, and avoidance of laryngeal irritants (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Patients with exercise related PVCM may benefit from using an inhaled anticholinergic agent prior to exercise. When PVCM coexists with asthma, medications for asthma should be continued during treatment for PVCM. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17199289\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Keith Saxon, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/1\">",
"      Patterson R, Schatz M, Horton M. Munchausen's stridor: non-organic laryngeal obstruction. Clin Allergy 1974; 4:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/2\">",
"      Skinner DW, Bradley PJ. Psychogenic stridor. J Laryngol Otol 1989; 103:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/3\">",
"      Christopher KL, Wood RP 2nd, Eckert RC, et al. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983; 308:1566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/4\">",
"      McCool FD. Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:48S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/5\">",
"      Perkner JJ, Fennelly KP, Balkissoon R, et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med 1998; 40:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/6\">",
"      Newman KB, Mason UG 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995; 152:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/7\">",
"      Goldman J, Muers M. Vocal cord dysfunction and wheezing. Thorax 1991; 46:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/8\">",
"      Martin, RJ, Blager, FB, Gay, ML. Paradoxical vocal cord motion in presumed asthmatics. Semin Respir Med 1987; 8:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/9\">",
"      Freedman MR, Rosenberg SJ, Schmaling KB. Childhood sexual abuse in patients with paradoxical vocal cord dysfunction. J Nerv Ment Dis 1991; 179:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/10\">",
"      Maricle R. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983; 309:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/11\">",
"      Powell SA, Nguyen CT, Gaziano J, et al. Mass psychogenic illness presenting as acute stridor in an adolescent female cohort. Ann Otol Rhinol Laryngol 2007; 116:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/12\">",
"      Gavin LA, Wamboldt M, Brugman S, et al. Psychological and family characteristics of adolescents with vocal cord dysfunction. J Asthma 1998; 35:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/13\">",
"      Sullivan MD, Heywood BM, Beukelman DR. A treatment for vocal cord dysfunction in female athletes: an outcome study. Laryngoscope 2001; 111:1751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/14\">",
"      Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest 2003; 123:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/15\">",
"      Morris MJ, Deal LE, Bean DR, et al. Vocal cord dysfunction in patients with exertional dyspnea. Chest 1999; 116:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/16\">",
"      Woo P, Mangaro M. Aberrant recurrent laryngeal nerve reinnervation as a cause of stridor and laryngospasm. Ann Otol Rhinol Laryngol 2004; 113:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/17\">",
"      Arndt GA, Voth BR. Paradoxical vocal cord motion in the recovery room: a masquerader of pulmonary dysfunction. Can J Anaesth 1996; 43:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/18\">",
"      Hammer G, Schwinn D, Wollman H. Postoperative complications due to paradoxical vocal cord motion. Anesthesiology 1987; 66:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/19\">",
"      Harbison J, Dodd J, McNicholas WT. Paradoxical vocal cord motion causing stridor after thyroidectomy. Thorax 2000; 55:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/20\">",
"      Larsen B, Caruso LJ, Villariet DB. Paradoxical vocal cord motion: an often misdiagnosed cause of postoperative stridor. J Clin Anesth 2004; 16:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/21\">",
"      Powell DM, Karanfilov BI, Beechler KB, et al. Paradoxical vocal cord dysfunction in juveniles. Arch Otolaryngol Head Neck Surg 2000; 126:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/22\">",
"      Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002; 112:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/23\">",
"      Maturo S, Hill C, Bunting G, et al. Pediatric paradoxical vocal-fold motion: presentation and natural history. Pediatrics 2011; 128:e1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/24\">",
"      Thomas PS, Geddes DM, Barnes PJ. Pseudo-steroid resistant asthma. Thorax 1999; 54:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/25\">",
"      Mobeireek A, Alhamad A, Al-Subaei A, Alzeer A. Psychogenic vocal cord dysfunction simulating bronchial asthma. Eur Respir J 1995; 8:1978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/26\">",
"      Perkins PJ, Morris MJ. Vocal cord dysfunction induced by methacholine challenge testing. Chest 2002; 122:1988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/27\">",
"      Guss J, Mirza N. Methacholine challenge testing in the diagnosis of paradoxical vocal fold motion. Laryngoscope 2006; 116:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/28\">",
"      Nastasi KJ, Howard DA, Raby RB, et al. Airway fluoroscopic diagnosis of vocal cord dysfunction syndrome. Ann Allergy Asthma Immunol 1997; 78:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/29\">",
"      Ooi LL. Re: Vocal cord dysfunction: two case reports. Ann Acad Med Singapore 1997; 26:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/30\">",
"      Sokol W. Vocal cord dysfunction presenting as asthma. West J Med 1993; 158:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/31\">",
"      Downing ET, Braman SS, Fox MJ, Corrao WM. Factitious asthma. Physiological approach to diagnosis. JAMA 1982; 248:2878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/32\">",
"      Corren J, Newman KB. Vocal cord dysfunction mimicking bronchial asthma. Postgrad Med 1992; 92:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/33\">",
"      Maceri DR, Zim S. Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD). Laryngoscope 2001; 111:1976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/34\">",
"      Randolph C, Lapey A, Shannon DC. Bilateral abductor paresis masquerading as asthma. J Allergy Clin Immunol 1988; 81:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/35\">",
"      Pitchenik AE. Functional laryngeal obstruction relieved by panting. Chest 1991; 100:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/36\">",
"      Heiser JM, Kahn ML, Schmidt TA. Functional airway obstruction presenting as stridor: a case report and literature review. J Emerg Med 1990; 8:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/37\">",
"      Weir M. Vocal cord dysfunction mimics asthma and may respond to heliox. Clin Pediatr (Phila) 2002; 41:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/38\">",
"      Christopher KL, Morris MJ. Vocal cord dysfunction, paradoxic vocal fold motion, or laryngomalacia? Our understanding requires an interdisciplinary approach. Otolaryngol Clin North Am 2010; 43:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/39\">",
"      Kivity S, Bibi H, Schwarz Y, et al. Variable vocal cord dysfunction presenting as wheezing and exercise-induced asthma. J Asthma 1986; 23:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/40\">",
"      Rogers JH, Stell PM. Paradoxical movement of the vocal cords as a cause of stridor. J Laryngol Otol 1978; 92:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/41\">",
"      Logvinoff MM, Lau KY, Weinstein DB, Chandra P. Episodic stridor in a child secondary to vocal cord dysfunction. Pediatr Pulmonol 1990; 9:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/42\">",
"      Cormier YF, Camus P, Desmeules MJ. Non-organic acute upper airway obstruction: description and a diagnostic approach. Am Rev Respir Dis 1980; 121:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/43\">",
"      Alpert SE, Dearborn DG, Kercsmar CM. On vocal cord dysfunction in wheezy children. Pediatr Pulmonol 1991; 10:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/44\">",
"      Pinho SM, Tsuji DH, Sennes L, Menezes M. Paradoxical vocal fold movement: a case report. J Voice 1997; 11:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/45\">",
"      McCabe D, Altman KW. Laryngeal hypersensitivity in the World Trade Center-exposed population: the role for respiratory retraining. Am J Respir Crit Care Med 2012; 186:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/46\">",
"      Murry T, Tabaee A, Aviv JE. Respiratory retraining of refractory cough and laryngopharyngeal reflux in patients with paradoxical vocal fold movement disorder. Laryngoscope 2004; 114:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/47\">",
"      Doshi DR, Weinberger MM. Long-term outcome of vocal cord dysfunction. Ann Allergy Asthma Immunol 2006; 96:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/48\">",
"      Ruddy BH, Davenport P, Baylor J, et al. Inspiratory muscle strength training with behavioral therapy in a case of a rower with presumed exercise-induced paradoxical vocal-fold dysfunction. Int J Pediatr Otorhinolaryngol 2004; 68:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/49\">",
"      Mathers-Schmidt BA, Brilla LR. Inspiratory muscle training in exercise-induced paradoxical vocal fold motion. J Voice 2005; 19:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16567/abstract/50\">",
"      Murry T, Sapienza C. The role of voice therapy in the management of paradoxical vocal fold motion, chronic cough, and laryngospasm. Otolaryngol Clin North Am 2010; 43:73.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 523 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-122.72.76.133-24348CF07F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16567=[""].join("\n");
var outline_f16_11_16567=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Psychosocial disorders and stress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Neurologic injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Postoperative",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Gastroesophageal reflux",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Irritants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pulmonary function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Laryngoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Acute management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Long-term prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17199289\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/523\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/523|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/31/35325\" title=\"figure 1\">",
"      Flow volume loops in airway obstruction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/31/38391?source=related_link\">",
"      An overview of angioedema: Pathogenesis and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/4/1098?source=related_link\">",
"      Bronchoprovocation testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=related_link\">",
"      Diagnosis and management of central airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19482?source=related_link\">",
"      Diagnosis of asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/48/36613?source=related_link\">",
"      Diagnosis of wheezing illnesses other than asthma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/49/14105?source=related_link\">",
"      Evaluation of severe asthma in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=related_link\">",
"      Factitious disorder and Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16009?source=related_link\">",
"      Hoarseness in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/10/33960?source=related_link\">",
"      Laryngopharyngeal reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=related_link\">",
"      Noninvasive positive pressure ventilation in acute respiratory failure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11434?source=related_link\">",
"      Overview of the management of postoperative pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/54/30568?source=related_link\">",
"      Physiology and clinical use of heliox",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_11_16568="Motility testing: When does it help?";
var content_f16_11_16568=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Motility testing: When does it help?",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16568/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16568/contributors\">",
"     Anthony J Lembo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16568/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16568/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16568/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16568/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/11/16568/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine motility tests such as esophageal manometry, gastric emptying, and anorectal manometry have become readily available. However, the utility of these tests in clinical practice and their appropriate indications are incompletely understood.",
"   </p>",
"   <p>",
"    This topic will review the indications for and utility of esophageal manometry, gastric emptying studies, and anorectal manometry. Specialized motility tests such as antroduodenal manometry, electrogastrography, and colonic manometry are under development and will not be discussed. Specific motility disorders are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13096?source=see_link\">",
"     \"Diffuse esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link\">",
"     \"Clinical manifestations and diagnosis of achalasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=see_link\">",
"     \"Etiology and diagnosis of delayed gastric emptying\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link\">",
"     \"Fecal incontinence in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link\">",
"     \"Etiology and evaluation of chronic constipation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Gastroenterological Association (AGA) guideline for the clinical use of esophageal manometry [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/1\">",
"     1",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ESOPHAGEAL MANOMETRY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal manometry is most useful in evaluating patients with dysphagia, noncardiac chest pain, and prior to antireflux surgery. It may also be helpful for excluding generalized gastrointestinal (GI) tract disease such as scleroderma or chronic idiopathic intestinal pseudo-obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/17/12569?source=see_link\">",
"     \"Evaluation of dysphagia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=see_link\">",
"     \"Chest pain of esophageal origin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=see_link\">",
"     \"Surgical management of gastroesophageal reflux in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29224?source=see_link&amp;anchor=H9#H9\">",
"     \"Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults\", section on 'Gastrointestinal involvement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/26/2474?source=see_link\">",
"     \"Chronic intestinal pseudo-obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Technical aspects",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two manometric methods in use today are the low compliance water-perfused catheter system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/2\">",
"     2",
"    </a>",
"    ] and the solid-state pressure system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/3\">",
"     3",
"    </a>",
"    ]. Placement of the transducers, configuration, and recording must be done accurately to assure the reliability of the data. Both systems are acceptable methods of performing routine esophageal manometry, although each has its advantages. The AGA technical review for the clinical use of esophageal manometry [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/4\">",
"     4",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The water-perfused system has the advantage of being relatively durable and inexpensive. Its disadvantages include the need for skilled personnel in its maintenance and use, and its inability to accurately record pharyngeal pressures.",
"     </li>",
"     <li>",
"      The solid-state system's extended frequency response makes it suitable for recording any intraluminal pressure activity, including that of the pharynx, and its baseline is not affected by body position. The high resolution manometry (HRM) assembly consists of a 36-channel catheter with circumferential sensors spaced at 1 cm intervals (",
"      <a class=\"graphic graphic_figure graphicRef77263 \" href=\"UTD.htm?37/13/38102\">",
"       figure 1",
"      </a>",
"      ). Space-time pressure data are displayed in a topographical form for analysis. Studies using the HRM suggest enhanced performance and accuracy for assessing pressure changes, especially in the sphincters [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/5\">",
"       5",
"      </a>",
"      ] over conventional manometry [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17785?source=see_link\">",
"       \"High resolution manometry\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dysphagia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate testing of patients who present with dysphagia depends upon the distinction between oropharyngeal and esophageal dysphagia. The former arises from disease of the upper esophagus and pharynx or from dysfunction of the upper esophageal sphincter (UES), while the latter arises from disorders affecting the body of the esophagus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2037?source=see_link\">",
"     \"Pathogenesis and clinical manifestations of oropharyngeal dysphagia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The history may provide clues that help distinguish between the two forms of dysphagia. As an example, patients with any cause of oropharyngeal dysphagia complain of symptoms immediately upon swallowing; by comparison, the onset of symptoms after swallowing is delayed in patients with esophageal dysphagia. Patients with oropharyngeal dysphagia point toward the cervical region when asked to identify the site of their symptoms; however, because the interpretation of visceral innervation is imprecise, dysphagia related to distal esophageal disease, such as a peptic stricture, may sometimes be felt in the suprasternal notch. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17000?source=see_link\">",
"     \"Diagnosis and treatment of oropharyngeal dysphagia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Esophageal manometry is seldom useful for the evaluation of patients with oropharyngeal dysphagia. By contrast, manometry may be helpful in patients who have esophageal dysphagia. Dysphagia in such patients may be due to mechanical causes, inflammation, or a motility disturbance. An upper endoscopy with or without a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    esophagram is usually the initial test of choice for excluding mechanical obstruction (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/17/12569?source=see_link&amp;anchor=H17#H17\">",
"     \"Evaluation of dysphagia in adults\", section on 'Specific testing'",
"    </a>",
"    ). Manometry should be performed if these initial tests are negative or nondiagnostic, or to confirm a specific diagnosis, such as achalasia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The value of manometry was demonstrated in a series of 251 patients with dysphagia in whom manometric abnormalities were detected in 53 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/7\">",
"     7",
"    </a>",
"    ]. Of these patients, 36 percent had achalasia and 38 percent had nonspecific esophageal motility disorders.",
"   </p>",
"   <p>",
"    Despite the high prevalence of nonspecific esophageal motility disorders in patients with dysphagia, their clinical significance is uncertain. For many patients, abnormal findings on motility studies do not correlate well with symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. As an example, esophageal bolus transit is usually normal in patients with nutcracker esophagus (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69821 \" href=\"UTD.htm?26/30/27118\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13096?source=see_link\">",
"     \"Diffuse esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17785?source=see_link&amp;anchor=H1871924#H1871924\">",
"     \"High resolution manometry\", section on 'Distal esophageal spasm (DES)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17785?source=see_link&amp;anchor=H1871168#H1871168\">",
"     \"High resolution manometry\", section on 'Hypertensive peristalsis (\"nutcracker esophagus\")'",
"    </a>",
"    .) Furthermore, therapeutic options for patients who have dysphagia and are diagnosed with esophageal motility disorders are limited. An exception is the diagnosis of achalasia, for which definitive treatment is available. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=see_link\">",
"     \"Clinical manifestations and diagnosis of achalasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=see_link\">",
"     \"Overview of the treatment of achalasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Gastroesophageal reflux disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with typical symptoms of esophageal reflux rarely require esophageal manometry for diagnosis or management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gastroesophageal reflux in adults\"",
"    </a>",
"    .) Some elements associated with gastroesophageal reflux disease (GERD) are evident manometrically, such as impaired peristalsis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/12\">",
"     12",
"    </a>",
"    ], decreased peristaltic amplitude, hypotensive lower esophageal sphincter (LES), and excessive transient relaxations. However, their presence does not predict the presence or severity of reflux.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Prior to antireflux surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important role of esophageal manometry in patients with GERD has traditionally been for evaluation prior to antireflux surgery. Manometry occasionally provides alternative diagnoses, such as scleroderma or achalasia, for which antireflux surgery may be contraindicated. In addition, manometry may lead to a modification of the surgical approach or a change in management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=see_link\">",
"     \"Surgical management of gastroesophageal reflux in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the need to modify the surgical procedure based upon the manometric findings has been questioned. One of the only controlled trials addressing this issue included 200 patients with a history of longstanding GERD who were randomly assigned to a standard laparoscopic Nissen fundoplication or to a modified \"Toupet\" fundoplication independent of the results of preoperative esophageal motility testing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/13\">",
"     13",
"    </a>",
"    ]. The Toupet fundoplication is usually recommended for patients with significant esophageal dysmotility since it involves a 270 rather than a 360 degree wrap. The authors found that preoperative esophageal dysmotility was associated with significantly more severe reflux symptoms and resistance to medical treatment. However, the postoperative clinical outcomes and reflux recurrence were similar in the two groups, suggesting that the presence of esophageal dysmotility does not require tailoring of the surgical approach.",
"   </p>",
"   <p>",
"    It is unclear whether these findings can be generalized [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/14\">",
"     14",
"    </a>",
"    ]. First, other centers have reported better outcomes with a modified Toupet procedure compared to a full Nissen fundoplication in patients with preoperative dysmotility [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/15\">",
"     15",
"    </a>",
"    ]. Second, one criterion that the authors used to define dysmotility (distal esophageal amplitude less than 40 mmHg) is conservative compared with the thresholds used in other centers. Other criteria, such as the number of failed or nontransmitted contractions may have greater relevance to postoperative symptoms. Third, the follow-up of four months was too short to determine the effectiveness of antireflux surgery. Finally, information on preoperative motility testing may be valuable for comparison in patients who require motility testing after surgery for persisting symptoms.",
"   </p>",
"   <p>",
"    Nonspecific motility disturbances such as low-amplitude peristaltic contractions, intermittent simultaneous contractions, and failed peristalsis are not contraindications to antireflux surgery since these abnormalities are probably secondary to the reflux [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/16\">",
"     16",
"    </a>",
"    ]. Whether these improve following antireflux surgery is controversial since a multitude of studies support disparate conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/14,17\">",
"     14,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Noncardiac chest pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;An esophageal source should be considered for chest pain only after cardiopulmonary factors are carefully investigated. Although esophageal manometry is often abnormal in patients with noncardiac chest pain, similar pain may result from many common esophageal disorders. For this reason, a patient complaining of chest pain should undergo manometry only after upper endoscopy and exclusion of gastroesophageal reflux (GERD). GERD is the most common cause of noncardiac chest pain and much more common than esophageal motility disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=see_link\">",
"     \"Chest pain of esophageal origin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Multisystem diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic diseases of the smooth muscle or autonomic nervous system may be evident on esophageal manometry. Patients with scleroderma and other collagen vascular diseases may have weak or absent peristalsis and low LES pressure (in contrast to achalasia in which the LES pressure is elevated or normal) (",
"    <a class=\"graphic graphic_figure graphicRef77263 \" href=\"UTD.htm?37/13/38102\">",
"     figure 1",
"    </a>",
"    ). Histologic evidence of esophageal involvement occurs in as many as 74 percent of patients with typical skin manifestations of scleroderma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/18\">",
"     18",
"    </a>",
"    ]. Similar associations have been found with other connective tissue diseases such as CREST syndrome, polymyositis, dermatomyositis, and mixed connective tissue disease, especially in patients in whom the Raynaud phenomenon is present. Such conditions often result in gastroesophageal reflux or dysphagia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/35/41529?source=see_link\">",
"     \"Gastrointestinal manifestations of systemic sclerosis (scleroderma)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43401?source=see_link\">",
"     \"Clinical manifestations of mixed connective tissue disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     GASTRIC EMPTYING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are suspected of having impaired gastric emptying should undergo evaluation by endoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    studies to exclude mucosal or structural disorders that could be contributing to symptoms. In addition, an assessment of gastric emptying study may be beneficial for patients with [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Unexplained nausea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vomiting",
"     </li>",
"     <li>",
"      \"Motility-like\" nonulcer dyspepsia",
"     </li>",
"     <li>",
"      Diabetes in whom gastroparesis is suspected (particularly those with poor glycemic control)",
"     </li>",
"     <li>",
"      Suspected dumping or stasis syndrome following gastric surgery",
"     </li>",
"     <li>",
"      Refractory gastroesophageal reflux disease",
"     </li>",
"     <li>",
"      Suspected chronic intestinal pseudoobstruction",
"     </li>",
"     <li>",
"      Known gastric emptying disturbance in whom an objective evidence of a response to motility-altering drugs is desired",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most commonly performed test to evaluate gastric emptying is gastric scintigraphy. This test involves ingestion of a test standard meal (typically &gt;200 kcal) labeled with a radioactive isotope (99mTc for solids and 111 Indium for liquids) and measurement of the percentage of gastric emptying after two and four hours. As a general rule, emptying of solids is more significant than emptying of liquids, since liquids usually empty normally unless the gastroparesis is severe. Emptying of liquids may be important in patients who are suspected of having dumping. Gastric emptying tests vary considerably, and therefore individual results should be interpreted cautiously unless the results are unequivocal. Excessively fast gastric emptying may be associated with dyspeptic symptoms in some patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=see_link\">",
"     \"Etiology and diagnosis of delayed gastric emptying\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A relatively new approach for measuring gastric emptying involves a wireless motility capsule (SmartPill&reg;, Buffalo, NY) that is used for the evaluation of gastric emptying in patients with suspected delayed gastric emptying (gastroparesis) and for the evaluation of colonic transit time in patients with chronic constipation (",
"    <a class=\"graphic graphic_figure graphicRef77372 \" href=\"UTD.htm?39/34/40490\">",
"     figure 2",
"    </a>",
"    ). The wireless motility capsule is an ingestible, wireless capsule (26 mm x 13 mm) with a battery life of at least five days that measures pressure, pH, and temperature as it traverses the GI tract [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastric emptying of the wireless motility capsule appears to occur with the Phase III migrating motor complex, signifying completion of the postprandial phase and return of the fasting state [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/22\">",
"     22",
"    </a>",
"    ]. The wireless motility capsule is able to assess regional transit times (ie, gastric emptying, small bowel and colonic transit time) and contractility throughout the GI tract. To date, the accumulated evidence validates the use of the wireless motility capsule for reliable measurement of gastric emptying time [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/21\">",
"     21",
"    </a>",
"    ] and colonic [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/23,24\">",
"     23,24",
"    </a>",
"    ] and whole gut transit time [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/25\">",
"     25",
"    </a>",
"    ]. It is particularly useful for testing individuals with suspected alterations of GI motility in multiple regions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/26\">",
"     26",
"    </a>",
"    ]. The wireless motility capsule study also provides information about GI contractility, such as the frequency of contraction, amplitude of contractions, and motility indexes, for which reference values are available for the gastric and proximal small bowel regions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686006\">",
"    <span class=\"h1\">",
"     ANORECTAL MANOMETRY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal manometry is most useful in patients with fecal incontinence and constipation, and may be performed in conjunction with additional tests of anorectal function (such as defecography, pelvic floor electromyography, and anal endosonography) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. After establishing a diagnosis, anorectal manometry can also be used therapeutically as part of biofeedback retraining [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30616?source=see_link&amp;anchor=H30890995#H30890995\">",
"     \"Management of chronic constipation in adults\", section on 'Biofeedback'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of catheters exist for measuring anorectal motility, each with advantages and disadvantages [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/32\">",
"     32",
"    </a>",
"    ]. Each permits measurements of anal sphincter pressure, rectal compliance and sensation, and anorectal inhibitory reflex, which comprise the essential components of anorectal manometry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686013\">",
"    <span class=\"h2\">",
"     Fecal incontinence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal manometry can help establish the diagnosis in patients in whom no cause of fecal incontinence is apparent based upon endoscopic and general clinical and neurologic evaluation (",
"    <a class=\"graphic graphic_table graphicRef74995 \" href=\"UTD.htm?25/38/26220\">",
"     table 1",
"    </a>",
"    ). Such patients often have decreased anal sphincter pressures at rest and during voluntary contraction, and have absent external sphincter contraction during rectal distension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In women, the pudendal nerve or anal sphincter may be injured during childbirth, which may contribute to weakening of continence mechanisms. This should be suspected when incontinence develops after childbirth, or in patients in whom abnormal symmetry of the anal sphincter is suspected on digital examination. In such cases, the diagnosis can be established by combining anorectal manometry and anal endosonography. In one series that evaluated this approach, the combination of these two tests correctly identified 90 percent of known anal sphincter injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link\">",
"     \"Fecal incontinence in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686020\">",
"    <span class=\"h3\">",
"     Biofeedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although biofeedback has been used for many years in the treatment of fecal incontinence, a benefit compared with other conservative treatments has not been clearly demonstrated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link&amp;anchor=H29#H29\">",
"     \"Fecal incontinence in adults\", section on 'Biofeedback'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686027\">",
"    <span class=\"h2\">",
"     Constipation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anorectal manometry can identify the cause of constipation in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=see_link\">",
"     \"Etiology and evaluation of chronic constipation in adults\"",
"    </a>",
"    .) However, the physiology of defecation and the correlation between manometric findings and other objective measures of anorectal function are not completely understood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/37\">",
"     37",
"    </a>",
"    ]. Furthermore, psychologic factors may influence test results in the laboratory setting. Thus, optimal patient selection for anorectal manometry in the evaluation of constipation is not well-established. As a general rule, anorectal manometry may be useful in constipated patients in whom nonmechanical causes of obstructive defecation are suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686034\">",
"    <span class=\"h3\">",
"     Pelvic floor dyssynergia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with pelvic floor dyssynergia or obstructive defecation do not straighten the anorectal angle during defecation as a result of failed relaxation of the puborectalis muscle and the external anal sphincter [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/38\">",
"     38",
"    </a>",
"    ]. The diagnosis is suggested during anorectal manometry by inappropriate contraction of the external anal sphincter while the patient is attempting to stimulate defecation (",
"    <a class=\"graphic graphic_figure graphicRef54087 \" href=\"UTD.htm?1/13/1237\">",
"     figure 3",
"    </a>",
"    ). However, a similar pattern can be seen in as many as 20 percent of healthy controls. The etiology of dyssynergia is not completely understood, but it may arise as a learned behavior to avoid the discomfort associated with defecating large, hard stool. The balloon expulsion test may also be useful for diagnosing this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686041\">",
"    <span class=\"h3\">",
"     Reduced rectal sensation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reduced rectal sensation during balloon distention can be associated with increased rectal compliance or megarectum, which is often seen in children and elderly persons with fecal impaction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686048\">",
"    <span class=\"h3\">",
"     Hirschsprung's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children and young adults with severe constipation from birth should be assessed for Hirschsprung's disease (congenital megacolon), a disorder associated with absence of intramural ganglion cells of the submucosal and myenteric plexuses as a result of arrest of neural crest cell migration during embryonic development. The presence of internal anal sphincter (IAS) relaxation on anorectal manometry excludes the diagnosis, while failure of the IAS to relax during rectal distention is suggestive of the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/40\">",
"     40",
"    </a>",
"    ]. In one report, the accuracy of motility testing (sensitivity and specificity of 83 and 93 percent respectively) for establishing the diagnosis in children suspected of having Hirschsprung's disease was similar to contrast studies, but less than that of a full-thickness biopsy (sensitivity and specificity of 93 and 100 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=see_link\">",
"     \"Congenital aganglionic megacolon (Hirschsprung disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A full thickness biopsy of the rectum should be performed to confirm the absence of ganglion cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/32\">",
"     32",
"    </a>",
"    ]. However, some patients have absence of ganglion cells in a short segment of the colon, in which case the only detectable abnormality may be absence of IAS relaxation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686055\">",
"    <span class=\"h3\">",
"     Biofeedback",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biofeedback may be helpful to some patients with nonmechanical causes of obstructive defecation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Three well-conducted randomized controlled studies suggest that biofeedback appears to be the preferred treatment for dyssynergic defecation in adults and is superior to the use of laxatives in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. Overall success rates are in the range of 70 to 80 percent.",
"   </p>",
"   <p>",
"    By contrast, the role of biofeedback for sphincter retraining in patients with slow transit constipation is questionable [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/47\">",
"     47",
"    </a>",
"    ]. Although multiple studies have been performed, they have not clearly identified subgroups of patients in whom biofeedback is most likely to be successful. A systematic review suggested that it may be most effective in patients with constipation in whom symptoms appear to have a significant psychological basis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16568/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30616?source=see_link\">",
"     \"Management of chronic constipation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42686770\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Esophageal manometry is most useful in evaluating patients with dysphagia, noncardiac chest pain, and prior to antireflux surgery. It may also be helpful for excluding generalized gastrointestinal (GI) tract disease such as scleroderma or chronic idiopathic intestinal pseudo-obstruction. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Esophageal manometry'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Esophageal manometry is seldom useful for the evaluation of patients with oropharyngeal dysphagia. By contrast, manometry may be helpful in patients who have esophageal dysphagia. Dysphagia in such patients may be due to mechanical causes, inflammation, or a motility disturbance. An upper endoscopy with or without a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      esophagram is usually the initial test of choice for excluding mechanical obstruction. Manometry should be performed if these initial tests are negative or nondiagnostic, or to confirm a specific diagnosis, such as achalasia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Dysphagia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Esophageal manometry is important in patients with GERD prior to antireflux surgery. Manometry may provide an alternative diagnosis, such as scleroderma or achalasia, for which antireflux surgery may be contraindicated. In addition, manometry may lead to a modification of the surgical approach or a change in management. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Gastroesophageal reflux disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Esophagea manometry may be part of the evaluation of noncardiac chest pain. However, an esophageal source should only be considered for chest pain after cardiopulmonary factors are carefully investigated. Although esophageal manometry is often abnormal in patients with noncardiac chest pain, similar pain may result from many common esophageal disorders. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Noncardiac chest pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who are suspected of having impaired gastric emptying should undergo evaluation by endoscopy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      studies to exclude mucosal or structural disorders that could be contributing to symptoms. If those tests are negative, gastric motility testing may be warranted. The most commonly performed test to evaluate gastric emptying is gastric scintigraphy. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Gastric emptying'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      An assessment of gastric emptying study may be beneficial for patients with:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Unexplained nausea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vomiting",
"     </li>",
"     <li>",
"      \"Motility-like\" nonulcer dyspepsia",
"     </li>",
"     <li>",
"      Diabetes in whom gastroparesis is suspected (particularly those with poor glycemic control)",
"     </li>",
"     <li>",
"      Suspected dumping or stasis syndrome following gastric surgery",
"     </li>",
"     <li>",
"      Refractory gastroesophageal reflux disease",
"     </li>",
"     <li>",
"      Suspected chronic intestinal pseudoobstruction",
"     </li>",
"     <li>",
"      Known gastric emptying disturbance in whom an objective evidence of a response to motility-altering drugs is desired",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A relatively new approach for measuring gastric emptying involves a wireless motility capsule that is used for the evaluation of gastric emptying in patients with suspected delayed gastric emptying (gastroparesis) and for the evaluation of colonic transit time in patients with chronic constipation. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Gastric emptying'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anorectal manometry is most useful in patients with fecal incontinence and constipation, and may be performed in conjunction with additional tests of anorectal function (such as defecography, pelvic floor electromyography, and anal endosonography). After establishing a diagnosis, anorectal manometry can also be used therapeutically as part of biofeedback retraining. (See",
"      <a class=\"local\" href=\"#H42686006\">",
"       'Anorectal manometry'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/1\">",
"      Pandolfino JE, Kahrilas PJ, American Gastroenterological Association. American Gastroenterological Association medical position statement: Clinical use of esophageal manometry. Gastroenterology 2005; 128:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/2\">",
"      Arndorfer RC, Stef JJ, Dodds WJ, et al. Improved infusion system for intraluminal esophageal manometry. Gastroenterology 1977; 73:23.",
"     </a>",
"    </li>",
"    <li>",
"     Vantrappen G, Janssens J. Manometric Techniques. In: Atlas of Gastrointestinal Motility in Health and Disease, Schuster M (Ed), Williams and Wilkins, Baltimore 1993. p.43.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/4\">",
"      Pandolfino JE, Kahrilas PJ, American Gastroenterological Association. AGA technical review on the clinical use of esophageal manometry. Gastroenterology 2005; 128:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/5\">",
"      Ghosh SK, Pandolfino JE, Zhang Q, et al. Quantifying esophageal peristalsis with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol 2006; 290:G988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/6\">",
"      Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology 2008; 135:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/7\">",
"      Katz PO, Dalton CB, Richter JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med 1987; 106:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/8\">",
"      Reidel WL, Clouse RE. Variations in clinical presentation of patients with esophageal contraction abnormalities. Dig Dis Sci 1985; 30:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/9\">",
"      Achem SR, Crittenden J, Kolts B, Burton L. Long-term clinical and manometric follow-up of patients with nonspecific esophageal motor disorders. Am J Gastroenterol 1992; 87:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/10\">",
"      Swift GL, Alban-Davies H, McKirdy H, et al. A long-term clinical review of patients with oesophageal pain. Q J Med 1991; 81:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/11\">",
"      Ott DJ, Richter JE, Chen YM, et al. Esophageal radiography and manometry: correlation in 172 patients with dysphagia. AJR Am J Roentgenol 1987; 149:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/12\">",
"      Kahrilas PJ, Dodds WJ, Hogan WJ, et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986; 91:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/13\">",
"      Fibbe C, Layer P, Keller J, et al. Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study. Gastroenterology 2001; 121:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/14\">",
"      Castell DO. Esophageal manometry prior to antireflux surgery: required, preferred, or even needed? Gastroenterology 2001; 121:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/15\">",
"      Lund RJ, Wetcher GJ, Raiser F, et al. Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility. J Gastrointest Surg 1997; 1:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/16\">",
"      Mughal MM, Bancewicz J, Marples M. Oesophageal manometry and pH recording does not predict the bad results of Nissen fundoplication. Br J Surg 1990; 77:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/17\">",
"      Heider TR, Behrns KE, Koruda MJ, et al. Fundoplication improves disordered esophageal motility. J Gastrointest Surg 2003; 7:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/18\">",
"      Rodnan GP. Dr. J. Claude Bennett to assume editorship. Arthritis Rheum 1975; 18:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/19\">",
"      Camilleri M, Hasler WL, Parkman HP, et al. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/20\">",
"      Parkman HP, Hutson A, Sarosiek I, et al. SmartPill capsule for assessment of gastric emptying: Comparison with simultaneous gastric emptying scintigraphy (abstract). Am J Gastroenterol 2006; 101(Suppl):S99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/21\">",
"      Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008; 27:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/22\">",
"      Cassilly D, Kantor S, Knight LC, et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008; 20:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/23\">",
"      Camilleri M, Thorne NK, Ringel Y, et al. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil 2010; 22:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/24\">",
"      Rao SS, Kuo B, McCallum RW, et al. Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation. Clin Gastroenterol Hepatol 2009; 7:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/25\">",
"      Maqbool S, Parkman HP, Friedenberg FK. Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit. Dig Dis Sci 2009; 54:2167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/26\">",
"      Rao SS, Camilleri M, Hasler WL, et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011; 23:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/27\">",
"      Kloetzer L, Chey WD, McCallum RW, et al. Motility of the antroduodenum in healthy and gastroparetics characterized by wireless motility capsule. Neurogastroenterol Motil 2010; 22:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/28\">",
"      Wald A. Colonic and anorectal motility testing in clinical practice. Am J Gastroenterol 1994; 89:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/29\">",
"      Rao SS, Patel RS. How useful are manometric tests of anorectal function in the management of defecation disorders? Am J Gastroenterol 1997; 92:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/30\">",
"      Noelting J, Ratuapli SK, Bharucha AE, et al. Normal values for high-resolution anorectal manometry in healthy women: effects of age and significance of rectoanal gradient. Am J Gastroenterol 2012; 107:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/31\">",
"      Glia A, Gylin M, Akerlund JE, et al. Biofeedback training in patients with fecal incontinence. Dis Colon Rectum 1998; 41:359.",
"     </a>",
"    </li>",
"    <li>",
"     Wald A. Anorectum. In: Atlas of Gastrointestinal Motility in Health and Disease, Schuster M (Ed), Williams and Wilkins, Baltimore 1993. p.229.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/33\">",
"      Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med 1992; 326:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/34\">",
"      Mitrani C, Chun A, Desautels S, Wald A. Anorectal manometric characteristics in men and women with idiopathic fecal incontinence. J Clin Gastroenterol 1998; 26:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/35\">",
"      Sentovich SM, Blatchford GJ, Rivela LJ, et al. Diagnosing anal sphincter injury with transanal ultrasound and manometry. Dis Colon Rectum 1997; 40:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/36\">",
"      Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med 1994; 121:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/37\">",
"      Papachrysostomou M, Smith AN. Effects of biofeedback on obstructive defecation--reconditioning of the defecation reflex? Gut 1994; 35:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/38\">",
"      Rao SS, Welcher KD, Leistikow JS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol 1998; 93:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/39\">",
"      Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology 2004; 126:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/40\">",
"      Osatakul S, Patrapinyokul S, Osatakul N. The diagnostic value of anorectal manometry as a screening test for Hirschsprung's disease. J Med Assoc Thai 1999; 82:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/41\">",
"      De Lorijn F, Reitsma JB, Voskuijl WP, et al. Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests. J Pediatr 2005; 146:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/42\">",
"      Rao SS, Welcher KD, Pelsang RE. Effects of biofeedback therapy on anorectal function in obstructive defecation. Dig Dis Sci 1997; 42:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/43\">",
"      Heymen S, Jones KR, Scarlett Y, Whitehead WE. Biofeedback treatment of constipation: a critical review. Dis Colon Rectum 2003; 46:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/44\">",
"      Chiarioni G, Whitehead WE, Pezza V, et al. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology 2006; 130:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/45\">",
"      Rao SS, Seaton K, Miller M, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol 2007; 5:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/46\">",
"      Heymen S, Scarlett Y, Jones K, et al. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum 2007; 50:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16568/abstract/47\">",
"      Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005; 129:86.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2238 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-9CA6F9C4F1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16568=[""].join("\n");
var outline_f16_11_16568=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H42686770\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ESOPHAGEAL MANOMETRY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Technical aspects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dysphagia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Gastroesophageal reflux disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Prior to antireflux surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Noncardiac chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Multisystem diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      GASTRIC EMPTYING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42686006\">",
"      ANORECTAL MANOMETRY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42686013\">",
"      Fecal incontinence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42686020\">",
"      - Biofeedback",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42686027\">",
"      Constipation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42686034\">",
"      - Pelvic floor dyssynergia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42686041\">",
"      - Reduced rectal sensation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42686048\">",
"      - Hirschsprung's disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42686055\">",
"      - Biofeedback",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42686770\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2238\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2238|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/30/27118\" title=\"diagnostic image 1\">",
"      Diffuse esophageal spasm barium swallow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2238|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/13/38102\" title=\"figure 1\">",
"      High resolution manometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/34/40490\" title=\"figure 2\">",
"      Wireless motility capsule studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/13/1237\" title=\"figure 3\">",
"      Pelvic floor dyssynergia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2238|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/38/26220\" title=\"table 1\">",
"      Causes of fecal incontinence",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/56/15240?source=related_link\">",
"      Chest pain of esophageal origin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/26/2474?source=related_link\">",
"      Chronic intestinal pseudo-obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14759?source=related_link\">",
"      Clinical manifestations and diagnosis of achalasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22168?source=related_link\">",
"      Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43401?source=related_link\">",
"      Clinical manifestations of mixed connective tissue disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=related_link\">",
"      Congenital aganglionic megacolon (Hirschsprung disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17000?source=related_link\">",
"      Diagnosis and treatment of oropharyngeal dysphagia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/50/13096?source=related_link\">",
"      Diffuse esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=related_link\">",
"      Etiology and diagnosis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13673?source=related_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/17/12569?source=related_link\">",
"      Evaluation of dysphagia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=related_link\">",
"      Fecal incontinence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/35/41529?source=related_link\">",
"      Gastrointestinal manifestations of systemic sclerosis (scleroderma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/23/17785?source=related_link\">",
"      High resolution manometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30616?source=related_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29224?source=related_link\">",
"      Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18039?source=related_link\">",
"      Overview of the treatment of achalasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2037?source=related_link\">",
"      Pathogenesis and clinical manifestations of oropharyngeal dysphagia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42905?source=related_link\">",
"      Surgical management of gastroesophageal reflux in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_11_16569="Mutations NRTIs";
var content_f16_11_16569=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F66938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F66938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 616px\">",
"   <div class=\"ttl\">",
"    Mutations in the reverse transcriptase gene associated with resistance to reverse transcriptase inhibitors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 596px; height: 717px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: the International AIDS Society-USA. Johnson VA, Brun-V&eacute;zinet F, Clotet B, G&uuml;nthard HF, Kuritzkes DR, Pillay D, Schapiro JM, and Richman DD. Update of the Drug Resistance Mutations in HIV-1: December 2010. Topics in HIV Medicine 2010; 18(5):156-163. Updated information (and thorough explanatory notes) are available at",
"     <a href=\"file://www.iasusa.org\" target=\"_blank\">",
"      www.iasusa.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16569=[""].join("\n");
var outline_f16_11_16569=null;
var title_f16_11_16570="Diagnostic amniocentesis";
var content_f16_11_16570=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic amniocentesis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Alessandro Ghidini, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/11/16570/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/11/16570/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocentesis is a technique for withdrawing amniotic fluid from the uterine cavity using a needle via a transabdominal approach. Laboratory tests to evaluate fetal health can be performed on amniotic fluid since this fluid is largely composed of fetal substances: urine, secretions, exfoliated cells, and transudate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497450\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common diagnostic indications for obtaining amniotic fluid are prenatal genetic studies and assessment of fetal lung maturity. Other indications include, but are not limited to, evaluation of the fetus for infection, degree of hemolytic anemia, blood or platelet type, hemoglobinopathy, and neural tube defects.",
"   </p>",
"   <p>",
"    Amniocentesis is also performed as a therapeutic procedure to remove excess amniotic fluid, such as in twin-to-twin transfusion syndrome. This procedure is termed amnioreduction and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/44/4808?source=see_link&amp;anchor=H9#H9\">",
"     \"Polyhydramnios\", section on 'Amnioreduction'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9913?source=see_link&amp;anchor=H3#H3\">",
"     \"Management of twin-twin transfusion syndrome\", section on 'Amnioreduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     COUNSELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocentesis, like other potentially morbid procedures, should be preceded by appropriate counseling regarding the:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Purpose of the procedure",
"     </li>",
"     <li>",
"      Potential complications, including technical problems that might necessitate a second procedure",
"     </li>",
"     <li>",
"      Time required before results will be available",
"     </li>",
"     <li>",
"      Accuracy and limitations of the diagnostic test(s) planned, including possible inability to make a diagnosis",
"     </li>",
"     <li>",
"      Alternatives that may yield the same or similar information",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Depending on the condition under investigation, invasive alternatives to amniocentesis may include chorionic villus sampling (CVS) and fetal blood sampling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28169?source=see_link\">",
"     \"Chorionic villus sampling: Risks, complications, and techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=see_link\">",
"     \"Fetal blood sampling\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sampling maternal blood for cell-free fetal DNA is a noninvasive method for diagnosing DNA-based conditions, but has limited commercial availability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1448?source=see_link\">",
"     \"Prenatal diagnosis using cell-free fetal nucleic acids in maternal blood\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TECHNICAL CONSIDERATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prenatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocentesis for prenatal genetic studies is technically possible at any gestational age after approximately 11 weeks of gestation, but is optimally performed at 15 to 17 weeks of gestation. Procedures performed before 15 weeks (ie, early amniocentesis) are associated with higher fetal loss and complication rates, including culture failure, and should be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/1\">",
"     1",
"    </a>",
"    ]. Later procedures can be problematic if termination of pregnancy is planned based upon abnormal results. However, late procedures for genetic studies are performed in some cases, such as when fetal abnormalities are discovered late in gestation, because the information can be useful for counseling and preparing parents, as well as for planning the optimal time, route, and site of delivery.",
"   </p>",
"   <p>",
"    Fetal karyotype can be determined by studying cells obtained via amniocentesis, CVS, or fetal blood sampling. Test results are available sooner when blood is the source of cellular material: 24 to 48 hours versus 7 to 10 days when amniocytes or chorionic villus cells are cultured. This is because cells from amniotic fluid and chorionic villi need to be stimulated to grow before they can be captured in metaphase for conventional G-banding, whereas cells from a blood sample are rapidly dividing and can be captured in metaphase immediately. Use of array comparative genomic hybridization (aCGH) appears to increase diagnostic yield because it can identify microdeletions and microduplications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=see_link&amp;anchor=H1897463#H1897463\">",
"     \"Use of array comparative genomic hybridization (aCGH) in obstetrics\", section on 'Clinical indications for aCGH in obstetrics'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    Most of the cells floating in amniotic fluid are morphologically and biochemically characterized as epithelioid; fibroblastoid and amniotic fluid-specific cells are also present [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/2\">",
"     2",
"    </a>",
"    ]. Cells shed from the amnion and the lower fetal urinary tract comprise the largest proportion of proliferating amniotic fluid cells. Although the amniotic fluid contains more than 200,000",
"    <span class=\"nowrap\">",
"     cells/mL",
"    </span>",
"    at 16 weeks of gestation, only a small number of the floating cells (average 3.5 &plusmn; 1.8",
"    <span class=\"nowrap\">",
"     cells/mL",
"    </span>",
"    of fluid) are capable of attaching to a culture substrate and yielding colonies. Cells derived from amniotic fluid before 15 weeks and at 24 to 32 weeks show a significant decline in cloning efficiency (fewer than 1.5 clone forming",
"    <span class=\"nowrap\">",
"     cells/mL",
"    </span>",
"    fluid) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497062\">",
"    <span class=\"h3\">",
"     Fluorescence in situ hybridization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interphase fluorescence in situ hybridization (FISH) provides a limited karyotype within 24 to 48 hours, but only detects aneuploidy of chromosomes 13, 18, 21, X, and Y, which are the most common causes of aneuploidy. Irrevocable actions (eg, pregnancy termination) should not be undertaken based on FISH results alone because rare false positives occur. The American College of Medical Genetics monograph Standards and Guidelines for Clinical Genetics Laboratories states that \"abnormalities detected by interphase FISH that are also considered reliably detectable by chromosome analysis should be confirmed by conventional cytogenetic analysis\" [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link&amp;anchor=H15538631#H15538631\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\", section on 'Fluorescence in situ hybridization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497125\">",
"    <span class=\"h3\">",
"     Evaluation of fetal demise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chromosomal abnormalities are more prevalent in stillborn than liveborn infants. Amniocentesis to obtain fetal cells as soon as possible after fetal demise is more likely to yield viable cells for analysis than tissue obtained after delivery. Use of array aCGH appears to increase diagnostic yield because it does not require cell culture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/35/1591?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis and management of stillbirth\", section on 'Fetal karyotype'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=see_link&amp;anchor=H12423093#H12423093\">",
"     \"Use of array comparative genomic hybridization (aCGH) in obstetrics\", section on 'Fetal demise'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fetal lung maturity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal lung maturity is usually assessed after 32 weeks of gestation since pulmonary maturity is unlikely before this time and the rate of falsely mature results is higher at earlier gestational ages. Fetal lung maturity is not assessed after 39 weeks because the risk of respiratory distress in the neonate is so low. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42919?source=see_link\">",
"     \"Assessment of fetal lung maturity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The efficacy of prophylactic antibiotics for reducing procedure-related pregnancy loss has not been evaluated extensively. One trial randomly assigned 33,748 women to receive either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    500 mg daily for three days before amniocentesis or no antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/4\">",
"     4",
"    </a>",
"    ]. All of the procedures were performed by a single operator. There were significantly fewer fetal losses in the four weeks after the procedure in the prophylaxis group than in the control group (0.03 versus 0.28 percent; relative risk [RR] 0.11, 95% CI 0.05-0.26). Nearly half of the fetal losses",
"    <span class=\"nowrap\">",
"     (21/43)",
"    </span>",
"    occurred in the setting of premature rupture of membranes, which also occurred less often in the prophylaxis group (0.06 versus 1.12 percent; RR 0.06, 95% CI 0.03-0.10).",
"   </p>",
"   <p>",
"    However, there were several limitations to this trial, such as lack of follow-up until delivery, an unusually high rate of membrane rupture within four weeks of the procedure, an unusually high rate of fetal death after membrane rupture (14 percent) in the control group, and the use of a single dedicated operator performing all procedures (raising the issue of reproducibility of the results). Thus, it is unlikely that the conclusions from the trial will change the standard of care, which is",
"    <strong>",
"     not",
"    </strong>",
"    to use antibiotic prophylaxis prior to amniocentesis. Results from a case control study support this conclusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Site selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;An obstetrical ultrasound examination is initially performed to determine fetal viability, position, biometry, location of the placenta, and anatomic survey. The presence and location of an amniochorionic separation, which may be seen as late as 16 to 17 weeks of gestation, should also be noted if present.",
"   </p>",
"   <p>",
"    The optimal needle insertion site is then selected, avoiding the placenta if possible. Some studies have suggested a greater risk of fetal complications with transplacental amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6-11\">",
"     6-11",
"    </a>",
"    ]; however, this has been challenged by other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. If a transplacental approach is required, options include traversing the placenta or delaying the procedure by one week to allow the greater intrauterine volume with advancing gestation to potentially create a placenta-free window. If the first option is chosen, the needle should be directed through the thinnest portion of the placenta. Color flow mapping may be helpful to identify and avoid the umbilical cord insertion site and large chorionic vessels. If the maternal bladder interferes with the path of the needle, the woman should void prior to needle insertion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497744\">",
"    <span class=\"h2\">",
"     Site preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The maternal abdomen is cleaned with an antiseptic solution and draped. It is prudent to cleanse a larger area of maternal abdomen than the site identified for needle insertion since fetal movements may change the location of the optimal pocket of fluid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497759\">",
"    <span class=\"h2\">",
"     Local anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local anesthesia is optional but usually unnecessary, as most women have no or mild discomfort and no intervention has been proven to reduce this discomfort [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Risk factors for pain at amniocentesis include maternal anxiety, history of menstrual cramps, previous amniocentesis, and needle insertion into the lower part of the uterus [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/16\">",
"     16",
"    </a>",
"    ]. When our patients request anesthesia, we tell them that amniocentesis is associated with two moments of discomfort, one at skin insertion and the other when the needle crosses the uterine muscle; local anesthesia may relieve the former sensation, but is ineffective for the latter [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Needle",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 20 or 22 gauge spinal needle is generally used for amniocentesis. Use of the larger bore needle lowers the risk of intrauterine bleeding if the needle is passed through the placenta and allows faster fluid retrieval compared with use of 22 gauge needle, but causes more maternal discomfort [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The standard length of a spinal needle is 8.9 cm (excluding the hub), but longer needles are available (15 cm). The length of the needle should take into account the thickness of the maternal panniculus, location of the target pocket of fluid, and the possibility that intervening events, such as uterine contractions, may increase the distance between the skin and target.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Needle insertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of concurrent ultrasound guidance rather than pre-amniocentesis ultrasound evaluation has not been associated with a reduced rate of fetal losses in controlled studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/21\">",
"     21",
"    </a>",
"    ]. Nevertheless, ultrasonographic monitoring with continuous visualization of the needle should be performed throughout the procedure to avoid direct fetal injury (see below) and to reduce the number of punctures and the incidence of bloody fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/21\">",
"     21",
"    </a>",
"    ]. The probe is either held by an assistant in an area of skin away from that cleansed with antiseptic or, more commonly, it is inserted in a sterile pouch (eg, a glove). Nonsterile gel is placed in the pouch in contact with the probe and sterile gel is placed on the outer surface of the pouch in contact with the maternal skin.",
"   </p>",
"   <p>",
"    A \"free-hand technique\" is preferred by most operators because it permits adjustments in the path of needle insertion. However, a needle-guiding device attached to the transducer may facilitate reaching the optimal pocket of fluid, particularly with less experienced operators. Most real-time ultrasound machines are equipped with an on-screen template of the needle tract that is used to target the sampling site.",
"   </p>",
"   <p>",
"    The maternal bowel and bladder should be identified and excluded from the path of the needle. Traversing the bowel, which is rare, can introduce bowel flora into the amniotic fluid, leading to infection and pregnancy loss.",
"   </p>",
"   <p>",
"    Most operators prefer to insert the needle while holding the transducer themselves; once the needle tip is in place, an assistant holds the transducer and maintains visualization of the needle tip while the operator draws amniotic fluid samples. Other operators prefer to be guided throughout the procedure by an assistant.",
"   </p>",
"   <p>",
"    The operator should be familiar with the appearance of the needle on the screen. If a \"parallel\" approach is taken to needle insertion, the needle enters the skin at the end of a curvilinear or sector probe and can be imaged along its entire extent from skin to target location (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67803 \" href=\"UTD.htm?21/49/22290\">",
"     image 1",
"    </a>",
"    ). If a \"perpendicular\" approach is taken, the needle is inserted adjacent to the middle of a linear or curvilinear probe, and only the area of the needle tip is imaged.",
"   </p>",
"   <p>",
"    The needle should not be advanced if the position of its tip cannot be identified on the screen. Using the operator's wrist, a sudden thrust of the needle as it passes from the uterine muscle into the amniotic cavity may help to avoid membrane tenting (see below). Entrance into the amniotic cavity is often accompanied by a tactile popping sensation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dry tap",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniotic fluid typically appears at the needle hub when the stylet is removed. If no amniotic fluid is visible at removal of the stylet, fetal membranes may have tented over the needle tip, thus preventing needle penetration into the amniotic cavity (ie, impingement of the membranes without piercing them). This occurs more often with insertions prior to 15 completed weeks of gestation due to incomplete physiological fusion of the amnion, chorion, and decidua parietalis.",
"   </p>",
"   <p>",
"    The needle may be rotated to redirect the bevel and puncture the membranes. However, if this maneuver is unsuccessful and the needle must be repositioned, the stylet should be reinserted before further thrusts are made. These subsequent attempts at redirecting the needle should be guided ultrasonographically.",
"   </p>",
"   <p>",
"    Alternatively, the needle may be withdrawn within the maternal abdomen and redirected to an area of the uterus where there is no amniochorionic separation. A second needle insertion may also be attempted. If a dry tap occurs, many clinicians will postpone another attempt until a week has passed, although procedure-related fetal losses are not related to the number of punctures [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Failure to obtain amniotic fluid after 15 weeks by experienced operators using ultrasound guidance occurs in less than 1 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,11,22\">",
"     6,11,22",
"    </a>",
"    ]. The rate of failure to aspirate fluid was much higher in older studies that did not use ultrasound guidance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Withdrawing and handling the sample",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial drop of amniotic fluid may contain maternal cells acquired by the needle from passage through the maternal abdominal and uterine walls. Most operators discard this drop because inclusion of this sample may be responsible for low level mosaicism with maternal cells in cytogenetic studies. Others aspirate the initial sample of fluid into a separate syringe for amniotic fluid alpha-fetoprotein determination.",
"   </p>",
"   <p>",
"    Twenty to 30 mL of amniotic fluid are aspirated into sterile syringes by gentle traction on the barrel or by use of vacuum tubes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/23\">",
"     23",
"    </a>",
"    ]. The amount of amniotic fluid withdrawn should be based upon gestational age since amniotic fluid volume increases across pregnancy (",
"    <a class=\"graphic graphic_figure graphicRef59704 \" href=\"UTD.htm?35/11/36030\">",
"     figure 1",
"    </a>",
"    ). One rule of thumb for removing an appropriate amount of amniotic fluid is to take a volume in milliliters equivalent to the gestational age in weeks (eg, 15 mL at 15 weeks).",
"   </p>",
"   <p>",
"    There have been a few case reports of growth inhibition in amniocentesis cell cultures due to prolonged contact of the fluid with the syringe stopper (the black, rubber-like, grommet on the end of the plunger rod). To minimize this risk, it is recommended that the syringe be kept in a tip down position until the fluid is transferred to the culture tubes, and that the time the amniotic fluid is kept in the syringe be minimized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Post-procedural care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fetal heart rate should be assessed sonographically after the procedure and recorded. Uterine cramping, transient spotting, and vaginal loss of a few drops of amniotic fluid may occur immediately after the procedure. The woman should be instructed to report any persistent loss of vaginal fluid or bleeding, severe uterine cramping lasting for several hours, or fever. Limitation of activity after the procedure is unnecessary.",
"   </p>",
"   <p>",
"    Electronic fetal and uterine monitoring following procedures performed after fetal viability are an option to assess for uterine contractions triggered by the procedure and to provide reassurance regarding fetal status. Alternatively, sonographic demonstration of normal fetal heart rate and activity post-procedure is adequate in most cases.",
"   </p>",
"   <p>",
"    Nonalloimmunized Rh(D) negative women should receive Rh(D) immune globulin (eg, RhoGAM) after the procedure to prevent Rh(D) sensitization. The American College of Obstetricians and Gynecologists (ACOG) recommends a dose of 300 mcg [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40648?source=see_link\">",
"     \"Prevention of Rh(D) alloimmunization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DISCOLORED SAMPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood-tinged amniotic fluid is aspirated in less than 1 percent of amniocenteses when the procedure is done under ultrasound guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,22\">",
"     6,22",
"    </a>",
"    ]. The blood is almost always of maternal origin and does not adversely affect amniotic cell growth. Two studies have reported an increased risk of fetal loss after bloody taps (odds ratios [OR] of 2.2 and 6.5) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/7,14\">",
"     7,14",
"    </a>",
"    ]. In contrast, a series of 5948 procedures performed under ultrasound guidance by the same operator reported a 3.7 percent rate of &lsquo;hemorrhagic&rsquo; amniotic fluid, but did not find an association between bloody fluid and fetal loss up to 24 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of green or brown pigment in second trimester amniotic fluid is more common (approximately 2 percent) than gross blood (",
"    <a class=\"graphic graphic_picture graphicRef54992 \" href=\"UTD.htm?42/35/43568\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,22\">",
"     6,22",
"    </a>",
"    ]. This type of discoloration indicates intraamniotic hemorrhage antedating amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/25,26\">",
"     25,26",
"    </a>",
"    ], since the fetus does not pass pigmented meconium in the early weeks of pregnancy. Green or brown fluid is associated with a higher rate of miscarriage or fetal death than clear fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. As an example, one randomized trial reported the relative risk of miscarriage of a euploid fetus after amniocentesis was increased 10-fold (95% CI 4.3-22.6) if discolored fluid was withdrawn [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"     6",
"    </a>",
"    ]. The rate of miscarriage was particularly high (occurring in one-third of pregnancies) if there was both abnormally colored fluid and an unexplained high maternal serum alpha-fetoprotein.",
"   </p>",
"   <p>",
"    Discolored amniotic fluid is more likely to be associated with chromosomal abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/30\">",
"     30",
"    </a>",
"    ], culture failure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/31\">",
"     31",
"    </a>",
"    ], and microbial contamination of the amniotic fluid (particularly Mycoplasma species) than clear fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Detection of Mycoplasma may indicate chronic endometrial infection, and possibly a higher rate of premature rupture of membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/34\">",
"     34",
"    </a>",
"    ] and preterm delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/35\">",
"     35",
"    </a>",
"    ]. Antibiotics have been reported to be useful in these cases, but data are insufficient to allow a recommendation for routine culture of discolored amniotic fluid and treatment of positive results [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/35-37\">",
"     35-37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     COMPLICATIONS AND ADVERSE OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety of genetic amniocentesis has been addressed by several case-control studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/9,22,38-40\">",
"     9,22,38-40",
"    </a>",
"    ] and one randomized clinical trial [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"     6",
"    </a>",
"    ]. The major complications of amniocentesis are rupture of membranes, direct fetal injury, indirect fetal injury, infection, and fetal loss. Maternal complications related to the procedure, such as amnionitis, are rare, occurring in less than",
"    <span class=\"nowrap\">",
"     1/1000",
"    </span>",
"    procedures. The following data regarding procedure-related complications of amniocentesis were derived from series in which ultrasound guidance was used concurrently to visualize needle placement. There is no evidence that specific techniques (eg, uterine relaxants) are associated with a reduced risk of complications [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Leakage of amniotic fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Temporary loss of amniotic fluid occurs more frequently in pregnancies that undergo amniocentesis than among controls not experiencing amniocentesis (1.7 versus 0.4 percent of pregnancies). Fluid loss is almost always small and usually spontaneously stops within one week, with reaccumulation of fluid and restoration of normal amniotic fluid volume in an average of three weeks (range one to seven weeks) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Cessation of leakage is probably not due to actual repair and regeneration of the membranes, but rather to changes in the decidua and myometrium that block further leakage [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/44\">",
"     44",
"    </a>",
"    ]. Temporary loss of fluid is generally associated with a good pregnancy outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic leakage for the duration of pregnancy, ie, frank membrane rupture, rarely occurs, but can also be associated with a good outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. In a study comparing premature rupture of membranes after amniocentesis with premature spontaneous rupture of membranes, women experiencing the former delivered at more advanced gestational ages than those with spontaneous premature rupture of membranes (34.2 versus 21.6 weeks), despite similar gestational ages at membrane rupture; perinatal survival was also higher (91 versus 9 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/43\">",
"     43",
"    </a>",
"    ]. Given this potential for a good outcome, conservative management with serial monitoring of amniotic fluid volume, fetal growth, and signs of maternal infection is appropriate as a reasonable option. However, patients with chronic fluid loss should be apprised of the increased risks of preterm delivery, skeletal deformation, and pulmonary hypoplasia, especially if anhydramnios is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27353?source=see_link&amp;anchor=H15#H15\">",
"     \"Midtrimester preterm premature rupture of membranes\", section on 'Pediatric outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Direct fetal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct fetal needle injury is rare during amniocentesis under ultrasound guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,38,47,48\">",
"     6,38,47,48",
"    </a>",
"    ]. In a randomized trial including 2239 pregnancies in which ultrasound guidance was used for amniocentesis, there were no direct fetal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fetal injuries that have been attributed to midtrimester amniocentesis, primarily in isolated case reports, include exsanguination, skin dimples, ocular injury, and intracranial and bowel abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/21\">",
"     21",
"    </a>",
"    ]. These attributions have mostly been based on association rather than direct evidence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Indirect fetal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;A few prospective studies have reported an increased rate of orthopedic malformations and respiratory problems in infants born after genetic amniocentesis compared with controls who did not undergo amniocentesis. The reported odds of talipes equinovarus or congenital hip dislocation in cases versus controls range from odds ratio (OR) 0.6-6.1; pooled data from over 10,000 pregnancies show the frequency of these problems in cases and controls are 0.76 and 0.56 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,38,49\">",
"     6,38,49",
"    </a>",
"    ]. For the risk of respiratory distress, the corresponding odds range from OR 2.1-3.4 and the pooled actual frequencies in cases and controls are 1.2 and 0.45 percent, respectively.",
"   </p>",
"   <p>",
"    The mechanism underlying both complications is thought to be fetal compression as a consequence of decreased amniotic fluid. Support for this hypothesis comes from observations that postural malformations are more common after early amniocentesis, when the amniotic fluid volume is lower, and following persistent amniotic fluid leakage after amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/50\">",
"     50",
"    </a>",
"    ]. In addition, there appears to be a correlation between the amount of amniotic fluid removed at amniocentesis and the risk of talipes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/51\">",
"     51",
"    </a>",
"    ]. Finally, talipes and suboptimal lung growth can be reproduced experimentally in animals undergoing amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to these data, a cohort study of consecutive liveborn offspring of women who had had amniocentesis and matched controls whose mothers had not had amniocentesis found that exposure to amniocentesis was not associated with a significantly increased rate of major disabilities at follow-up (7 to 18 years after birth) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Taken together, these studies do not show a consistent significant increase in risk of indirect fetal injury; however, the possibility of these risks should be addressed during the process of informed consent. Even if the increased risk is statistically significant, the absolute excess risk is small and may be minimized by avoiding the removal of an excess amount of fluid for gestational age or the performance of early (&lt;15 weeks) procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Vertical transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports have described mother-to-infant transmission of infections, such as hepatitis C virus, cytomegalovirus, toxoplasmosis, and human immunodeficiency virus, where transmission was presumed to be related to amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Indirect evidence also suggests higher rates of neonatal infection in the offspring of chronically infected women who undergo amniocentesis compared to controls who do not have the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The best data on the possible risk of vertical transmission with invasive procedures come from studies of women with HIV infection. The rate of vertical HIV transmission from amniocentesis is low in women under treatment for HIV, and the residual risk may be related to the type of therapy. The risk appears to be lowest in women receiving highly active antiretroviral therapy (HAART):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A multicenter Italian study evaluated the risk of HIV transmission following early invasive diagnosis (amniocentesis or CVS) in HIV infected women delivered between 1997 and 2003, ie, after widespread use of HAART [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/58\">",
"       58",
"      </a>",
"      ]. Two of 60 viable infants had neonatal HIV infection after invasive procedures (3.3 percent, 95% CI 0.6-10.1 percent); this rate was not significantly different from the rate in HIV infected women who did not undergo invasive procedures (1.7 percent).",
"     </li>",
"     <li>",
"      The French Perinatal HIV cohort included 166 amniocenteses performed among 9302 singleton pregnancies [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/59\">",
"       59",
"      </a>",
"      ]. There were no cases of maternal to child transmission among 81 mothers receiving HAART.",
"      <br/>",
"      <br/>",
"      However, in mothers not receiving antiviral therapy, there was a trend toward an increased risk of mother to child transmission with amniocentesis: 25 percent",
"      <span class=\"nowrap\">",
"       (3/12)",
"      </span>",
"      transmission with amniocentesis versus 16.2 percent",
"      <span class=\"nowrap\">",
"       (343/2113)",
"      </span>",
"      transmission with no amniocentesis. This trend was also observed among mothers receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"       zidovudine",
"      </a>",
"      monotherapy or double-nucleoside reverse transcriptase inhibitors: mother to child transmission 6.1 percent",
"      <span class=\"nowrap\">",
"       (3/49)",
"      </span>",
"      versus 3.3 percent",
"      <span class=\"nowrap\">",
"       (117/3556)",
"      </span>",
"      with no amniocentesis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rate of vertical transmission of hepatitis B virus was not increased with amniocentesis in two small case-control studies and a prospective longitudinal study [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=see_link\">",
"     \"Pregnancy in women with pre-existing chronic liver disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=see_link\">",
"     \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is biologically plausible that mother-to-child transmission can occur during amniocentesis, particularly in women with high viremic loads and if the needle crosses the placenta. Epidemiological evidence is scant. Until more data become available on the safety of amniocentesis in such women, these patients should be informed of the potential risk of fetal infection and alternatives for prenatal diagnosis of aneuploidy should be offered. The latter include nuchal translucency measurements and biochemical screening between 11 and 14 weeks of gestation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    second trimester biochemical screening with or without ultrasound assessment of Down syndrome (&ldquo;genetic ultrasound&rdquo;) prior to proceeding with amniocentesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=see_link\">",
"     \"Sonographic findings associated with fetal aneuploidy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497852\">",
"    <span class=\"h2\">",
"     Innoculation by bowel flora",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, traversing the bowel, which is rare, can introduce bowel flora into the amniotic fluid leading to intrauterine infection, pregnancy loss and, rarely, septic shock.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cell culture failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocytes fail to grow in culture in 0.1 percent of samples [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14974658\">",
"    <span class=\"h2\">",
"     Mosaicism",
"    </span>",
"    &nbsp;&mdash;&nbsp;True mosaicism is defined as one or more abnormal cell lines plus a normal cell line in at least two primary cultures from the same individual; it occurs in 0.1 to 0.2 of pregnancies undergoing amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Pseudomosaicism (an abnormal cell line is confined to one culture flask) is more common, occurring in up to 8 percent of pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When mosaicism is detected on amniocentesis, fetal blood sampling can be performed to see if the same abnormal cell line is present in fetal blood, thus confirming the fetal mosaicism.&nbsp;Even if the fetal blood sampling result is normal, the abnormal cell line may be present in other fetal tissues, such as skin. In either case, phenotype can be difficult to predict; consultation with a geneticist and serial ultrasound examinations of the fetus are advised. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Fetal loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary of the fetal loss rates in published studies with concurrent real-time ultrasound guidance is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef57339 \" href=\"UTD.htm?40/40/41611\">",
"     table 1",
"    </a>",
"    ). An increase in the rate of fetal loss was observed in all study groups following amniocentesis compared with controls, although the difference did not reach statistical significance in most series. It should be noted that different studies used different definitions of fetal loss; as an example, the FASTER trial [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/65\">",
"     65",
"    </a>",
"    ] and other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/28\">",
"     28",
"    </a>",
"    ] used fetal loss at less than 24 weeks of gestation as the criterion, whereas another study included all fetal losses at less than 28 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/9\">",
"     9",
"    </a>",
"    ], and yet another study included all losses until delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/66\">",
"     66",
"    </a>",
"    ]. The choice of the control population also differed from study to study, and in one study, the authors chose to compare the observed rates of fetal losses after amniocentesis in their cohort with the expected rates of spontaneous losses based on published data adjusted for ethnicity and maternal age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our review, the excess rate of spontaneous loss attributed to the amniocentesis procedure (ie, procedure-related loss rate) ranged from 0.06 to 1.0 percent",
"    <span class=\"nowrap\">",
"     (1/100",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     1/1000).",
"    </span>",
"    The ACOG Practice Bulletin cites a procedure-related rate of loss of",
"    <span class=\"nowrap\">",
"     1/300",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     1/500",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most fetal losses occur up to four weeks following amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,65,66\">",
"     6,65,66",
"    </a>",
"    ]. The cause of such losses remains unknown because no study has consistently examined the placenta and fetus in these cases. A systematic review calculated the total rate of pregnancy loss within 14 days of amniocentesis was 0.6 percent (95% CI 0.5-0.7)",
"    <span class=\"nowrap\">",
"     (1/143",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     1/200),",
"    </span>",
"    but could not determine how many of these losses were procedure-related [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variety of factors has been studied to determine whether they affect the risk of procedure-related fetal loss:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The best evidence suggests that operator experience does not play a role in the fetal loss rate [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6,68\">",
"       6,68",
"      </a>",
"      ], but may affect other outcomes such as sample quality [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/69,70\">",
"       69,70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The number of punctures appeared to be independently associated with an increased risk of fetal loss in one series [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/9\">",
"       9",
"      </a>",
"      ], but not in others [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/11,14,28\">",
"       11,14,28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Higher loss rates were observed when an elevated maternal serum alpha-fetoprotein (MSAFP) value was the indication for amniocentesis. In one study, the relative risk for fetal loss was 8.3 (95% CI 2.4-19.8) after amniocentesis performed for MSAFP greater than 2.0 multiples of the median (MoM) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Vaginal bleeding during the current pregnancy and history of abortion (spontaneous or induced) are additional risk factors for spontaneous losses after amniocentesis. In one report, vaginal bleeding prior to the procedure was associated with a significantly higher rate of spontaneous fetal loss before 28 weeks of gestation compared with controls without vaginal bleeding (5.9 versus 3.8 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/22\">",
"       22",
"      </a>",
"      ]. A history of three or more abortions in the first trimester or one or more abortions in the second trimester was also associated with a higher rate of pregnancy loss after amniocentesis (6.9 versus 3.5 percent in controls without a history of abortion) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/22\">",
"       22",
"      </a>",
"      ]. The observation has been confirmed by a large cohort study [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Higher gestational age at amniocentesis may play a role in procedure-related spontaneous losses. Two studies reported an increased rate of fetal losses for amniocenteses performed after 18 weeks of gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/14,71\">",
"       14,71",
"      </a>",
"      ], while another did not [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Maternal body mass index (BMI) &ge;40",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      is associated with a significant increase in fetal loss compared with BMI lower than 25",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"      </span>",
"      (adjusted OR 2.2, 95% CI 1.2-3.9) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1497992\">",
"    <span class=\"h3\">",
"     Limitations of available data",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although amniocentesis is one of the most commonly performed procedures for prenatal diagnosis, a precise assessment of its safety is elusive for several reasons. Because the rate of fetal loss and other complications is significantly affected by maternal age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/73-75\">",
"     73-75",
"    </a>",
"    ] and, to a lesser extent, by other maternal factors (eg, abnormal serum screening results, past history of fetal loss, bleeding), randomized trials are ideally positioned to provide the best estimates of the procedure-related risk of fetal loss, fetal death, and preterm delivery after amniocentesis. However, only one such trial has been conducted [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"     6",
"    </a>",
"    ]. In this trial, outcome of pregnancy was studied in 4606 women 25 to 34 years of age without known risk of genetic disease randomly assigned to undergo amniocentesis or routine care (ultrasound and determination of MSAFP). In both groups, 99 percent of women followed the examination schedule of the group to which they had been allocated. The total spontaneous abortion rate was 1.7 percent in the study group and 0.7 percent in the control group (RR 2.3, 95% CI",
"    <span class=\"nowrap\">",
"     1/3-4.0).",
"    </span>",
"    Eleven of the 15 pregnancies with chromosomal aneuploidies in the study group were terminated, whereas in the control group, only one chromosomally abnormal pregnancy was diagnosed and terminated, suggesting that the 1 percent excess risk of spontaneous fetal loss in the amniocentesis group is underestimated.",
"   </p>",
"   <p>",
"    Several large case-control and cohort studies have attempted to fill in the gap in information on amniocentesis-related risks and complications. A consistent limitation of these studies is the underestimation of the post-amniocentesis spontaneous fetal loss rate because of preemptive pregnancy termination after amniocentesis when abnormal karyotypes are detected. Fetal losses after amniocentesis primarily involve euploid fetuses (since aneuploid pregnancies are usually actively terminated), whereas fetal losses in controls tend to include both normal and abnormal karyotypes. This limitation explains the paradoxical finding of the FASTER trial in which amniocentesis was associated with significantly lower odds of spontaneous fetal loss before 24 weeks than controls who did not undergo amniocentesis (adjusted odds ratio [OR] 0.4, 95% CI 0.3-0.7) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/65\">",
"     65",
"    </a>",
"    ]. Not surprisingly, the rate of termination of pregnancy was significantly higher among women undergoing amniocentesis than in those who did not (2.9 versus 0.2 percent).",
"   </p>",
"   <p>",
"    In the FASTER trial, some patients who were screen negative in both trimesters elected to undergo amniocentesis anyway [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/65\">",
"     65",
"    </a>",
"    ]. This subpopulation of women with screen negative results represents a group in which underestimation of procedure-related spontaneous losses before 24 weeks is minimized because these women would be expected to have a low risk of fetal aneuploidy and thus a low rate of active pregnancy termination. The excess spontaneous loss rate with amniocentesis in screen negative women was 0.15 percent (95% CI -0.25 to 0.81) or a procedure-related loss rate of",
"    <span class=\"nowrap\">",
"     1/600",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     1/700",
"    </span>",
"    procedures. Of note, certain aneuploidies with increased risk of spontaneous midtrimester loss or active pregnancy termination, such as some cases of trisomy 21, 18 and 13 and Turner syndrome, would be expected to be present among screen negative women.",
"   </p>",
"   <p>",
"    Another limitation of the published data on safety of amniocentesis is that, in some series, outcome information was not available in all cases or cases lost to follow-up were excluded from analysis. This introduces a bias in the data since pregnancies that are the most difficult to follow up are often associated with fetal loss [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The earliest studies on procedure-related risk of fetal loss were also compromised by lack of ultrasound guidance during the procedure. The total excess miscarriage rate after amniocentesis is lower in series that used ultrasound guidance compared with those that did not. For this reason, the following analysis of procedure-related fetal losses will include only studies in which concurrent real-time ultrasound examination was used to guide the procedure, thus excluding studies predating ultrasound guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29289167\">",
"    <span class=\"h2\">",
"     Obstetrical complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies that have examined whether exposure to first or second trimester amniocentesis is associated with an increased risk of subsequent obstetric complications have generally found no significant increase in risk of pregnancy-related hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/76\">",
"     76",
"    </a>",
"    ], low birth weight or very low birth weight [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/77\">",
"     77",
"    </a>",
"    ], abruption [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/78\">",
"     78",
"    </a>",
"    ], preterm delivery, premature rupture of membranes, stillbirth, neonatal mortality, or perinatal mortality (",
"    <a class=\"graphic graphic_table graphicRef64831 \" href=\"UTD.htm?17/37/18011\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Third trimester amniocentesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety and efficacy of third trimester, ultrasound-guided amniocentesis is illustrated by two controlled studies on risks of third trimester amniocentesis.",
"   </p>",
"   <p>",
"    In one study, women undergoing amniocentesis for fetal lung maturity studies at &gt;32 weeks were matched with controls undergoing antepartum testing based on gestational age at testing and maternal age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/79\">",
"     79",
"    </a>",
"    ]. There was no significant difference between groups in the rate of obstetric complications within 48 hours of testing",
"    <span class=\"nowrap\">",
"     (0/167",
"    </span>",
"    versus",
"    <span class=\"nowrap\">",
"     1/167).",
"    </span>",
"   </p>",
"   <p>",
"    In the other study, the outcome of pregnancy in 91 women with preterm premature rupture of membranes (PPROM) who underwent amniocentesis was compared to the outcome of 46 controls with PPROM who did not undergo the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/80\">",
"     80",
"    </a>",
"    ]. There was no significant difference between groups in interval to delivery.",
"   </p>",
"   <p>",
"    The safety of third trimester amniocentesis is also supported by several uncontrolled observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/81-84\">",
"     81-84",
"    </a>",
"    ]. These studies reported low (&lt;1 percent) rates of obstetrical complications, such as emergency delivery or the decision to deliver before completion of lung maturity studies, proximate to the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     MULTIPLE GESTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Genetic amniocentesis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Multineedle technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most operators perform separate procedures on each sac for genetic studies of multiple gestations, using separate and sequential insertion of a new needle for each amniotic cavity. The multi-needle technique does not appear to increase the risk of adverse outcome compared with the single needle technique [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sampling only one sac usually will be adequate in monochorionic twins with no sonographic evidence of abnormalities and with concordant growth [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/86\">",
"     86",
"    </a>",
"    ], but reports of discordant karyotype in monozygotic twins have been described so the one specimen approach is fallible [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With the multi-needle technique, amniotic fluid is aspirated from one sac and blue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    dye (2 to 3 mL) is injected prior to withdrawal of the needle.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     Methylene blue",
"    </a>",
"    should",
"    <strong>",
"     not",
"    </strong>",
"    be used because it can cause methemoglobinemia in the neonate, increase the risk of small bowel atresia, and stain the skin. Amniocentesis is subsequently performed in the other sac by inserting a new needle and aspirating amniotic fluid, which should be free of dye, thus confirming that a different sac has been sampled. Experienced operators often feel comfortable performing the multi-needle technique without dye injection, particularly when the dividing membranes are clearly visualized. However, misdiagnosis using such a technique has been reported in as many as 3.5 percent of samples [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If triplets or higher order gestations are present,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    is commonly injected into the second sac and a third needle is inserted into the third sac (and so forth until each sac has been sampled). Withdrawal of clear fluid confirms that a new sac has been successfully entered, while aspiration of blue-tinged fluid indicates that the previously tapped sac was reentered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Single needle technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aspiration of both twin sacs using a single needle insertion into the uterus is an alternative technique [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/88-91\">",
"     88-91",
"    </a>",
"    ]. This technique reduces maternal discomfort.",
"   </p>",
"   <p>",
"    The needle is inserted into the more anterior sac, choosing a pocket of fluid that is contiguous to the deepest twin's sac. After aspiration of fluid from the first sac, the needle is advanced under ultrasound guidance through the dividing membrane into the second sac. No dye is used for confirmation of the origin of the fluid.",
"   </p>",
"   <p>",
"    Theoretic concerns with this procedure include the potential for mixing the two fluids leading to inaccurate interpretation of genetic tests and shearing of the dividing membrane, resulting in a functionally monoamniotic pregnancy with its attendant risks. Placental location or fetal position may make this procedure either too difficult or too risky. Data using a single needle insertion are too limited to allow an adequate assessment of the associated risks and safety of this approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/11/5306?source=see_link&amp;anchor=H17#H17\">",
"     \"Twin pregnancy: Labor and delivery\", section on 'Monoamniotic twins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Loss rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of amniocentesis-related loss in twin pregnancies is likely increased by about 1 percent above the baseline risk of loss among twin gestations, but the exact risk is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. In a systematic review and meta-analysis of amniocentesis in twin pregnancies using double entry technique and ultrasound guidance, the odds of total pregnancy loss in twin pregnancies undergoing amniocentesis were significantly higher than in those not undergoing amniocentesis (pooled OR 1.8, 95% CI 1.2-2.7; seven studies) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/92\">",
"     92",
"    </a>",
"    ]. The pooled loss rate for one or both fetuses before 24&thinsp;weeks following amniocentesis was 3.5 percent (95% CI 2.6-4.7; 7 studies). Although this loss rate is similar to the natural loss rate in twin pregnancies, these results are difficult to interpret because of variations in the definition of pregnancy loss (fetal death or",
"    <span class=\"nowrap\">",
"     miscarriage/delivery),",
"    </span>",
"    whether one or both fetuses were lost, and the timing of loss after the procedure. In the only study that reported procedure-related loss rates by chorionicity, the risk of loss was significantly higher in monochorionic twins that underwent amniocentesis compared with monochorionic twins that did not undergo the procedure (7.7 versus 1.4 percent).",
"   </p>",
"   <p>",
"    There are inadequate data from large, well-controlled studies to conclude whether the risk of early procedure-related fetal loss is higher in twin than singleton pregnancies undergoing amniocentesis. Confounders that need to be addressed include maternal age, chorionicity, ultrasound findings, and maternal analyte screening results. Other important factors include the completeness of ascertainment of pregnancy outcome and how fetal loss is defined (all losses up to term versus losses up to 24 weeks versus losses within 4 weeks of the procedure).",
"   </p>",
"   <p>",
"    The only two observational studies that compared amniocentesis to CVS in twin pregnancies did not find a significant difference between techniques in pregnancy loss rate [",
"    <a class=\"abstract\" href=\"UTD.htm?16/11/16570/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Amniocentesis for lung indices or signs of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocentesis performed late in pregnancy for lung maturity studies only requires that one sac be sampled; ideally, the sac of the twin less likely to be mature is chosen. As an example, if the twins have discordant sexes, the sac of the male fetus is sampled, whereas if the twins are of the same sex, the sac of the larger twin is chosen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/11/5306?source=see_link&amp;anchor=H5#H5\">",
"     \"Twin pregnancy: Labor and delivery\", section on 'Assessment of pulmonary maturity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Only the lower-most sac needs to be sampled in procedures done in the late second or early third trimester for evaluation of infection in preterm premature rupture of membranes or preterm labor, since infection generally follows an ascending route from the vagina. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=see_link&amp;anchor=H10#H10\">",
"     \"Intraamniotic infection (chorioamnionitis)\", section on 'Amniocentesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/57/42897?source=see_link\">",
"       \"Patient information: Amniocentesis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/28/14785?source=see_link\">",
"       \"Patient information: Amniocentesis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Amniocentesis should be performed after 15 weeks of gestation because earlier procedures are less likely to be successful, are associated with higher rates of cell culture failure, and carry greater fetal risks. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest not using antibiotic prophylaxis for amniocentesis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Antibiotic prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The true rate of pregnancy loss associated with amniocentesis is uncertain. When the procedure is performed under ultrasound guidance, reported rates of fetal loss range from about",
"      <span class=\"nowrap\">",
"       1/100",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       1/1000",
"      </span>",
"      procedures. The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin cites a procedure-related rate of loss of",
"      <span class=\"nowrap\">",
"       1/300",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       1/500.",
"      </span>",
"      A systematic review calculated",
"      <span class=\"nowrap\">",
"       1/143",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       1/200",
"      </span>",
"      rate of pregnancy loss within 14 days of the procedure, but could not determine how many of these losses were procedure-related. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Fetal loss'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Green or brown fluid is associated with an increased risk of subsequent spontaneous abortion or fetal death compared with clear fluid. Chromosomal abnormalities, culture failure, and microbial contamination of the amniotic fluid (particularly Mycoplasma species) are also more common when the fluid is discolored. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Discolored samples'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risks of direct fetal injury or maternal injury during amniocentesis are minimal. There may be a small risk of indirect fetal injury, such as orthopedic abnormalities and respiratory problems. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Direct fetal injury'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Indirect fetal injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Temporary leakage of amniotic fluid occurs more frequently in pregnancies that undergo amniocentesis than among controls (1.7 versus 0.4 percent), but is generally associated with a normal pregnancy outcome. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Leakage of amniotic fluid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Maternal to fetal transmission of infection may occur in women with",
"      <span class=\"nowrap\">",
"       viremia/bacteremia",
"      </span>",
"      at the time of the procedure, but the risk is low. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Vertical transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When performing amniocentesis in a multiple gestation, we suggest insertion of a new needle for each amniotic cavity. The risk of amniocentesis-related loss in twin pregnancies is likely increased above the baseline risk of loss among twin gestations, but the exact risk is uncertain. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Multiple gestation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/1\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007; 110:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/2\">",
"      Gosden CM. Amniotic fluid cell types and culture. Br Med Bull 1983; 39:348.",
"     </a>",
"    </li>",
"    <li>",
"     www.acmg.net//AM/Template.cfm?Section=Home3. (Accessed October 28, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/4\">",
"      Giorlandino C, Cignini P, Cini M, et al. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial. Prenat Diagn 2009; 29:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/5\">",
"      Gramellini D, Fieni S, Casilla G, et al. Mid-trimester amniocentesis and antibiotic prophylaxis. Prenat Diagn 2007; 27:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/6\">",
"      Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/7\">",
"      Kappel B, Nielsen J, Brogaard Hansen K, et al. Spontaneous abortion following mid-trimester amniocentesis. Clinical significance of placental perforation and blood-stained amniotic fluid. Br J Obstet Gynaecol 1987; 94:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/8\">",
"      Bombard AT, Powers JF, Carter S, et al. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis. Am J Obstet Gynecol 1995; 172:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/9\">",
"      Andreasen E, Kristoffersen K. Incidence of spontaneous abortion after amniocentesis: influence of placental localization and past obstetric and gynecologic history. Am J Perinatol 1989; 6:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/10\">",
"      Reid KP, Gurrin LC, Dickinson JE, et al. Pregnancy loss rates following second trimester genetic amniocentesis. Aust N Z J Obstet Gynaecol 1999; 39:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/11\">",
"      Kalogiannidis I, Prapa S, Dagklis T, et al. Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis. Clin Exp Obstet Gynecol 2011; 38:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/12\">",
"      Crane JP, Kopta MM. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss. Am J Obstet Gynecol 1984; 150:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/13\">",
"      Giorlandino C, Mobili L, Bilancioni E, et al. Transplacental amniocentesis: is it really a higher-risk procedure? Prenat Diagn 1994; 14:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/14\">",
"      Kong CW, Leung TN, Leung TY, et al. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Prenat Diagn 2006; 26:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/15\">",
"      Marthin T, Liedgren S, Hammar M. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet Gynecol Scand 1997; 76:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/16\">",
"      Harris A, Monga M, Wicklund CA, et al. Clinical correlates of pain with amniocentesis. Am J Obstet Gynecol 2004; 191:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/17\">",
"      Van Schoubroeck D, Verhaeghe J. Does local anesthesia at mid-trimester amniocentesis decrease pain experience? A randomized trial in 220 patients. Ultrasound Obstet Gynecol 2000; 16:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/18\">",
"      Gordon MC, Ventura-Braswell A, Higby K, Ward JA. Does local anesthesia decrease pain perception in women undergoing amniocentesis? Am J Obstet Gynecol 2007; 196:55.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/19\">",
"      Mujezinovic F, Alfirevic Z. Analgesia for amniocentesis or chorionic villus sampling. Cochrane Database Syst Rev 2011; :CD008580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/20\">",
"      Athanasiadis AP, Pantazis K, Goulis DG, et al. Comparison between 20G and 22G needle for second trimester amniocentesis in terms of technical aspects and short-term complications. Prenat Diagn 2009; 29:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/21\">",
"      Seeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol 2004; 191:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/22\">",
"      Antsaklis A, Papantoniou N, Xygakis A, et al. Genetic amniocentesis in women 20-34 years old: associated risks. Prenat Diagn 2000; 20:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/23\">",
"      Calda P, Brestak M. Amniovacucentesis vs standard syringe technique for amniocentesis: experience with 1219 cases. Am J Obstet Gynecol 2009; 201:593.e1.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Prevention of D isoimmunization. ACOG Practice Bulletin #4, American College of Obstetricians and Gynecologists, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/25\">",
"      Hankins GD, Rowe J, Quirk JG Jr, et al. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis. Obstet Gynecol 1984; 64:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/26\">",
"      Zorn EM, Hanson FW, Greve LC, et al. Analysis of the significance of discolored amniotic fluid detected at midtrimester amniocentesis. Am J Obstet Gynecol 1986; 154:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/27\">",
"      Hess LW, Anderson RL, Golbus MS. Significance of opaque discolored amniotic fluid at second-trimester amniocentesis. Obstet Gynecol 1986; 67:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/28\">",
"      Odibo AO, Gray DL, Dicke JM, et al. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol 2008; 111:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/29\">",
"      Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA 1976; 236:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/30\">",
"      Isada NB, Koppitch FC 3rd, Johnson MP, Evans MI. Does the color of amniotic fluid still matter? Fetal Diagn Ther 1990; 5:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/31\">",
"      Golbus MS, Loughman WD, Epstein CJ, et al. Prenatal genetic diagnosis in 3000 amniocenteses. N Engl J Med 1979; 300:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/32\">",
"      Cassell GH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/33\">",
"      Gray DJ, Robinson HB, Malone J, Thomson RB Jr. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992; 12:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/34\">",
"      Perni SC, Vardhana S, Korneeva I, et al. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004; 191:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/35\">",
"      Nguyen DP, Gerber S, Hohlfeld P, et al. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004; 32:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/36\">",
"      Berg TG, Philpot KL, Welsh MS, et al. Ureaplasma/Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol 1999; 19:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/37\">",
"      Horowitz S, Mazor M, Romero R, et al. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995; 40:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/38\">",
"      Sant-Cassia LJ, MacPherson MB, Tyack AJ. Midtrimester amniocentesis: is it safe? A single centre controlled prospective study of 517 consecutive amniocenteses. Br J Obstet Gynaecol 1984; 91:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/39\">",
"      Tongsong T, Wanapirak C, Sirivatanapa P, et al. Amniocentesis-related fetal loss: a cohort study. Obstet Gynecol 1998; 92:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/40\">",
"      Farahani G, Goldman MA, Davis JG, et al. Use of the ultrasound aspiration transducer in midtrimester amniocentesis. J Reprod Med 1984; 29:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/41\">",
"      Mujezinovic F, Alfirevic Z. Technique modifications for reducing the risks from amniocentesis or chorionic villus sampling. Cochrane Database Syst Rev 2012; 8:CD008678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/42\">",
"      Gold RB, Goyert GL, Schwartz DB, et al. Conservative management of second-trimester post-amniocentesis fluid leakage. Obstet Gynecol 1989; 74:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/43\">",
"      Borgida AF, Mills AA, Feldman DM, et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol 2000; 183:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/44\">",
"      Devlieger R, Millar LK, Bryant-Greenwood G, et al. Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence. Am J Obstet Gynecol 2006; 195:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/45\">",
"      Simpson JL, Socol ML, Aladjem S, Elias S. Normal fetal growth despite persistent amniotic fluid leakage after genetic amniocentesis. Prenat Diagn 1981; 1:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/46\">",
"      Crane JP, Rohland BM. Clinical significance of persistent amniotic fluid leakage after genetic amniocentesis. Prenat Diagn 1986; 6:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/47\">",
"      Isenberg SJ, Heckenlively JR. Traumatized eye with retinal damage from amniocentesis. J Pediatr Ophthalmol Strabismus 1985; 22:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/48\">",
"      Admoni MM, BenEzra D. Ocular trauma following amniocentesis as the cause of leukocoria. J Pediatr Ophthalmol Strabismus 1988; 25:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/49\">",
"      Cederholm M, Haglund B, Axelsson O. Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG 2005; 112:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/50\">",
"      Vedantam R, Douglas DL. Congenital dislocation of the knee as a consequence of persistent amniotic fluid leakage. Br J Clin Pract 1994; 48:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/51\">",
"      Eiben B, Hammans W, Goebel R, Epplen JT. Safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998; 351:1435; author reply 1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/52\">",
"      Hislop A, Fairweather DV. Amniocentesis and lung growth: an animal experiment with clinical implications. Lancet 1982; 2:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/53\">",
"      Baird PA, Yee IM, Sadovnick AD. Population-based study of long-term outcomes after amniocentesis. Lancet 1994; 344:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/54\">",
"      Giorlandino C, Bilancioni E, D'Alessio P, Muzii L. Risk of iatrogenic fetal infection at prenatal diagnosis. Lancet 1994; 343:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/55\">",
"      Minola E, Maccabruni A, Pacati I, Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 33:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/56\">",
"      Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996; 175:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/57\">",
"      Cohen, J, Dussaix E, Bernard O. Transmission du virus de l'hepatite C de la mere a l'enfant: une etude de 44 enfants. Gastroenterol Clin Biol 1998; 22:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/58\">",
"      Somigliana E, Bucceri AM, Tibaldi C, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 2005; 193:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/59\">",
"      Mandelbrot L, Jasseron C, Ekoukou D, et al. Amniocentesis and mother-to-child human immunodeficiency virus transmission in the Agence Nationale de Recherches sur le SIDA et les H&eacute;patites Virales French Perinatal Cohort. Am J Obstet Gynecol 2009; 200:160.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/60\">",
"      Ko TM, Tseng LH, Chang MH, et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection. Arch Gynecol Obstet 1994; 255:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/61\">",
"      Alexander JM, Ramus R, Jackson G, et al. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999; 7:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/62\">",
"      Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 2001; 184:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/63\">",
"      Bui TH, Iselius L, Lindsten J. European collaborative study on prenatal diagnosis: mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cell cultures. Prenat Diagn 1984; 4 Spec No:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/64\">",
"      Hsu LY, Kaffe S, Jenkins EC, et al. Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies. Prenat Diagn 1992; 12:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/65\">",
"      Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006; 108:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/66\">",
"      Mazza V, Pati M, Bertucci E, et al. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases. Prenat Diagn 2007; 27:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/67\">",
"      Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/68\">",
"      Halliday JL, Lumley J, Sheffield LJ, et al. Importance of complete follow-up of spontaneous fetal loss after amniocentesis and chorion villus sampling. Lancet 1992; 340:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/69\">",
"      Welch RA, Salem-Elgharib S, Wiktor AE, et al. Operator experience and sample quality in genetic amniocentesis. Am J Obstet Gynecol 2006; 194:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/70\">",
"      Hockstein S, Chen PX, Thangavelu M, Pergament E. Factors associated with maternal cell contamination in amniocentesis samples as evaluated by fluorescent in situ hybridization. Obstet Gynecol 1998; 92:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/71\">",
"      Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/72\">",
"      Harper LM, Cahill AG, Smith K, et al. Effect of maternal obesity on the risk of fetal loss after amniocentesis and chorionic villus sampling. Obstet Gynecol 2012; 119:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/73\">",
"      Mackenzie WE, Holmes DS, Newton JR. Spontaneous abortion rate in ultrasonographically viable pregnancies. Obstet Gynecol 1988; 71:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/74\">",
"      Risch HA, Weiss NS, Clarke EA, Miller AB. Risk factors for spontaneous abortion and its recurrence. Am J Epidemiol 1988; 128:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/75\">",
"      Cohen-Overbeek TE, Hop WC, den Ouden M, et al. Spontaneous abortion rate and advanced maternal age: consequences for prenatal diagnosis. Lancet 1990; 336:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/76\">",
"      Lindgren P, Cederholm M, Haglund B, Axelsson O. Invasive procedures for fetal karyotyping: no cause of subsequent gestational hypertension or pre-eclampsia. BJOG 2010; 117:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/77\">",
"      Mazza V, Pati M, Bertucci E, et al. Second trimester amniocentesis is not a risk factor for very low birth weight and extremely low birth weight. ISRN Obstet Gynecol 2011; 2011:313206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/78\">",
"      Cederholm M, Haglund B, Axelsson O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG 2003; 110:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/79\">",
"      Hodor JG, Poggi SH, Spong CY, et al. Risk of third-trimester amniocentesis: a case-control study. Am J Perinatol 2006; 23:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/80\">",
"      Yeast JD, Garite TJ, Dorchester W. The risks of amniocentesis in the management of premature rupture of the membranes. Am J Obstet Gynecol 1984; 149:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/81\">",
"      Haeusler MC, Konstantiniuk P, Dorfer M, Weiss PA. Amniotic fluid insulin testing in gestational diabetes: safety and acceptance of amniocentesis. Am J Obstet Gynecol 1998; 179:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/82\">",
"      Stark CM, Smith RS, Lagrandeur RM, et al. Need for urgent delivery after third-trimester amniocentesis. Obstet Gynecol 2000; 95:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/83\">",
"      Gordon MC, Narula K, O'Shaughnessy R, Barth WH Jr. Complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 2002; 99:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/84\">",
"      Gabbay R, Yogev Y, Melamed N, et al. Pregnancy outcome after third trimester amniocentesis: a single center experience. J Matern Fetal Neonatal Med 2012; 25:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/85\">",
"      Simonazzi G, Curti A, Farina A, et al. Amniocentesis and chorionic villus sampling in twin gestations: which is the best sampling technique? Am J Obstet Gynecol 2010; 202:365.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/86\">",
"      Weisz B, Rodeck CH. Invasive diagnostic procedures in twin pregnancies. Prenat Diagn 2005; 25:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/87\">",
"      Rustico MA, Baietti MG, Coviello D, et al. Managing twins discordant for fetal anomaly. Prenat Diagn 2005; 25:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/88\">",
"      Jeanty P, Shah D, Roussis P. Single-needle insertion in twin amniocentesis. J Ultrasound Med 1990; 9:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/89\">",
"      van Vugt JM, Nieuwint A, van Geijn HP. Single-needle insertion: an alternative technique for early second-trimester genetic twin amniocentesis. Fetal Diagn Ther 1995; 10:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/90\">",
"      Buscaglia M, Ghisoni L, Bellotti M, et al. Genetic amniocentesis in biamniotic twin pregnancies by a single transabdominal insertion of the needle. Prenat Diagn 1995; 15:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/91\">",
"      Sebire NJ, Noble PL, Odibo A, et al. Single uterine entry for genetic amniocentesis in twin pregnancies. Ultrasound Obstet Gynecol 1996; 7:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/92\">",
"      Vink J, Fuchs K, D'Alton ME. Amniocentesis in twin pregnancies: a systematic review of the literature. Prenat Diagn 2012; 32:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/93\">",
"      Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: a systematic review. Ultrasound Obstet Gynecol 2012; 40:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/94\">",
"      Antsaklis A, Souka AP, Daskalakis G, et al. Second-trimester amniocentesis vs. chorionic villus sampling for prenatal diagnosis in multiple gestations. Ultrasound Obstet Gynecol 2002; 20:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/11/16570/abstract/95\">",
"      Wapner RJ, Johnson A, Davis G, et al. Prenatal diagnosis in twin gestations: a comparison between second-trimester amniocentesis and first-trimester chorionic villus sampling. Obstet Gynecol 1993; 82:49.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5390 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-9EF4B3CCD6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16570=[""].join("\n");
var outline_f16_11_16570=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1497450\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      COUNSELING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TECHNICAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prenatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1497062\">",
"      - Fluorescence in situ hybridization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1497125\">",
"      - Evaluation of fetal demise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fetal lung maturity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Site selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1497744\">",
"      Site preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1497759\">",
"      Local anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Needle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Needle insertion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dry tap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Withdrawing and handling the sample",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Post-procedural care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DISCOLORED SAMPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COMPLICATIONS AND ADVERSE OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Leakage of amniotic fluid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Direct fetal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Indirect fetal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Vertical transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1497852\">",
"      Innoculation by bowel flora",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cell culture failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14974658\">",
"      Mosaicism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Fetal loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1497992\">",
"      - Limitations of available data",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29289167\">",
"      Obstetrical complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Third trimester amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      MULTIPLE GESTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Genetic amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Multineedle technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Single needle technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Loss rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Amniocentesis for lung indices or signs of infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5390\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5390|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/49/22290\" title=\"diagnostic image 1\">",
"      Ultrasound guided amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5390|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/11/36030\" title=\"figure 1\">",
"      Normal amniotic fluid volume",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5390|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/35/43568\" title=\"picture 1\">",
"      Discolored amniotic fluid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5390|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/40/41611\" title=\"table 1\">",
"      Miscarriage rate after amnio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/37/18011\" title=\"table 2\">",
"      Stillbirth rate after amnio",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42919?source=related_link\">",
"      Assessment of fetal lung maturity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28169?source=related_link\">",
"      Chorionic villus sampling: Risks, complications, and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/35/1591?source=related_link\">",
"      Diagnosis and management of stillbirth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=related_link\">",
"      Fetal blood sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42761?source=related_link\">",
"      Intraamniotic infection (chorioamnionitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9913?source=related_link\">",
"      Management of twin-twin transfusion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27353?source=related_link\">",
"      Midtrimester preterm premature rupture of membranes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/28/14785?source=related_link\">",
"      Patient information: Amniocentesis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/57/42897?source=related_link\">",
"      Patient information: Amniocentesis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/44/4808?source=related_link\">",
"      Polyhydramnios",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22777?source=related_link\">",
"      Pregnancy in women with pre-existing chronic liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1448?source=related_link\">",
"      Prenatal diagnosis using cell-free fetal nucleic acids in maternal blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40648?source=related_link\">",
"      Prevention of Rh(D) alloimmunization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=related_link\">",
"      Sonographic findings associated with fetal aneuploidy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/11/5306?source=related_link\">",
"      Twin pregnancy: Labor and delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=related_link\">",
"      Use of array comparative genomic hybridization (aCGH) in obstetrics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_11_16571="Narcotics PI";
var content_f16_11_16571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F85592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F85592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of common narcotic pain medicines",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Generic name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sample brand names",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oxycodone",
"       </td>",
"       <td>",
"        OxyContin&reg;, Roxicodone&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fentanyl",
"       </td>",
"       <td>",
"        Duragesic&reg;, Actiq&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrocodone",
"       </td>",
"       <td>",
"        <p>",
"         Vicodin&reg; (with acetaminophen)",
"        </p>",
"        Vicoprofen&reg; (with ibuprofen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methadone",
"       </td>",
"       <td>",
"        Methadose&reg;, Dolophine&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Morphine",
"       </td>",
"       <td>",
"        MS Contin&reg;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Codeine",
"       </td>",
"       <td>",
"        Tylenol&reg; with codeine no. 3 (with acetaminophen)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    To find out more about the specific narcotic medicine you take, ask your doctor or nurse for the Lexicomp patient information handout for that medicine. Lexicomp drug information handouts are available through UpToDate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16571=[""].join("\n");
var outline_f16_11_16571=null;
var title_f16_11_16572="Contraindications to exercise treadmill testing";
var content_f16_11_16572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Absolute and relative contraindications to exercise treadmill testing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Absolute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute myocardial infarction (within two days)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unstable angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptomatic severe aortic stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uncontrolled symptomatic heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute pulmonary embolus or pulmonary infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute myocarditis or pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Active endocarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute aortic dissection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute noncardiac disorder that may affect exercise performance or be aggravated by exercise (eg, infection, renal failure, thyrotoxicosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inability to obtain consent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Relative*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Left main coronary stenosis or its equivalent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate stenotic valvular heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrolyte abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe hypertension (systolic &ge;200 mmHg and/or diastolic &ge;110 mmHg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tachyarrhythmias or bradyarrhythmias, including atrial fibrillation with uncontrolled ventricular rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypertrophic cardiomyopathy and other forms of outflow tract obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mental or physical impairment leading to inability to cooperate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High-degree atrioventricular block",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Relative contraindications can be superseded if benefits outweigh risks of exercise.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104:1694; and Gibbons, RJ, Balady, GJ, Bricker, JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106:1883.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16572=[""].join("\n");
var outline_f16_11_16572=null;
var title_f16_11_16573="Diagnostic eval wheezing";
var content_f16_11_16573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Approach to evaluation of wheezing in children based upon suspected diagnosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Suspected diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Signs and symptoms",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnostic evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Acute",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asthma",
"       </td>",
"       <td>",
"        History of recurrent wheeze, cough, at least partial response to bronchodilator",
"       </td>",
"       <td>",
"        History, PFT with bronchodilators, empiric trial of bronchodilators, exercise or methacholine challenge testing, chest radiography only if atypical, skin (or",
"        <em>",
"         in vitro",
"        </em>",
"        ) testing for aeroallergen sensitization if history suggests inhalant allergen triggers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Viral bronchiolitis",
"       </td>",
"       <td>",
"        Prodrome with rhinitis, occurs in infancy and early childhood, seasonal pattern",
"       </td>",
"       <td>",
"        History, age, season, rapid antigen testing (RSV, influenza), viral cultures, chest radiography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Foreign body",
"       </td>",
"       <td>",
"        Sudden onset of coughing and wheezing",
"       </td>",
"       <td>",
"        History, physical examination, chest radiography, bronchoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Chronic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Asthma",
"       </td>",
"       <td>",
"        As above",
"       </td>",
"       <td>",
"        As above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tracheomalacia",
"       </td>",
"       <td>",
"        Persistent wheeze, starts early in life, poor response to bronchodilators, varies with position and activity",
"       </td>",
"       <td>",
"        History, fluoroscopy, flexible bronchoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cystic fibrosis",
"       </td>",
"       <td>",
"        Chronic productive cough, crackles, with or without clubbing, failure to thrive, recurrent respiratory infections",
"       </td>",
"       <td>",
"        Sweat chloride test, genetic testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Swallowing dysfunction",
"       </td>",
"       <td>",
"        Neurological abnormality (non universal), choking with eating, symptoms exaggerated by feeding",
"       </td>",
"       <td>",
"        Radiographic swallowing study",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gastroesophageal reflux",
"       </td>",
"       <td>",
"        Symptoms sometimes related to eating, vomiting, refusal to eat, failure to thrive",
"       </td>",
"       <td>",
"        Barium swallow, pH probe, bronchoscopy and bronchoalveolar lavage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vascular ring or sling",
"       </td>",
"       <td>",
"        Persistent symptoms, starts early in infancy, may be exaggerated by position, homophonous wheeze",
"       </td>",
"       <td>",
"        Barium swallow, MRI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tracheal stenosis",
"       </td>",
"       <td>",
"        Persistent symptoms, with or without stridor, homophonous wheeze",
"       </td>",
"       <td>",
"        Chest radiograph, CT scan, bronchoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mediastinal nodes or mass",
"       </td>",
"       <td>",
"        Persistent symptoms, localized wheezing, no response to bronchodilator, systemic symptoms of underlying disease",
"       </td>",
"       <td>",
"        Chest radiograph, CT scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Immunodeficiency",
"       </td>",
"       <td>",
"        Recurrent sinopulmonary infections, crackles, FTT, clubbing",
"       </td>",
"       <td>",
"        Immunoglobulins, humoral immunity panel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Primary ciliary dyskinesia",
"       </td>",
"       <td>",
"        Persistent sinusitis and otitis media with draining ears, recurrent respiratory infection, wet cough with sputum production, crackles, clubbing, FTT",
"       </td>",
"       <td>",
"        Ciliary biopsy, with or without genetic testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vocal cord dysfunction",
"       </td>",
"       <td>",
"        Inspiratory stridor, poor response to bronchodilators, absent symptoms during sleep, teenage, exercise related",
"       </td>",
"       <td>",
"        Exercise testing, pulmonary function tests, laryngoscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bronchiolitis obliterans",
"       </td>",
"       <td>",
"        History of predisposing disease, ie, viral infection or transplantation, dyspnea, persistent wheezing",
"       </td>",
"       <td>",
"        Chest CT scan, lung biopsy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Dorkin HL. Noisy breathing. In: Respiratory Disease in Children: Diagnosis and Management, Loughlin GM, Eigen H (Eds), Williams and Wilkins 1994. p.171.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16573=[""].join("\n");
var outline_f16_11_16573=null;
var title_f16_11_16574="High frequency vent modes";
var content_f16_11_16574=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54248&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Modes of high frequency ventilation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 312px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Modes of high frequency ventilation. With high frequency positive pressure ventilation (top), high-pressure conditioned gas (a) is delivered during inhalation and flows predominantly through an endotracheal tube (b) to the patient with partial escape to the atmosphere. During exhalation, the gas exits through an optional one-way valve (c). With high frequency jet ventilation (middle), conditioned high-pressure gas enters from a cannula (a) at a selected level along the endotracheal tube or trachea (c). This gas entrains additional conditioned gas (b) by the Venturi effect. During exhalation the gas exits passively through an optional one-way valve (d). With high frequency oscillation (bottom), the piston or diaphragm (a) oscillates while fresh conditioned gas (bias flow) enters (b) and exhaust gas exits (c) at a balanced constant rate. The bias flow ports can be positioned anywhere along the path from the external tip of the endotracheal tube to within the trachea itself.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16574=[""].join("\n");
var outline_f16_11_16574=null;
var title_f16_11_16575="Treatment of fever and neutropenia";
var content_f16_11_16575=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F81789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F81789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 484px\">",
"   <div class=\"ttl\">",
"    Management of febrile neutropenic patients with unknown etiology of neutropenia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 464px; height: 561px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TPR: temperature, pulse, respiration; BP: blood pressure; Wt: weight; CBC: complete blood count; ANC: absolute neutrophil count; VS: vital signs.",
"     <br>",
"      * See topic for antibiotic regimens.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_11_16575=[""].join("\n");
var outline_f16_11_16575=null;
            